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Abstract
Mathematical models are widely used for understanding the transmission mechanisms
and control of infectious diseases. Numerous infectious diseases such as those caused
by bacterial and viral infections do not confer life long immunity after recovering
from the first episode. Consequently, they are characterized by partial or complete
loss of immunity and subsequent reinfection. This thesis explores the epidemiological
implications of loss of immunity using simple and complex mathematical models. First,
a simple basic model mimicking transmission mechanisms of tuberculosis (TB) is
proposed with the aim of correcting problems that are often repeated by mathematical
modellers when determining underlying bifurcation structures. Specifically, the model
makes transparent the problems that may arise if one aggregates all the bifurcation
parameters when computing backward bifurcation thresholds and structures. The
backward bifurcation phenomenon is an important concept for public health and disease
management. This is because backward bifurcation signals that disease will not be
eliminated even when the basic reproduction number R0 is decreased below unity;
rather, for the disease to be eliminated, R0 has to be reduced below another critical
threshold. I provide conditions to find the threshold correctly.
Secondly, the simple basic TB model is extended to incorporate epidemiological and
biological aspects pertinent to TB transmission such as recurrent TB, which is defined
as a second episode of TB following successful recovery from a previous episode. I
study the conditions for backward bifurcation in this extended model that features
recurrent TB. Mathematical techniques based on the center manifold approach, are
used to derive an exact backward bifurcation threshold. Furthermore, both analytical
and numerical findings reveal that recurrent TB is capable of inducing a new and rare
hysteresis effect where TB will persist when the basic reproduction number is below
unity even though there is no backward bifurcation. Moreover, when the reinfection
pathway among latently infected individuals is switched off, leaving only recurrent TB,
the model analysis indicates that recurrent TB can independently induce a backward
vbifurcation. However, this will only occur if recurrent TB transmission exceeds a
certain threshold. Although this threshold seems to be relatively high when realistic
parameters are used, it falls within the recent range estimated in the relevant literature.
The second TB model is extended by dividing the latent compartment into two: fast
(early latent) and slow (late latent) latent compartments, to enhance realism. Individu-
als in both early and late compartments are subjected to treatment. The proposed TB
model is used to investigate how heterogeneity in host susceptibility influences the effec-
tiveness of treatment. It is found that making the assumption that individuals treated
with preventive therapy and recovered individuals (previously treated for active TB)
acquire equal levels of protection after initial infection, and are therefore reinfected at
the same rate, may obscure dynamics that are imperative when designing intervention
strategies. Comparison of reinfection rates between cohorts treated with preventive
therapy and recovered individuals who were previously treated from active TB provides
important epidemiological insights. That is, the reinfection parameter accounting for
the relative rate of reinfection of the cohort treated with preventive therapy is the one
that plays the key role in generating qualitative changes in TB dynamics. In contrast,
the parameter accounting for the risk of reinfection among recovered individuals (pre-
viously treated for active TB) does not play a significant role. The study shows that
preventive treatment during early latency is always beneficial regardless of the level of
susceptibility to reinfection. And if patients have greater immunity following treatment
for late latent infection, then treatment is again beneficial. However, if susceptibility
increases following treatment for late latent infection, the effect of treatment depends
on the epidemiological setting: (a) for (very) low burden settings, the effect on reacti-
vation predominates and burden declines; (b) for high burden settings, the effect on
reinfection predominates and burden increases. This is mostly observed between the
two reinfection thresholds, RT2 and RT1, respectively associated with individuals being
treated with preventive therapy and individuals with untreated late latent TB infection.
Finally, a mathematical model that examines how heroin addiction spreads in society
is formulated. The model has many commonalities with the TB model. The global
stability properties of the proposed model are analysed using both the Lyapunov
direct method and the geometric approach by Li and Muldowney. It is shown that
even for a four dimensional model, the use of two well known nonlinear stability
techniques becomes nontrivial. When all the parameters of the model are accounted
vi
for, it is difficult if not impossible, to design a Lyapunov function. Here I apply
the geometric approach to establish a global condition that accounts for all model
parameters. If the condition is satisfied, then heroin persistence within the community
is globally stable. However, if the global condition is not satisfied heroin users can
oscillate periodically in number. Numerical simulations are also presented to give a
more complete representation of the model dynamics. Sensitivity analysis performed
by Latin hypercube sampling (LHS) suggests that the effective contact rate in the
population, the relapse rate of heroin users undergoing treatment, and the extent of
saturation of heroin users, are the key mechanisms fuelling heroin epidemic proliferation.
However, in the long term, relapse of heroin users undergoing treatment back to a
heroin using career, has the most significant impact.
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Chapter 1
Introduction
1.1 Background on epidemics
The conceptualization of the existence of invisible creatures capable of transmitting
disease can be traced back at least to the writings of Aristotle (384 BC-322 BC). This
idea was further developed as a theory in the 16th century [2]. With the help of the
first microscope, Leeumenhoek (1632-1723) confirmed the existence of microorganisms
and this led to the inception of the germ theory of disease by Jacob Henle (1809-1885)
in 1840. In the nineteenth and the early part of the twentieth century the germ
theory was later developed by Robert Koch (1843-1910), Joseph Lister (1827-1912)
and Louis Pasteur (1827-1875). In the 21st century, the transmission mechanisms of
many diseases is now well known, as is the operation of the human immune system.
For example, diseases whose aetiological agent is a virus, such as influenza, measles,
rubella (German measles) and chicken pox, are known to render immunity against
reinfection. In contrast, diseases spread by bacteria such as tuberculosis, meningitis
and gonorrhea render no immunity against reinfection [2].
A disease in a particular place and host population may either be categorized as
epidemic or endemic. Loosely speaking, an epidemic might be described as an abrupt
occurrence of a disease which infects an often substantial proportion of a population,
possibly causing many deaths over a short period of time before vanishing. Endemic
refers to diseases that persist within the population for a sustained and possibly
indefinite period of time, usually only infecting a relatively small proportion of the pop-
ulation [3]. Moreover, when an epidemic occurs on a scale which crosses international
boundaries, usually affecting a large number of people it is referred to as a pandemic
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[4]. Pandemics are a common phenomenon in human history [3]. For instance, in the
14th century (beginning in 1346-1350) the Black Death (bubonic plague) spread from
Asia throughout Europe causing the death of about one third of the population of
Europe [5]. The disease remained chronic (endemic) for a period of about 300 years
(for instance the great plague of London (1656-1666)), but then gradually disappeared
from Europe. Over three hundred million people died from small pox in the 19th
century [6]. Another devastating pandemic was the 1918 influenza pandemic (Spanish
Flu) which globally affected one third of the human population and resulted in the
death of some 20 to 100 million people [6].
Epidemics continue to emerge and invade. For example, the human immuno-deficiency
virus (HIV) which came to be known in 1980 as the causative agent of AIDS (Acquired
Immuno-Deficiency virus) has killed approximately 25 million people globally and
approximately 33 million people are currently living with HIV/AIDS [7]. Annually,
malaria infects about three hundred million people and kills approximately two million
people [8]. Infections such as cholera, hemorrhagic fevers and plague occasionally recur
in some regions, while others (such as malaria, HIV/AIDS, mycobacterium tuberculo-
sis, typhus, cholera, schistosomiasis, etc.) have become endemic in various locations
worldwide.
There has been tremendous improvement and innovation in medical science over the
late 20th and 21st century, but nonetheless infectious diseases continue to be a major
contribution of high morbidity and mortality in human populations, especially in devel-
oping countries. Recent studies conducted in sub-Saharan Africa show that infectious
diseases are responsible for more than half of human deaths [9]. Consequently, infectious
diseases impose heavy public health and sociol-economic burdens on populations that
are least able to bear them [9]. It is imperative to note that the infectious disease
hazards go beyond human populations and affect domestic animals, wildlife and plant
populations. A number of factors such as complex ecology, fast evolution in response
to changing circumstances, and emergence of new pathogens ensure that infectious
diseases will continue to pose serious challenges for the foreseable future [10]. Often
public health officials ask particular questions when there is an outbreak within a given
community [5]:
(i) How many people will be infected?
1.1 Background on epidemics 3
(ii) How many people require treatment?
(iii) For how long will the epidemic persist in the community?
(iv) Does infection confer immunity against a second episode?
(v) What is the appropriate intervention strategy (such as use of treatment, vaccina-
tion or quarantine) to minimise the impact of the epidemic?
Mathematical modelling acts as an invaluable tool in attempting to find answers to
these questions. Historical time-series of epidemic outbreaks illustrate that infectious
diseases can exhibit complex dynamics typical of non-linear systems. Mathematical
models allow rigorous analysis of such complex dynamics, including:
(a) Prediction of epidemiological threshold phenomena (such as the basic reproduction
number) and expected disease burden (morbidity, mortality, attack rate);
(b) Assessment and comparison of different prophylaxis (preventive) and therapeutic
measures;
(c) Formulation and validation of theories, qualitatively determining sensitivities to
changes in parameter values;
(d) Provision of insight on how an infectious disease spreads in the real world and how
various complexities impact the dynamics;
(e) Identification of overall trends of an epidemic and making general forecasts.
1.1.1 Birth of mathematical epidemiology
The application of mathematical modelling in tracking transmission dynamics of in-
fectious diseases was in use as early as the eighteenth century. An example is the
pioneering work by Daniel Bernoulli on smallpox (1760) in which he developed a
mathematical model to assess the impact of variolation against smallpox, thereby
increasing individual life expectancy. His work incorporated the concept of differential
mortality to enable him to approximate the rate of deaths attributable to a certain
disease. Furthermore, his idea of differential mortality has been used to approximate
disease death rates of past epidemics [2], for example, the influenza pandemic which
occurred in 1918.
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In the late nineteenth and twentieth centuries, both public-health physicians and
biologists laid the foundations of mathematical epidemiology. Such persons include P.D.
En’ko [11], W. H. Hamer [12], J. Brownlee [13], Sir R. A Ross [14], A. G. McKendrick
and W.O Kermack [15, 16, 17]. After Bernoulli’s smallpox model, various mathematical
models began to emerge. In 1906 Ronald Ross discovered that mosquitoes were the
agents responsible for spreading malaria from human to human. He then developed
a model to describe the spread of malaria [14]. From the model he deduced that by
reducing the mosquito population in a region, malaria can be effectively controlled. His
malaria model was the first example that clearly demonstrated the epidemic threshold
concept, which became fundamental in epidemiology theory ever since [2]. Two decades
later, Kermack and McKendrick developed the theory further and demonstrated that
if the density of suceptible individuals exceeds a critical threshold then an epidemic
is likely to occur, but below the critical threshold an epidemic cannot be triggered
[15]. This theory, together with the principle of mass action, formed the cornerstone of
modern mathematical biology.
The so-called “SIR model” equations used by Kermack and McKendrick to describe
the transmission mechanisms of bubonic plague may be written down as [15]
dS
dt
= −βSI
N
,
dI
dt
= βSI
N
− αI, (1.1)
dR
dt
= αI.
Here the total population, denoted by N(t), is classified into three mutually-exclusive
disease states, with S(t) representing the susceptible population, I(t) the infected
and R(t) the recovered or removed population. Hence, N(t) = S(t) + I(t) + R(t).
The parameter β is the transmission coefficient (effective contact rate) and α is the
per-capita rate of recovery (or removal) for infected individuals. The interaction of
two individuals, one susceptible (S) and another infected (I) may result in susceptible
individuals becoming infected. Individuals infected are removed from the infectious
state at recovery rate α. The behaviour of model equation (1.1) is entirely determined
by its initial conditions and the deterministic rules which describe the development of
the model; hence it is considered deterministic.
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The SIR model equations (1.1) have been extended to incorporate important and
realistic epidemiological and biological features such as loss of immunity, or extended
to consider latent or exposed individuals who are not yet infectious and do not manifest
disease symptoms. Such possibilities cannot be described by simple SIR models. Models
then typically take the form of SIR, SIS, SIRS, SEIR , SEIRS, SEIRE or SEIRI where
the notation E represents the population of individuals who have been exposed to
infection and are not yet infectious. Note that non-italic symbols are used to define
each infectious state while italic symbols are used to count the number of individuals
in each state. Variables for compartment labels are italicized.
1.2 Disease incidence functions
In epidemic models incidence functions describe the rate at which new infections are
generated. A general method for formulating infection incidence functions is described
in [18]. Hence, following [18], let β(N) represent the mean number of effective contacts
per person per unit time. Now the force of infection λ = β(N)I/N is the mean
number of effective contacts between infectious and susceptible individuals per unit
time. Hence, new cases of infectives are generated at a rate proportional to λS. For
a constant β(N) (that is β(N) = β), λS is termed a frequency-dependent incidence
function. The frequency-dependent incidence function reflects a situation where the
number of contacts is independent of the size of the population [18, 19].
Moreover, if β(N) is a function of the total population size (e.g., β(N) = βN)
then λS is referred to as a density-dependent incidence function [20]. The density-
dependent incidence function assumes that “as the size of the population increases
so does the contact rate” [19]. Both frequency-dependent and density-dependent
incidence functions are widely used in the modelling of infectious diseases [18, 21]. The
preference of which incidence function to use is largely determined by the disease being
modelled, although in some cases (as it will be seen) the choice has been dictated by
mathematical tractability. In the literature some studies have pointed out that the
frequency-dependent incidence formulation is more appropriate for human infections
[22, 23].
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1.3 Reproduction number and common bifurcation
structures
The basic reproduction number, sometimes referred to as the reproduction ratio R0,
is one of the most celebrated quantities in the literature pertaining to mathematical
epidemiology. The definition of R0 is the average number of new infections that a
typical infected individual gives rise to over the lifetime of the infection when introduced
into a wholly susceptible population [24, 25]. Although the R0 concept was formalized
much earlier in the context of demographic theory, and despite numerous opportunities
to cross over to other disciplines such as ecology and epidemiology [26], it was not until
1980 that it fully developed and its applicability was realized in theoretical epidemiology
(see [25, 27]).
1.3.1 Forward bifurcation
The reproduction number is a fundamental epidemiological quantity since it determines
whether an infection will be able on average to reproduce itself (R0 > 1) in the
population and spread, or not (R0 < 1) and so die out. Characteristically, when R0 is
below unity, the introduction of a few infected individuals in a susceptible population
will only lead to disease die-out as the infection is unable to reproduce itself or transmit
through the population effectively. Conversely, when R0 is above unity an epidemic
may occur and long-term disease persistence is feasible. Classical epidemic models
are therefore usually found to have two intrinsic equilibria: a disease free equilibrium
(DFE); and a non-trivial endemic equilibrium point (EEP). By endemic is meant
an equilibrium in which the number of infectives is greater than zero. The stability
of these equilibria switch at the (transcritical) bifurcation point which occurs when
R0 = 1. Thus, the point R0 = 1 defines an important threshold for understanding the
transmission dynamics of infectious diseases. Figure 1.1 illustrates the more typical
forward bifurcation by plotting the force of infection at equilibrium λ∗ = βI∗/N in a
population as a function of R0. (Here the star notation refers to equilibrium values.)
The figure shows that a stable DFE in which λ∗ = 0 exists when R0 < 1. However,
when crossing the threshold to a regime where R0 > 1, there is a change of stability
where the DFE becomes unstable and the endemic equilibrium point stabilizes.
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Figure 1.1: Qualitative illustration of forward bifurcation at the point R0 = 1, where
the vertical axis represents the equilibrium force of infection λ∗ = βI∗/N.
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1.3.2 Backward bifurcation phenomena
For decades, it has been widely accepted that the condition R0 < 1 is an essential
requirement for the elimination of a disease. However, this viewpoint has been recently
challenged with a number of theoretical studies demonstrating that the criterion may
not always be sufficient. Instead, the phenomenon of backward bifurcation offers a
different interpretation since it shows that although R0 < 1 and the DFE is stable,
there might still be another stable endemic equilibrium coexisting simultaneously. Thus,
even though R0 < 1, a population may still be at an endemic equilibrium in which
the disease persists indefinitely. When there are multiple stable equilibria coexisting
simultaneously, the final equilibrium a population will reach depends on the initial
conditions (in terms of numbers of individuals) of its sub-populations. Figure 1.2
provides a typical bifurcation diagram that shows the key features of a backward bifur-
cation. Note that three equilibria coexist when R0 is in the range 0 < Rc < R0 < 1,
where Rc is a critical value, which in Figure 1.2 is Rc = 0.83. In this range, the
“middle” equilibrium is unstable, while the other two outer equilibria (the DFE and the
endemic equilibrium) are both stable. When R0 < Rc, only the DFE exists and is stable.
Multiple coexisting equilibria can lead to interesting dynamics when, for example, R0
varies slowly as can be understood from examining Figure 1.2. Suppose, for example,
that the infected population is close to extinction (I∗ = 0) (i.e., close to the DFE)
and R0 increases slowly. As soon as R0 passes through the threshold point R0 = 1
the number of infectives will jump from close to I∗ = 0 (λ = 0) to the large positive
endemic equilibrium I∗ > 0 (λ > 0), as indicated by the arrow in Figure 1(b). Similarly,
when the infective population sits close to the endemic equilibrium and R0 reduces
slowly through the threshold point R0 = 1, rather than switching to the DFE, the
infectives remain close and converge to the stable endemic equilibrium. When R0 falls
below the threshold Rc, the infective population jumps towards zero (the DFE), while
the endemic equilibrium disappears. These jumps are a well known phenomenon in
nonlinear dynamical systems where hysteresis effects can arise. Hysteresis refers to a
scenario where multiple endemic equilibria coexist when R0 > 1.
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Figure 1.2: Qualitative illustration of backward bifurcation at the point R0 = 1, where
the vertical axis represents the equilibrium force of infection λ∗ = βI∗/N .
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1.3.3 A review on backward bifurcation phenomena
The epidemiological importance of backward bifurcation phenomena in public health
management triggered a renewed interest amongst the mathematical modelling commu-
nity [28]. In terms of epidemiological models, the phenomenon was first observed in an
HIV model that segregated the sexually active population into n mixing cohorts with dif-
ferential risk levels of infection [29]. However, the backward bifurcation phenomena has
since been discovered in many other disease contexts and has been associated with im-
plementation of intervention strategies that are imperfect [30, 31], behavioral responses
[29, 30, 31], epidemic models accounting for immunological factors [32, 33], cohort-
structured models for fatal diseases [34, 35], incomplete immunity [30, 36, 37, 38, 39, 40],
models with non-constant contact rates [41], vaccination [42, 43, 44, 45], infection-age
structuring [43], vertical transmission and non-linear incidence [46], inadaquate treat-
ment resources [47, 48, 49, 50] and in standard incidence versus mass action contact
models [51]. Numerous infectious diseases studied at the population and imunnological
level have been shown to be capable of exhibiting backward bifurcation phenomena.
Pathogens include HIV as demonstrated in [51, 52, 53, 54], bovine respiratory syn-
cytial virus amongst cattle [36, 55], TB [52, 56, 57, 58, 59, 60, 61, 62], HTLV-1 [46],
dengue [51, 63], syphilis [64], West Nile virus [65, 66], hepatitis B and C [67, 68], H5N1
influenza [69], H1N1 influenza [70], malaria [35, 69, 71, 72, 73], Toxoplasma gondii [33]
and echinococcus [74]. Backward bifurcation also occurs in epidemic models of drug
abuse [75, 76].
1.3.4 Definition of reinfection TB, recurrent TB and endoge-
nous reactivation
Reinfection TB (or exogenous reinfection) refers to a TB episode that results after being
reinfected with a new TB strain from another infectious individual [56, 77]. Recurrent
TB is defined as the emergence of a second episode of TB after the first episode has
been successfully cured. It is important to note that there are two mechanisms by
which recurrent TB can occur: (i) relapse with the previously responsible strain or (ii)
exogenous reinfection from a new exposure [78, 79, 80, 81]. Note that reinfection of
those who have latent state TB is not considered recurrent TB.
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The difference between the two terminologies is that for reinfection TB one does not
need to have recovered from the first episode while in the second case, for TB to be
referred as recurrent TB, a person must have been successfully cured from the first
episode of TB. Endogenous reactivation is defined as the reactivation of a preexisting
dormant infection [82, 83]. Within the context of TB, endogenous reactivation occurs
among latently infected individuals [56].
1.4 Objective, motivation and outline of the thesis
This thesis concerns mathematical models of infectious diseases especially those in
which the phenomenon of immunity and loss of immunity arises. Many diseases are
characterized by this behaviour including, for example, tuberculosis, influenza, chicken
pox, and some sexually transmitted diseases. But also cultural phenomena, such as
drug addiction, provide classic examples of this behaviour. In this thesis it is found
that for nonlinear mathematical models, loss of immunity introduces different types
of unusual dynamical behaviours. A key goal is to understand how loss of immunity
generates backward bifurcations and other complex bi-stability phenomena. This thesis
revolves around five main research questions:
(i) How do backward bifurcations arise in epidemic models, and how can one deter-
mine analytic thresholds for backward bifurcations?
(ii) How are backward bifurcation phenomena in models of tuberculosis impacted
by loss of immunity and subsequent reinfection among recovered individuals,
especially in light of recent new empirical evidence that loss of immunity and sub-
sequent reinfection is quite high (approximately four times higher in comparison
to rates of new TB [84])?
(iii) How does variability in risk of reinfection alter TB dynamics in a model accounting
for heterogeneity in host susceptibility?
(iv) How does variability in risk of reinfection influence the effectiveness of treatment?
(v) How can one establish global stability properties of models that have complex
non-linear treatment rates?
The first research question addresses two main problems that have been noted in the
current mathematical literature regarding backward bifurcations. Backward bifurca-
tions are generally studied by varying a bifurcation parameter which in epidemiological
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models is usually the basic reproduction number R0. However, it is often overlooked
that the basic reproduction number R0 is an aggregate of parameters in the model.
Therefore, it will not be correct for one to simply vary the aggregate R0 while leaving
all model parameters constant as has happened many times in the literature (e.g.,
[21, 48, 52, 63, 85, 86, 87, 88, 89, 90]). Moreover, this research question emphasizes
the correct approach for computing the critical value of the basic reproduction number
Rc. This clarifies a great deal of confusion in the literature on how to compute the
critical value. In this thesis these problems are addressed and resolved.
The second research question investigates the role of loss of immunity and subsequent
reinfection amongst recovered individuals in a tuberculosis (TB) model. This research
question was inspired by the recent understanding that despite tremendous improve-
ments in TB treatment over recent years, individuals who have been adequately treated
and assumed to have developed immunity against TB, are in fact still at risk of being
infected [84, 91]. They can develop pulmonary recurrent TB, which is defined as
an episode of TB following recovery from a previous episode. Recent estimates of
the rates of recurrent TB across various regions point to a mean of 2300 cases per
100,000 person-years at twelve months after treatment. The recurrent TB rate can be
significantly higher in high-incidence TB regions, with an average TB recurrence rate
reaching 7850 per 100,000 person-years [92]. With modern technology, especially DNA
fingerprinting techniques, it is possible to reveal whether a new episode of tuberculosis
is a result of infection with the same strain as the previous one or is due to a different
strain. A study conducted in areas of South Africa where TB incidence is high found
that the majority of TB cases (approximately 77%) occur as a result of reinfection [84].
Furthermore, in the same study the rate of recurrent TB was found to be four times
higher than that of new TB. This raised an important question regarding the underlying
mechanisms [91]. Although, worldwide about 10-30% [84] of cases of TB are recurrent,
the role of recurrent TB as far as the formation of backward bifurcation is concerned,
is rarely if ever studied. Hence, the main objective in this research question will be to
analyse how recurrent tuberculosis impacts the formation of backward bifurcation. An
epidemiological model that provides a comprehensive description of the transmission
pathways involved for recurrent tuberculosis, whereby cured individuals can become re-
infected is proposed. The model incorporates progressive primary infection, exogenous
reinfection, endogenous reactivation and recurrent TB as transmission mechanisms.
Moreover, unlike other studies of TB dynamics that make use of frequency-dependent
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transmission rates [56], the analysis conducted in this thesis provides exact analytic
backward bifurcation threshold conditions without resorting to commonly applied
approximations and simplifying assumptions. Lastly, by switching off reinfection of
latently infected individuals it shall be shown that recurrent TB can independently
induce backward bifurcation phenomena if it exceeds a certain threshold.
The TB model studied in research question two is extended by splitting latently in-
fected individuals into two subgroups and used to investigate questions relating to
heterogeneity in reinfection rates (i.e., cases (iii) and (iv)). Through clinical observation
it has been revealed that variable rates of progression to active TB following infection
exist [93]. Evidence, from the interferon-gamma release assay indicate that over the
first 23 months following infection about 12.9% of infected individuals progress to
active TB [93]. In contrast, after the high risk period the rate at which active TB
occurs is relatively low and is approximately 5-10% over 20 years [94]. To account for
this clinical observation past mathematical models devoted to tracking TB dynamics
have incorporated two major pathways from susceptible to actively infected: fast and
slow TB pathways. In such models a fraction of exposed susceptibles progress directly
to the infective stage passing the latency compartment [56, 94, 95, 96]. Thus, a tuber-
culosis model that accounts for heterogeneity in host susceptibility by treatment status
is proposed. The new model relaxes the assumption made in [97], that individuals
treated with preventive therapy and recovered individuals previously treated from
active TB are reinfected at the same rate. As will be shown in chapter 5, disregarding
the assumption made in [97] leads to new epidemiological insights that are vital in
deciphering the impact of treatment under different levels of susceptibility to reinfection.
The fifth research question investigates the implication of a nonlinear treatment rate
in a heroin addiction model. A mathematical model is developed that examines how
heroin addiction spreads in society. The model has similarities to epidemic equations
for the spread of infectious diseases. The proposed model takes into account the
treatment of heroin users by incorporating a realistic functional form that “saturates”,
representing the limited availability of treatment. In these circumstances, bifurcation
analysis reveals that the model has an intrinsic backward bifurcation whenever the
saturation parameter is larger than a fixed threshold. The main objective of this
model is to determine its stability properties. In the absence of backward bifurcations,
Lyapunov functions can often be found and used to prove global stability. However,
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in the presence of backward bifurcations, such Lyapunov functions may not exist or
may be difficult to construct. Consequently, a geometric approach to global stability
proposed in [98] is applied to provide conditions that ensure the system is globally
asymptotically stable. Furthermore, numerical simulations are performed to verify
theoretical findings.
The organization of the chapters in the thesis is as follows. Mathematical preliminaries
that will be used in the thesis for deriving some important results are described in
chapter 2. Two simple models for tuberculosis that will be used to investigate research
question one are formulated in chapter 3. The models will be used to investigate
problems that arise with aggregation of bifurcation parameters in epidemic models. In
this chapter the equilibrium points are the main interest and therefore they shall be
obtained under two scenarios: (i) a model with density-dependent incidence and (ii) a
model with frequency-dependent incidence rates. A proof for the existence of backward
bifurcation shall be given using a Center Manifold approach as developed by [58].
In chapter 4 the simple TB model in chapter 3 with frequency-dependent incidence
is extended to incorporate new infection processes such as primary progression and
recurrent TB. This model shall be used to answer question three which investigates the
implication of recurrent TB in tuberculosis epidemics models as far as the phenomenon
of backward bifurcation is concerned. Chapter 5 will be an extension of the model
studied in chapter 4. The latently infected population is subdivided into two subgroups
to represent high and low risk latent individuals. The high risk latent individuals shall
be referred to as early latent, while the low risk individuals shall be referred to as late
latent. Both early and late latent individuals shall be treated with preventive therapy.
Thus, a new compartment shall be added to account for individuals who have received
preventive therapy. To investigate the effect of heterogeneity, late latent individuals
treated with preventive therapy and recovered individuals previously treated from
active TB will be assumed to be susceptible to exogenous reinfection. Chapter 6
contains related work which involves stability analysis of a heroin addiction model with
a non-linear treatment rate. The heroin model is based on an SIR epidemic model and
thus has many features in common, including backward bifurcations. Finally, chapter
7 will outline the main contribution of this thesis as well as point out new directions
to explore.
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1.5 Published work
The work contained in some of the chapters in this thesis was submitted for publication,
thus resulting in the following publications:
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I. M. Wangari, S. Davis, and L. Stone. Backward bifurcation in epidemic models:
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▶ Chapter 4 was published and can be accessed online from:
I. M. Wangari, L. Stone. Backward bifurcation and hysteresis in models of re-
current tuberculosis. PLoS One (Public Library of Science), 13(3): 1-29, 2018.
https://doi.org/10.1371/journal.pone.0194256;
▶ Chapter 5 was publihsed and can be accessed online from:
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bility to tuberculosis and its effect on public health interventions. PLoS One (Public
Library of Science), 13(11): 1-26, 2018.
doi:10.1371/journal.pone.0206603;
▶ Chapter 6 includes other published work and can be accessed online from:
I. M. Wangari and L. Stone. Analysis of a heroin epidemic model with satu-
rated treatment function. Journal of Applied Mathematics, 1–21, 2017.
https://dx.doi.org/10.1155/2017/1953036.
Chapter 2
Mathematical preliminaries
This chapter is a summary of important mathematical concepts and methodologies that
are applied throughout this thesis. The concepts given are mostly standard definitions
and results as documented in the literature on mathematical theory. However, a few
concepts are adopted from the readily available theory of mathematical modelling of
infectious diseases.
2.1 Linear and non-linear systems equilibria
Given a system of ODEs (ordinary differential equations) as shown below:
y˙ = g(y, t;µ), y ∈ U ⊂ Rn, t ∈ R, and µ ∈ V ⊂ Rp, (2.1)
where U and V are respectively, open sets in Rn and Rp, and µ is a parameter. Then
the right-hand side function g(y, t;µ) of equation (2.1) is referred to as a vector field.
ODEs which do not explicitly depend on time are referred to as autonomous differential
equations while those that are explicitly dependent on time are called non-autonomous
differential equations.
Consider the following general autonomous system
y˙ = g(y), y ∈ Rn, (2.2)
then the following definitions, theorems and lemmas are stated:
Definition 2.1.1 The autonomous system (2.2) equilibrium solution is given by y =
y¯ ∈ Rn, where g(y¯) = 0. The vector or point y¯ is referred to as an equilibrium point.
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Theorem 2.1.1 (Perko [99]). Fundamental existence-uniqueness theorem.
Suppose D is an open subset of Rn containing y0 and assume that g ∈ C1(D). Then
there exists c > 0 such that the initial value problem (IVP)
y˙ = g(y), y(0) = y0,
has a unique solution y(t) on the interval [−c, c].
Lemma 2.1.1 (Perko [99]). Let D be an open subset of Rn and let g : D 7−→ Rn.
Then, if g ∈ C1(D), g is locally Lipsitch on D.
Definition 2.1.2 The Jacobian matrix of g at the equilibrium point y¯, denoted by
Dg(y¯), is the matrix of partial derivatives of g evaluated at y¯ and can be obtained as
Dg(y¯) =

∂g1(y¯)
∂y1
. . . ∂gm(y¯)
∂ym... . . . ...
∂gm(y¯)
∂y1
. . . ∂gm(y¯)
∂ym
 .
Definition 2.1.3 Suppose y = y¯ is an equilibrium solution of (2.2). Then y¯ is called
hyperbolic if none of the eigenvalues of Dg(y¯) has zero real part. An equilibrium point
that is not hyperbolic is called non-hyperbolic.
2.2 Stable, unstable solutions and bifurcations
Here the definitions and theorems that are relevant to analyzing the stability of an
autonomous system are stated. Letting y¯(t) be any solution of the general autonomous
system (2.2), then y¯(t) is considered stable if solutions starting “close” to y¯(t) at a
given time remain close to y¯(t) for all later times. It is said to be asymptotically-stable
if close solutions are attracted to y¯(t) as t→∞.
Definition 2.2.1 (Wiggins [100]). Let ϵ > 0, then a solution y¯(t) is considered to
be stable if there exists a δ = δ(ϵ) > 0, such that for any solution x(t) of (2.2),
|y¯(t0)− x(t0)| < δ, |y¯(t)− x(t)| < ϵ for every t > t0, t0 ∈ R.
Definition 2.2.2 (Wiggins [100]). The solution y¯(t) is considered to be asymptotically
stable if it has the following properties: (i) it is stable and (ii) a constant c > 0
exists such that any solution x(t) of (2.2) fulfills conditions |y¯(t0) − x(t0)| < c and
limt→∞ |y¯(t)− x(t)| = 0.
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Definition 2.2.3 A solution which is not stable is considered to be unstable.
Theorem 2.2.1 (Wiggins [100]). The equilibrium solution of (2.2) is said to be locally
asymptotically stable if its Jaccobian matrix Dg(y¯) evaluated at equilibrium point y¯ has
all eigenvalues with negative real part. The equilibrium y¯ is said to be unstable if at
least one of the eigenvalues has positive real part.
2.3 Method for computing R0 (next generation op-
erator method)
The basic reproduction number R0 is defined as the average number of new infections
that a typical infected individual gives rise to over the lifetime of the infection when
introduced into a wholly susceptible population. van den Driessche and Watmough
[25] developed a technique for calculating the basic reproduction number of disease
transmission models. This method is called the next generation operator (NGO)
method. The technique is also becoming increasingly popular in establishing the local
asymptotic stability of the associated disease free equilibrium. Here the procedure as
given in [41] is briefly outlined below.
Consider a disease transmission model that has non-negative initial conditions and can
be expressed in terms of the following autonomous system:
y˙i = fi(y) = Fi(y)− Vi(y), i = 1, . . . n, (2.3)
where Vi = V −i − V +i and the functions fulfill the properties (A1)-(A5) stated below.
In terms of disease transmission modelling Fi(y) represent the rate at which new
infections occur in compartment i, V +i (y) represent the rate at which individuals flow
into compartment i by all other means and finally V −i (y) represent the rate at which
individuals flow out of compartment i [25]. The functions Fi(y), V +i (y), V −i (y) are
assumed to be at least twice continuous-differentiable in each variable [25].
First note that Ys = {y ≥ 0|yi = 0, i = 1, . . . ,m} define the set of all disease free
states (disease free) of the model, where y = (y1, . . . , yn)T , yi ≥ 0 account for the
number of individuals residing in respective compartments of the model. Properties
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(A1)-(A5) are:
(A1) If yi ≥ 0, then Fi, V +i , V −i ≥ 0 for i = 1, . . .m;
(A2) Fi = 0 if i > m;
(A3) If yi = 0, then V −i = 0. That is if y ∈ Ys then V −i = 0 for i = 1, . . . ,m;
(A4) If y ∈ Ys, then Fi(y) = 0 and V +i (y) = 0 for i = 1, . . . ,m;
(A5) If F (y) is set to zero, then all eigenvalues of DF (y¯) have negative real part.
Definition 2.3.1 (Plemmons [101]). M-Matrix. An n× n matrix A is an M-Matrix
if and only if every off-diagonal entry of A is non-positive, the diagonal entries are all
positive and the real parts of the eigenvalues of the matrix A are non-negative.
Lemma 2.3.1 (van den Driessche and Watmough [25]). If y¯ is the DFE of (2.3)
and fi(y) fulfills conditions (A1)-(A5) then the derivatives DF (y¯) and DV (y¯) are
partitioned as
DF (y¯) =
F 0
0 0
 , DV (y¯) =
V 0
J3 J4

where F and V are m×m matrices and can be obtained as
F =
[
∂Fi(y¯)
∂yj
]
and V =
[
∂Vi(y¯)
∂yj
]
with 1 ≤ i, j ≤ m.
Note that F is non-negative and V is a non-singular M-Matrix. J3 and J4 are matrices
associated with the transition terms of the model and all eigenvalues of J4 have positive
real parts. Considering the above discussion and formulations the reproduction number
is given as
R0 = ρ(FV −1),
where ρ denotes the spectral radius. Consequently, Theorem 2.3.1 follows:
Theorem 2.3.1 (van den Driessche and Watmough [25]). Consider the system (2.3)
representing disease transmission, where fi(y) fulfills the stated axioms (A1)-(A5). If y¯ is
a DFE of the model then y¯ is locally asymptotically stable whenever R0 = ρ(FV −1) < 1
and unstable whenever R0 > 1.
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2.4 Bifurcations
Typically all systems of equations are characterized by a set of variables and parameters.
The qualitative structure of the solution of the system may be altered when certain
parameter values within the system are varied within a given interval. These changes
are called bifurcations. The parameter value where the bifurcation occurs is called a
bifurcation value (or bifurcation point). The definition of a bifurcation can be given as
follows:
Definition 2.4.1 (Gros [102]). Let
y˙ = g(y;µ), y ∈ R, µ ∈ R (2.4)
be a one-parameter family of one-dimensional ODEs. An equilibrium solution of (2.4)
given by (y,µ) = (0, 0) is said to undergo bifurcation at µ = 0 if the flow for µ near
zero and y near zero is not qualitatively the same as the flow near y = 0 at µ = 0.
There are several types of bifurcations in dynamical systems, including saddle-node,
transcritical, pitchfork, backward, Bogdanov-Takens and Hopf bifurcations as described
in [100]. Backward and forward bifurcations are pertinent to this thesis and have been
described in chapter 1. Other types of bifurcations such as forward bifurcation with
a hysteresis loop, sometimes referred to as the hysteresis effect are very rare in the
existing literature on mathematical modelling of infectious diseases. Currently, there
is an available theorem (as deduced in [58]) that is used to establish the existence of
backward bifurcation phenomena. This theorem shall be applied in chapters 3, 4 and
5 for both simple and slightly complex models. Hence, it is important to state the
theorem:
Theorem 2.4.1 (Castillo-Chavez and Song [58]). Consider the following general
system of ordinary differential equations with a parameter φ:
dx
dt
= f(x, φ), f : Rn × R→ Rn and f ∈ C(Rn × R), (2.5)
where 0 is an equilibrium point of the system (that is, f(0, φ) ≡ 0 for all φ) and
assume:
(i) A = Dxf(0, 0) =
(
∂fi
∂xj
(0, 0)
)
is the linearization matrix of the (2.5) around the
equilibrium 0 with φ evaluated at 0. Zero is a simple eigenvalue of A and other
eigenvalues of A have negative real parts;
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(ii) Matrix A has a right eigenvector w and a left eigenvector v (each corresponding
to the zero eigenvalue).
Let fk be the kth component of f and
a =
n∑
k,i,j=1
vkwiwj
∂2fk
∂xi∂xj
(0, 0),
b =
n∑
k,i=1
vkwi
∂2fk
∂xi∂φ
(0, 0).
Then, the local dynamics of the system (2.5) around 0 are determined by the signs of a
and b:
(i) a > 0, b > 0. When φ < 0 with |φ| ≪ 1, 0 is locally asymptotically stable and
there exists a positive unstable equilibrium; when 0 < φ≪ 1, 0 is unstable and
there exists a negative, locally asymptotically stable equilibrium;
(ii) a < 0, b < 0. When φ < 0 with |φ| ≪ 1 0 is unstable; when 0 < φ ≪ 1, 0 is
a locally asymptotically stable equilibrium, and there exists a positive unstable
equilibrium;
(iii) a > 0, b < 0. When φ < 0 with |φ| ≪ 1 0 is unstable, and there exists a locally
asymptotically stable negative equilibrium; when 0 < φ ≪ 1, 0 is stable, and a
positive unstable equilibrium appears;
(iv) a < 0, b > 0. When φ changes from negative to positive, 0 changes its stability
from stable to unstable. Correspondingly a negative unstable equilibrium becomes
positive and locally asymptotically stable.
In particular, if a > 0 and b > 0, then a backward bifurcation occurs at φ = 0.
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2.5 Lyapunov functions and Lasalle’s invariance prin-
ciple
Definition 2.5.1 A function V : R 7−→ R is said to be a positive-definite function if:
(i) V(y) > 0 for all y ̸= 0;
(ii) V(y) = 0 if and only if y = 0.
Definition 2.5.2 Consider the following system
y˙ = g(y), y ∈ Rn. (2.6)
Let y¯ be an equilibrium solution of (2.6) and assume V : U 7−→ R is a C1 function
defined on some neighbourhood U of y¯ such that:
(a) V is positive definite;
(b) V˙ ≤ 0 in U\{y¯}.
Then any function V which satisfies the conditions (a) and (b) is called a Lyapunov
function [100, 103].
Now the general Lyapunov function theorem is given as below:
Theorem 2.5.1 (Lasalle’s Invariance Principle [103]). Consider the system (2.6).
Let S = {y ∈ U¯ : V˙(y) = 0} and suppose M is the largest invariant set of (2.6) in S.
Now if V is a Lyapunov function on U and γ+(y0) is a bounded orbit of (2.6) which lies
in S, then the ω-limit set of γ+(y0) belongs to M (that is y(t, y0) −→M as t −→∞).
Corollary 2.5.1 If V(y) −→∞ as |y| −→ ∞ and V˙ ≤ 0 on Rn, then every solution
of (2.6) is bounded and approaches the largest invariant set M of (2.6) in the set where
V˙ = 0. To be precise if M = {0}, then the solution y = 0 is globally asymptotically
stable (GAS).
Theorem 2.5.2 (Wiggins [100]). Suppose there is a continuously differentiable positive-
definite and radially unbounded function V : Rn −→ R, such that
∂V
∂y
(y − y¯).g(y) = ▽V(y − y¯).g(y) ≤ W (y) ≤ 0 ∀ y ∈ Rn,
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where W (y) is any continuous function on U . Then y¯ is said to be a globally stable
equilibrium. The solution y(t) converges to the largest invariant set S contained in
E = {x ∈ Rn : W (y) = 0}.
Chapter 3
Backward bifurcation in epidemic
models: problems arising with
aggregated bifurcation parameters
3.1 Chapter overview
Epidemiological models have become important tools for helping understand the
qualitative dynamics controlling the spread of infectious diseases. Many of these
models have strong non-linearities and therefore exhibit complex population dynamics
and possess subtle bifurcation properties. Currently, there is a renewed interest in
so-called “backward bifurcations” because of the unusual thresholds they introduce. In
this chapter an overlooked problem that has arisen in the literature when calculating
backward bifurcations, especially in the context of epidemic modelling is examined
and resolved. In mathematical modelling a range of different epidemiological models
have been found to exhibit backward bifurcation, including models that incorporate
behavioural responses to perceived risks [30], vaccination [42, 104], multiple groups [29],
vector-borne diseases [63] and exogenous reinfection [52, 56, 57, 58, 59] (just to mention
a few). The presence of backward bifurcation is important in a practical sense because
control programs must reduce the basic reproduction number, R0, further than below
unity to eliminate a disease. Thus, the problem addressed in this chapter stems from
studies of backward bifurcation in the literature where there have been instances where
authors illustrate the phenomena by varying R0 without properly considering the fact
that R0 is an aggregate of parameters in the model. Hence, it would be incorrect to
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simply vary the aggregate R0 while leaving all model parameters constant as has been
the practice in a number of important studies [21, 48, 52, 63, 85, 86, 87, 88, 89, 90].
In this chapter the two scenarios investigated include:
(i) For the incorrect approach, all parameters in the aggregate R0 are fixed to
constant values, but R0 is nevertheless varied as a bifurcation parameter;
(ii) In the correct approach, a key parameter in R0 is allowed to vary, and hence R0
itself varies and acts as a natural bifurcation parameter.
The main results will show how the outcomes of these two approaches are substantially
different. To explore the aforementioned problem a simple tuberculosis (TB) model that
incorporates reinfection as the parameter to induce backward bifurcation is examined,
although any other example can be used to exhibit the difference.
3.2 Model construction
The total population is partitioned into four sub-populations: susceptible (S); ex-
posed/latent individuals (E) (those who have been infected but do not manifest TB
symptoms and are not capable of infecting others); infectious individuals (I) (symp-
tomatic and infectious) and recovered (R) individuals (recovery due to treatment or
spontaneous cure). The total population denoted by N(t) is given by
N(t) = S(t) + E(t) + I(t) +R(t).
The numbers of susceptible individuals increase by recruitment through births and
immigration at a rate Λ. Susceptibles who come into contact with infected individuals
move straight to the exposed E class but they are not themselves yet infective. The
susceptible population is thus diminished due to contact with infected individuals
at a rate βSI, where β represents the per-capita effective contact rate of acquiring
TB bacteria. Concomitantly, the numbers in the exposed class increase at a rate
βSI. Progression to the infectious state occurs when an exposed individual harbors a
dormant infection that becomes active due to immune system destabilization. This
is the usual “slow TB” which can take years or decades before progression. Exposed
individuals move to the infected class I at rate kE. In addition, exposed individuals
can encounter infectious individuals (I) and be reinfected leading to an acceleration
into the infectious class at rate pβEI. The infected subpopulation is diminished when
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individuals recover from TB due to treatment or spontaneous cure at rate rI and
disease induced death rate µd. Finally, the recovered sub-population (R) is generated
by recovery of infected individuals (at rate rI). The natural death rate decreases all
classes at the same rate via the background mortality parameter µ. A brief description
of the model parameters and variables is given in Table 3.1 while a flow diagram is
depicted in Figure 3.1.
Table 3.1: Description of model parameters and variables of model equation (3.1).
Variable Description
S Population of susceptible individuals
E Population of exposed (asymptomatic and non-infectious) individuals
I Population with active TB (symptomatic and infectious)
R Recovered individuals
Parameters Description
µ Per capita natural mortality rate
Λ Recruitment rate into the population
µd Per capita disease-induced death rate
k Per capita endogenous reactivation rate
β Transmission coefficient
r Per capita recovery rate
p Reinfection factor
S(t) E(t) I(t) R(t)
βSI kE rI
pβEµS
µEΛ
(µ+ µd)I µR
Figure 3.1: Schematic diagram for the model equation (3.1). The red curved dashed
arrow indicates the reinfection process.
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The basic model governing change of status from one compartment to another is given
by the following system of non-linear differential equations
dS
dt
= Λ− βSI − µS,
dE
dt
= βSI − pβEI − (µ+ k)E, (3.1)
dI
dt
= pβEI + kE − (µ+ r + µd)I,
dR
dt
= rI − µR.
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3.3.1 Basic properties
The model equation (3.1) monitors TB transmission dynamics in a human population,
thus all the associated parameters are non-negative. Hence, the following non-negative
result needs to be satisfied.
Theorem 3.3.1 The state variables of the model are non-negative for all time. That
is all the trajectories of the model equations with non-negative initial data will remain
non-negative for all time t > 0.
Proof Let t1 = sup{t > 0 : S > 0, E > 0, I > 0, R > 0}. Now for t1 > 0 it follows from
the first equation of model (3.1) that dS
dt
= Λ− (Ψ + µ)S (where Ψ = βI) which can
be written as
dS(t)
dt
+ (Ψ + µ)S(t) = Λ > 0. (3.2)
The solution of (3.2) can be shown to be non-negative. Thus, rewriting (3.2) as
d
dt
[
S(t) exp
(
µt+
∫ t
0
Ψ(τ)dτ
)]
= Λexp
[
µt+
∫ t
0
Ψ(τ)dτ
]
> 0, (3.3)
and integrating both sides of (3.3) leads to
S(t1) exp
[
µt1 +
∫ t1
0
Ψ(τ)dτ
]
− S(0) =
∫ t1
0
Λexp
(
µx+
∫ x
0
Ψ(τ)dτ
)
dx > 0,(3.4)
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which can be rewriten as
S(t1) = S(0) exp
{
−µt1 −
∫ t1
0
Ψ(τ)dτ
}
+
{
exp
(
−µt1 −
∫ t1
0
Ψ(τ)dτ
)} ∫ t1
0
Λexp
(
µx+
∫ x
0
Ψ(τ)dτ
)
dx > 0.
Thus, S(t1) > 0. Similarly it can be shown that E(t) > 0, I(t) > 0 and R(t) > 0 for all
t > 0. Theorem (3.3.1) can also be proven by applying the approach in Appendix A of
[105].
Theorem 3.3.2 The closed set
κ =
{
(S(t), E(t), I(t), R(t)) ∈ R4+ : S + E + I +R ≤
Λ
µ
}
is positively invariant and attracting.
Proof. Summing all the equations of model system (3.1) yields
dN
dt
= Λ− µN − µdI. (3.5)
Supposing dN
dt
≤ Λ− µN, then dN
dt
≤ 0 if N ≥ Λ
µ
.
Using the standard comparison theorem [106] it can be shown that
N(t) ≤ N(0)e−µt + Λ
µ
(1− e−µt). (3.6)
Note that N(t) ≤ Λ
µ
if N(0) ≤ Λ
µ
. Consequently, the region κ is positively invariant.
Moreover, for N(0) > Λ
µ
the solution N(t) may enter in the region κ infinitely many
times or asymptotically approaches Λ
µ
. Thus, all the solutions in R4+ converge in the
region κ. Since the region κ is positively invariant the dynamics of all the trajectories
generated by the model (3.1) are considered in κ.
The disease free equilibrium of model (3.1) can be obtained by setting the right-hand
terms of the model equation (3.1) to zero as
ε0 = (S0, E0, I0, R0) =
(
Λ
µ
, 0, 0, 0
)
.
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Following the next generation operator method (given in chapter 2), the local stability
of the disease free equilibrium will be explored. Using similar notation as in [25], the
non-negative matrix F (representing new infections) and M-matrix V (representing
inflow and outflow) can respectively be obtained from model equation (3.1) as
F =
0 βΛµ
0 0
 , V =
µ+ k 0
−k µ+ r + µd
 .
Hence, it follows that the basic reproduction number is
R0 = ρ(FV −1),
= kβΛ
µ(µ+ k)(µ+ r + µd)
,
where ρ is the spectral radius.
The reproduction number R0, measures the average number of new infections a single
infected individual will generate when introduced into a wholly susceptible population.
Lemma 3.3.1 The DFE of model equation (3.1) is locally asymptotically stable when-
ever R0 < 1 and unstable whenever R0 > 1.
The result deduced in Lemma 3.3.1 was established and proved in [25] and thus the
proof is not repeated here. Lemma 3.3.1 implies that TB can be eliminated from the
community if the initial sizes of the sub-populations of the model are in the basin
of attraction of the disease free equilibrium ε0. It is important to observe that the
parameter p which accounts for reinfection is not included in the basic reproduction
number, yet the mechanism does increase the population of infectives. Thus, further
analysis is needed to elucidate the role played by the reinfection process. Now the
endemic equilibrium of model equation (3.1) and the associated bifurcation structure
is established.
3.3.2 Existence of backward bifurcation
It is imperative to note that the precursor for the existence of the backward bifurcation is
existence of multiple equilibria (both stable and unstable) when the associated threshold
quantity R0 is below unity. Let ε∗ = (S∗, E∗, I∗, R∗) be an arbitrary equilibrium of
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model equation (3.1). Now equating the right-hand terms of model equation (3.1) to
zero and solving leads to
S∗ = Λ
µ+ βI∗ , E
∗ = (µ+ r + µd)I
∗
pβI∗ + k , R
∗ = rI
∗
µ
,
in terms of the number of infectives I∗, where I∗ can be obtained by solving the
quadratic expression
f(I∗) = c2I∗2 + c1I∗ + c0 = 0, (3.7)
where
c2 = pβ2(µ+ r + µd),
c1 = (µ+ k + µp)(µ+ r + µd)β − β2pΛ,
c0 = µ(µ+ k)(µ+ r + µd)(1−R0).
The endemic equilibria of model equation (3.1) are summarized through the following
Theorem 3.3.3:
Theorem 3.3.3 The model equation (3.1) has:
(i) A unique endemic equilibrium if c1 < 0 and c0 = 0 or the discriminant △ =
c21 − 4c2c0 = 0;
(ii) A unique endemic equilibrium if c0 < 0;
(iii) Two positive endemic equilibria if c1 < 0, c0 > 0 and c21 − 4c2c0 > 0;
(iv) No endemic equilibrium if c1 > 0 and c0 > 0.
Proof. It is easy to note that in the polynomial (4.12) c2 is always positive and
c0 > 0 if R0 < 1. For case (i) where c1 < 0 and R0 = 1 (i.e., c0 = 0) the quadratic
equation f(I∗) reduces to c2I∗ + c1 = 0 and in this case the model equation (3.1)
will have a unique positive endemic equilibrium if c1 < 0 and no positive non-trivial
equilibrium if c1 ≥ 0. From case (ii) where c0 < 0 (that is R0 > 1) a unique endemic
equilibrium exists since there is only one change of sign according to Descarte’s Rule
of Signs. However, for case (iii) where c1 < 0 and R0 < 1 there is exactly two changes
of sign indicating the existence of two non-trivial equilibria. For case (iv) where
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c1 > 0 and R0 < 1 there are no changes of sign, thus there is no endemic equilib-
rium in such a case. Hence, from case (iii) it is concluded that model equation (3.1)
has a maximum of two endemic equilibria (I∗1,2) when R0 < 1, c1 < 0 and c21−4c2c0 > 0.
The above equilibrium analysis suggests a possibility of backward bifurcation since two
endemic equilibria exist as exhibited by case (iii) when R0 < 1, which is actually a
necessary criterion for the occurrence of backward bifurcation phenomena.
The problem arises when retrieving these two non-trivial solutions (I∗1,2) as a function of
the aggregate parameter R0. A number of studies [21, 48, 52, 63, 85, 86, 87, 88, 89, 90]
incorrectly plot the solutions (I∗1,2) by varying R0 in equation (4.12), that is, without
varying any parameter within R0. Such a practice leads to an incorrect backward
bifurcation diagram yielding a simple (though incorrect) parabolic shape such as shown
in Figure 3.2. The correct approach for drawing the bifurcation diagram requires first
choosing a proper specific model bifurcation parameter to vary, say the transmission
rate β. The bifurcation diagram can then be determined through varying this model
bifurcation parameter. Once obtained, the bifurcation diagram can then be rescaled so
that the x-axis is given in terms of the aggregated parameter R0. For the particular
model above, by varying the transmission rate β in the interval β ∈ [0.025, 0.175],
Figure 3.3 is obtained. Using this approach the figure no longer appears parabolic
in shape and has shifted to the left compared to Figure 3.2. Another outstanding
difference between Figures 3.2 and 3.3 is the gap between the bifurcation branches.
From 3.3 the gap between the bifurcation curves is wider than for Figure 3.2. This
implies that the endemic equilibrium predicted when β is varied is higher than for the
case where all parameters are kept constant i.e., the incorrect approach. Also, one can
observe that the critical value of the basic reproduction number denoted by Rc where
the backward bifurcation initiates (defined in more detail below) will be incorrect if
estimated using the aggregated parameter method. (Hence, in the subsequent section
comparison of the two methods, incorrect and correct approaches are analysed.)
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Figure 3.2: Backward bifurcation when all the parameters in R0 are fixed at constant
values but the aggregated R0 is nonetheless varied. Parameters used are Λ = 10,
µ = 0.016, r = 2, µd = 0.4, k = 0.0005, p = 0.2, β = 0.036. Black solid line represents
stable equilibria while the red solid line represents unstable equilibria.
3.3 Mathematical analysis 33
Figure 3.3: Backward bifurcation when one parameter β in R0 is varied. Parameters
used are Λ = 10, µ = 0.016, r = 2, µd = 0.4, k = 0.0005, p = 0.2, β ∈ [0.025, 0.175].
Black solid lines represent stable equilibria while the red solid line represents an
unstable equilibrium.
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3.4 The backward bifurcation threshold, Rc
As seen in the bifurcation diagram of Figure 3.3, there is a threshold quantity Rc which
is the value of R0 where the two non-trivial endemic equilibria collide and annihilate
each other, leaving only the disease free equilibria as the only stationary solution. For
instance in Figure 3.3, this occurs at the threshold Rc = 0.42. If R0 < Rc then the
only model equilibrium is the stable disease free equilibrium. Now the two approaches
for computing Rc [21, 86, 87, 88, 107] are explored.
(i) Incorrect aggregated parameter approach
Recall that this approach wrongly assumes that all parameters in R0 are kept
constant while R0 may be varied to obtain the backward bifurcation diagram, as
in Figure 3.2. If the discriminant (△ = c21 − 4c2c0) of equation (4.12) is set to
zero it is possible to obtain the critical point Rc1. This is just the value of R0
where the stable and unstable endemic curves coincide, namely
Rc1 = 1− c
2
1
4c2Ω
where Ω = µ(µ+ k)(µ+ r + µd). Using the above equation, it is possible to
investigate how the parameters that induce backward bifurcation affect Rc1. For
example, a plot of Rc1 as a function of p is shown in Figure 3.4.
(ii) Correct approach
The correct value for Rc is obtained by first selecting a specific bifurcation
parameter of the model. For illustration the parameter β is chosen. By setting
the discriminant △ = 0 and rearranging for the critical transmission rate βc yields
βc =
−ϕ1 ±
√
ϕ21 − 4ϕ2ϕ0
2ϕ2
,
where
ϕ2 = p2Λ2,
ϕ1 = 4pΛk(µ+ r + µd)− 2pΛ(µ+ k + µp)(µ+ r + µd),
ϕ0 = (µ+ k + µp)2(µ+ r + µd)2 − 4µp(µ+ r + µd)2(µ+ k).
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Replacing β in R0 with βc yields
Rc2 =
(
k
µ(µ+ k)(µ+ r + µd)
)
√
ϕ21 − 4ϕ2ϕ1 − ϕ1
2Λp2
 .
A plot of Rc2 as a function of p is shown in Figure 3.4.
The two methods of Rc computation are graphically represented in Figure 3.4. A
plot of Rc1 as a function of the reinfection parameter p would suggest there is an
optimum value of reinfection using the incorrect approach. However, a plot of Rc2 as a
function of p using the correct approach produces a totally different curve and shows
no such optimum. Note that pmin, the minimum value of the reinfection parameter
that induces bi-stability, may be calculated as pmin =
(
k
µ
)(
µ+ k
µ
)
as found using
the Center Manifold approach described in [58] (see section 3.4). Using the parameter
values used to obtain Figure 3.4. The point pmin = 0.0322 corresponds to the value
indicated at the arrow on Figure 3.4. The analysis that now follows in section 3.4.1 is
important since it confirms the coexistence of a stable disease free equilibrium with
two endemic equilibria where one is unstable and the other is stable as shown in Figure
3.3.
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Figure 3.4: The red dashed line is a plot of Rc1 as a function of p while the blue solid
line illustrates a plot of the correct backward bifurcation threshold Rc2 as a function
of p. Parameters used are Λ = 10, µ = 0.016, r = 2, µd = 0.4, k = 0.0005, β = 0.0195.
The plot of Rc as a function of reinfection is due to the fact that Rc decreases as
reinfection p increases. pmin is the minimum value of exogenous reinfection that triggers
backward bifurcation.
3.4.1 Proof of existence of backward bifurcation for model
equation (3.1)
Theorem 3.4.1 The model system (3.1) exhibits backward bifurcation whenever p >
pmin and no backward bifurcation otherwise.
Proof: Making use of the Centre Manifold approach as described in Castillo-Chavez
and Song [58] (see chapter 2 Theorem 2.4.1) it is shown that
pmin =
(
k
µ
)(
µ+ k
µ
)
,
indicated by the arrow in Figure 3.4, acts as a threshold that determines the positivity
of the bifurcation coefficient a.
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To help explain the Center Manifold Theorem (2.4.1) it is convenient to transform
the model variables of system (3.1) as follows: x1 = S, x2 = E, x3 = I, x4 = R and
N = ∑4j=1 xj . Now letting X = (x1, x2, x3, x4)T (where T denotes transpose) the model
equation (3.1) can be written as dX
dt
= F (X) where F = (f1, f2, f3, f4)T . Hence, it
follows that
dx1
dt
= Λ− βx1x3 − µx1 = f1,
dx2
dt
= βx1x3 − pβx2x3 − (µ+ k)x2 = f2, (3.8)
dx3
dt
= pβx2x3 + kx2 − (µ+ r + µd)x3 = f3,
dx4
dt
= rx3 − µx4 = f4.
The Jacobian matrix of the system (3.8) evaluated at the disease free equilibrium
P0 =
(
Λ
µ
, 0, 0, 0
)
is obtained as
J =

−µ 0 −βΛ
µ
0
0 −(µ+ k) βΛ
µ
0
0 k −(µ+ r + µd) 0
0 0 r −µ
 .
At R0 = 1 suppose β is the bifurcation parameter, hence solving for β from R0 = 1
yields
β∗ = µ(µ+ k)(µ+ r + µd)
kΛ .
With β = β∗ the transformed system (3.8) has a simple eigenvalue with zero real part
and all other eigenvalues are negative (i.e., has a hyperbolic equilibrium point). Thus,
the Center Manifold Theory can be applied [58] to investigate the dynamics of the
transformed system (3.8) near β = β∗. It is possible to obtain the right eigenvectors of
J(ε0)|β=β∗ which are denoted by w = (w1, w2, w3, w4)T where
w1 =
−βΛw3
µ2
, w2 =
βΛw3
µ(µ+ k) , w3 = w3 > 0, w4 =
rw3
µ
.
Similarly it is easy to obtain the left eigenvectors denoted as v = (v1, v2, v3, v4)T where
v1 = 0, v2 =
kv3
µ+ k , v3 = v3 > 0, v4 = 0.
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Now, the associated bifurcation coefficients respectively denoted by a and b as described
in Theorem 4.1 of [58] can be obtained. As indicated in Theorem 4.1 of [58] if bifur-
cation coefficients a and b are both non-negative then the system exhibits backward
bifurcation where an unstable and a stable non-trivial equilibrium coexist with a stable
disease free equilibrium.
Computation of a : The transformed model equation (3.8) has the following
non-vanishing partial derivatives of J evaluated at the disease free equilibrium ε0;
∂2f1(0, 0)
∂x1x3
= −β, ∂
2f2(0, 0)
∂x1x3
= β, ∂
2f2(0, 0)
∂x2x3
= −pβ, ∂
2f3(0, 0)
∂x2x3
= pβ.
Hence,
a =
4∑
k,i,j=1
vkwiwj
∂2fk(0, 0)
∂xi∂xj
= v1w2w3
∂2f1(0, 0)
∂x1∂x3
+ v2w1w3
∂2f2(0, 0)
∂x1∂x3
+ v2w2w3
∂2f2(0, 0)
∂x2∂x3
+ v3w2w3
∂2f3(0, 0)
∂x2∂x3
= v3w3Λβ
∗2
(µ+ k)2
(
p−
(
k
µ
)(
µ+ k
µ
))
w3.
Computation of b : Similarly, to compute the bifurcation coefficient b, it can easily
be shown that the non-vanishing partial derivatives associated with the Jacobian matrix
J include
∂2f1(0, 0)
∂x3∂β∗
= −Λ
µ
,
∂2f2(0, 0)
∂x3∂β∗
= Λ
µ
.
so that,
b =
4∑
k,i=1
vkwi
∂2fk(0, 0)
∂xi∂β∗
= v1w3
∂2f1(0, 0)
∂x3∂β∗
+ v2w3
∂2f2(0, 0)
∂x3∂β∗
= kΛv3w3
µ(µ+ k) > 0.
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Existence of multiple equilibria when R0 < 1 is possible if the bifurcation coefficients a
and b are positive. In fact a > 0 if and only if
p > pmin =
(
k
µ
)(
µ+ k
µ
)
.
3.4.2 Equilibrium expressed in terms of the force of infection
It is important to note that some authors may choose to study backward bifurcations in
epidemic models by expressing the endemic equilibria in terms of the force of infection
[21, 86, 87, 88, 107] especially where the frequency-dependent transmission rate is used.
This practice results in bifurcation diagrams that are different in shape to those seen
in say Figure 2. Nevertheless, the same errors described here occur, no matter which
way one chooses to plot the bifurcation diagram, if the aggregated parameter R0 is not
dealt with correctly.
I now reformulate model equation (3.1) with a frequency dependent transmission rate,
as in [21, 86, 87, 88, 107], where the endemic equilibrium is given in terms of the force
of infection λ∗ = βI∗∗
N∗∗ . Note that this is done by replacing βI in model equation (3.1)
with βI
N
. Hence, the endemic equilibria expressed in terms of the force of infection are
given as
S∗∗ = Λ
λ∗ + µ, E
∗∗ = Λλ
∗
(pλ∗ + µ+ k)(λ∗ + µ) , I
∗∗ = Λλ
∗(pλ∗ + k)
(pλ∗ + µ+ k)(λ∗ + µ)(µ+ r + µd)
,
R∗∗ = rΛλ
∗(pλ∗ + µ+ k)
µ(pλ∗ + µ+ k)(λ∗ + µ)(µ+ r + µd)
,
where λ∗ can be obtained by solving the following equation
g(λ∗) = Aλ∗2 +Bλ∗ + C = 0, (3.9)
where
A = (µ+ r)p,
B = µp(µ+ r + µd) + µ(µ+ r + µd) + k(µ+ r)− µpβ,
C = µ(µ+ k)(µ+ r + µd)(1−R0).
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Note that
R0 =
kβ
(µ+ k)(µ+ r + µd)
.
Figures 3.5(a) and 3.5(b), respectively show a plot of the solution of equation (3.9)
as a function of R0 when all parameters in R0 are fixed to constant values and when
one parameter in R0 is varied. There is a distinct difference between Figure 3.5(a)
and Figure 3.5(b) as exhibited by the variation in their shape. Figure 3.5(a) where
all parameters in R0 are fixed to constant values represents the incorrect approach for
obtaining backward bifurcation and therefore depict a parabolic shape. In fact Figure
3.5(a) resembles the plots of backward bifurcation produced in [21, 86, 87, 107] where
all parameters in R0 were kept constant. However, Figure 3.5(b) where β ∈ [3.6, 6]
is varied is the correct approach for obtaining backward bifurcation and in fact the
parabolic shape is lost. Moreover, there is a difference in the gap between bifurcation
curves with Figure 3.5(b) having a wider gap than Figure 3.5(a). In general varying at
least one parameter in R0, one allows the bifurcation curves to choose the colliding point
but keeping parameters constant it is as if you have already determined the meeting
point of the two bifurcation curves. Thus, keeping parameters constant in R0 when
obtaining backward bifurcation may result in either underestimating or overestimating
the backward bifurcation threshold Rc.
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(a) (b)
Figure 3.5: Backward bifurcation when endemic equilibria are expressed in terms of
the force of infection. (a) Backward bifurcation when all the parameters in R0 are fixed
at constant values. Parameters used are µ = 0.01, r = 0.85, µd = 0.1, k = 0.002316, p =
0.5, β = 4.5. (b) Backward bifurcation when one parameter in R0 is varied. Parameters
used are µ = 0.01, r = 0.85, µd = 0.1, k = 0.002316, p = 0.5, β ∈ [3.6, 6]. In both figures
the blue solid lines represent stable equilibria while red solid lines represent unstable
equilibria.
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3.5 Summary of the chapter
In this chapter it is shown that there is a profound difference in the backward bifurcation
characteristics when the parameters in R0 are fixed and R0 is wrongly varied, as
compared to validly varying a true model bifurcation parameter. Using the wrong
approach, for constant values of R0 a parabolic shape is observed. However, when a
true model parameter in R0 is varied this parabolic shape disappears. Moreover, if
parameters inR0 are incorrectly fixed researchers may overestimate or underestimate the
backward bifurcation threshold Rc, below which R0 needs to be reduced to eradicate the
disease from the community. Since the ultimate goal of modelling is to give insight into
disease dynamics, knowing the correct value of Rc is important to public health. Thus,
one has to be careful in plotting and calculating backward bifurcation, since if not done
correctly errors can be introduced as in the studies [21, 48, 52, 63, 85, 86, 87, 88, 89, 90].
The correction shown here on how to obtain backward bifurcation in epidemic models
will be useful for others investigating this interesting phenomena in the future.
Chapter 4
Backward bifurcation and
hysteresis in TB models
incorporating recurrent
tuberculosis
4.1 Chapter overview
This chapter concerns modelling tuberculosis dynamics in a population giving careful
attention to reinfection processes. Most of the previous TB modelling literature has
been concerned only with the reinfection of individuals with latent TB i.e., reinfection of
individuals whose TB is asymptomatic and non-infectious (see [56, 108, 109]). However,
there are other important reinfection pathways that need to be dealt with. In particular,
over the last decade it has now become appreciated that reinfection among individuals
who have been successfully cured from the first episode of TB is substantial [77, 84, 110].
The second episode of TB which is referred to as recurrent TB often arises following
treatment, because an individual who has recovered from a first episode of the disease
does not necessarily gain permanent immunity to a second. Approximately, 10-30%
of all cases of TB are due to recurrent tuberculosis [79] and multiple episodes are
largely attributable to ineffective or poorly implemented tuberculosis control programs.
Recent medical research concerning recurrent TB shows that individuals who have
already had TB once are at a strongly increased risk of developing TB a second time
through reinfection [84]. Moreover, the studies suggest that the incidence rate of TB
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attributable to reinfection after successful treatment is four times higher than that of
new TB [84].
Although recurrent TB is recognized as a serious problem it receives little attention [79].
The few studies that have attempted to model this form of TB (for instance see [56]) did
not point out that recurrent TB can introduce new bifurcation structures besides the
well known backward bifurcation structure. The contribution of this chapter is to assess
how reinfection of recovered individuals can alter TB dynamics. In epidemic models
the phenomenon of backward bifurcation is characterized by persistence of the disease
when the associated basic reproduction number is below the endemic threshold. In this
chapter, conditions that give rise to backward bifurcations are studied. Surprisingly, a
rare hysteresis bifurcation may be observed where TB will continue to persist when the
associated basic reproduction number is less than one, even though there is no backward
bifurcation. Further, in this chapter the controversy raised by Lipsitch and Murray
[111] regarding whether the phenomenon of backward bifurcation in TB models can
occur in real life situations without compromising biological realism is revisited. It is
revealed that when recurrent TB is accounted for, through incorporation of previously
omitted reinfection pathways, then the phenomenon of backward bifurcation in TB
epidemic models can occur in real life scenarios.
4.2 Introduction
In 1882 Mycobacterium tuberculosis was identified by Robert Koch as the aetiological
agent responsible for tuberculosis (TB), yet despite all attempts to control its spread
by modern medical science, it has become one of the most widespread and serious of all
infectious diseases today [112]. The disease is transmitted from one person to another
in tiny microscopic droplets when a person with pulmonary TB expels bacteria into the
air by either coughing, sneezing, singing, laughing or other related activities that make
use of airborne pathways. Amongst all infectious diseases, TB is one of the leading
causes of death worldwide, and second only to HIV [1, 113]. Approximately a quarter of
the global population harbours the TB bacteria and another eight to nine million new
cases of tuberculosis emerge every year [114, 115]. Extraordinarily, TB is a treatable
disease and can be prevented and cured through the use of prophylaxis and therapeutics
for individuals with latent and clinically active TB respectively. Such treatment should
in theory be an effective strategy for controlling the spread of TB. However, it has
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failed in practice due to the inability to distribute sufficient drug treatment, usually
in the form of antibiotics, to the world’s population combined with the difficulties of
ensuring compliance to the required lengthy treatment program. Moreover, erratic
treatment has led to the evolution of multi-drug resistant tuberculosis giving rise to
the fear that TB may become an untreatable disease in the not too distant future.
These problems, taken together, have led the WHO (World Health Organization) to
formulate a post-2015 global “Stop TB Strategy” [112] to “end the global TB epidemic”.
A TB episode may have an exogenous or endogenous origin. Exogenous refers to a
disease episode that results from recent exposure to some external infectious source
(typically, contact with an infectious person). Endogenous designates situations where
the individual is already harbouring the causative agent, under some healthy control
by the immune system, which destabilizes and leads to disease. The pathogenesis of
TB is characterized by the infection either remaining dormant, often for a long period
that may last years, or progressing directly to active TB where clinical symptoms
immediately manifest. The latter process is referred to as fast primary progression.
The particular course of the disease depends on the host’s immune response towards the
tubercle bacilli. Thus, the exposure to tubercle bacilli does not necessarily result in the
manifestation of clinical forms of TB. Studies suggest that only 5-10% of individuals
progress directly to the active stage after exposure to bacilli [116, 117]. The other
component of the population of exposed individuals develop dormant TB and may
remain latently infected possibly for the rest of their lifetime. However, destabilization
of the immune system by the pathogen within the latently infected host can trigger
endogenous reactivation, in which latent bacilli are reactivated and cause clinical My-
cobacterium tuberculosis. The lifetime risk of a latently infected individual to progress
to the infectious stage is approximately 5-10% [118].
4.2.1 Evidence of recurrent TB
Recurrent TB is defined as the emergence of a second episode of TB after the first
episode has been successfully cured [77]. This often arises following treatment, because
an individual that recovers from a first episode of the disease does not necessarily
gain permanent immunity to a second. Approximately 10-30% of all cases of TB are
due to recurrent tuberculosis [79], and multiple episodes are largely attributable to
ineffective or poorly implemented tuberculosis control programs. Although recurrent
4.3 Model of recurrent tuberculosis 46
TB is recognized as a serious problem it receives little attention [79]. Through the use
of advanced molecular fingerprinting techniques TB recurrence has been classified into
two fundamental forms of infection: i) relapse of the original infecting strain, and ii)
reinfection with a new strain of Mycobacterium tuberculosis. The role of reinfection
and relapse to the overall burden of tuberculosis recurrence is not well understood and
this has potential public health implications [119]. It is important to note that the
system adopted by the WHO in recording and reporting TB cases does not differenti-
ate between true relapse (i.e., reactivation of latent TB) and reinfection (exogenous
acquisition of TB) and classifies relapse as any recurrence of TB [120]. This greatly
affects the collection and analysis of data making it even more difficult to assess the
specific role of reinfection. Studies conducted in [84] show that persons who had TB
once are at a strongly increased risk of developing TB when reinfected. Moreover, the
study suggests that the incidence rate of TB attributable to reinfection after successful
treatment is four times higher than that of new TB [84].
There is concrete evidence that supports the view that exogenous reinfection forms an
important source of recurrent TB among the successfully cured [56, 77, 84, 108, 109, 110].
Modern studies depict that exogenous reinfection is common in regions with a relatively
high incidence of TB. A recent study conducted in Shanghai revealed that 61.5% of
recurrent cases in a span of five years (1999 through 2004) were attributed to exogenous
reinfection [110]. Thus, through detailed mathematical modelling, a model incorporat-
ing recurrent TB will now be formulated to investigate the impact of recurrent TB
on the formation of backward bifurcations. The model will also be used to reveal new
bifurcation structures that recurrent TB can induce.
4.3 Model of recurrent tuberculosis
Although there are numerous TB models that have attempted to include the recurrent
TB pathway (for instance see [28, 56, 59, 85, 121, 122]), none have explored its role in
inducing new bifurcation structures besides formation of backward bifurcation. Yang
and Raimundo [59] investigated the impact of multiple infections and long latency
on the dynamics of recurrent tuberculosis. Their results suggest that a backward
bifurcation is expected to occur when a critical value of the disease incubation period
is exceeded. However, in their analysis they assume that the reinfection of recovered
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individuals is negligible, arguing that such a pathway increases non-linearity and makes
the model mathematically intractable. The models of Feng et al. [56] and Kar and
Mondal [85] were all based on the assumption that individuals went through a long
latency period before TB reactivated to clinically active TB. However, based on the
natural history of TB, fast primary progression of TB forms an important process
through which symptomatic TB emerges [123] and needs to be included. Indeed, Feng
et al. [56] incorporated a particular recurrent TB pathway in their model; however,
their simplifying assumptions hindered further exploration with regard to its role in
causing a backward bifurcation. The models developed by Gomes et al. [121] and
Herrera et al. [122] attempted to incorporate exogenous reinfection, partial immunity to
reinfection and primary progression. However, neither group examined how recurrent
TB reinfection pathways could lead to a backward bifurcation; instead their main
objective was to study the reinfection threshold. Hence, the main aim here is to study
reinfection among recovered individuals and deduce the epidemiological implications,
especially with regards to the possible formation of a backward bifurcation and other
new bifurcation structures. For this purpose a TB model that includes fast primary
progression and possible reinfection pathways is proposed.
The model is represented graphically in Figure 4.1 and assumes that every individual
in the population belongs to one of four broad classes: susceptible individuals (S);
exposed individuals (E) (these are infected individuals who are not able to transmit
infection); individuals with active TB (I) (who manifest symptoms and are able to pass
on the infection); and recovered/treated individuals (R). Individuals have the potential
to move through these four classes, as for example in the loop S→ E→ I→ R → I or
S→ E→ I→ R → E, upon contact with the disease.
Susceptible individuals are generated by recruitment through births and immigration
at a rate Λ. Upon effective contact with an infective, a small proportion q of infected
susceptible individuals follow the fast primary progression route (i.e., they move directly
to the infective class) while the rest (1− q) move to the exposed class where they pass
through a long latency period before reactivation and becoming infectious. Infected
individuals who recover from the disease then move to the recovered class.
The model includes three different pathways for exogenous reinfection as shown in
Figure 4.1:
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(i) Path A = pλE, where exposed individuals (see [56]), become reinfected and
progress to active TB;
(ii) PathB = (1−σ)θλR, where recovered individuals become reinfected and progress
to the exposed sub-population;
(iii) Path C = σθλR, where recovered individuals become reinfected and progress to
active TB.
In the proposed model, the parameter p measures the degree of protection against TB
among latently infected individuals and pλE is the exogenous reinfection incidence
rate. σ measures the probability of fast progression to the infectious class after rein-
fection. Following the studies of [56, 85, 121, 122, 124], p = 1 implies that the body
does not render protection against exogenous reinfection while 0 < p < 1 implies the
body is partially immune against exogenous reinfection (i.e., latent infection provides
partial immunity against new infections) [28, 83]. Note that p > 1 would imply that
an individual with latent TB infection has increased susceptibility to become newly
infected compared to the susceptibility of the general population [28]. This would
correspond to the results of studies which have found that recovered individuals are
more likely to be susceptible to future TB infection than TB-naive individuals [84].
The model parameter θ (0 < θ < 1) quantifies the amount of exogenous reinfection
among TB recovered individuals via paths B and C, while σ represents the probability
of fast progression after reinfection amongst recovered individuals. θ < 1 indicates that
recovered individuals have acquired some degree of partial protective immunity to TB
while θ > 1 indicates increased susceptibility.
The full set of model equations is given in terms of the rates of change of each of the
sub-populations S,E, I, and R, namely:
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dS
dt
= Λ− λS − µS,
dE
dt
= (1− q)λS + (1− σ)θλR− pλE − (k + µ)E, (4.1)
dI
dt
= qλS + σθλR + pλE + kE − (µ+ r + µd)I,
dR
dt
= rI − θλR− µR.
Note that the total population at time t is given by N(t),
N(t) = S(t) + E(t) + I(t) +R(t).
The model assumes a frequency-dependent incidence rate. Here the convention of
working with the so-called “force of infection” λ defined as
λ = cβI(t)
N(t) , (4.2)
where c represents the host-host contact rate is used. The parameter β is the prob-
ability of a contact being infectious [125] and I(t)/N(t) denotes the likelihood that
the encounter is with an individual with active TB [126]. That is, individuals become
infected when they come in contact with infected individuals regardless of the size
of the human population [19, 127]. This form of incidence is considered to be more
appropriate for infections in human populations [19]. It is important to note that
although a large number of the previous TB models utilised frequency-dependent inci-
dence rates, most assume that the disease-induced death rate (µd) is negligible for the
purpose of mathematical simplification. Indeed the analysis becomes mathematically
difficult or even intractable without making such assumptions, since otherwise the
total population of the model N(t) might never remain constant. Both [56] and [117]
resorted to this assumption, even though this was not true of their more general model
formulation. In the analysis here no such assumptions or simplifications are made and
the total population is considered to be varying in time.
In more detail, as equation (4.1) shows, new susceptible individuals are generated by
recruitment through births and immigration at a rate Λ. Susceptible individuals move
to the latently infected class E upon an effective contact with an infected individual
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(I) at a rate λS. The exposed sub-population (E) increases with the infection of
susceptible individuals at rate (1− q)λS and reinfection (recurrent TB) of recovered
individuals at a rate (1− σ)θλR. It decreases by exogenous reinfection (pλEI), and
endogenous reactivation (kE) upon which exposed individuals move to the infectious
class. The infected sub-population is generated by fast primary progression of TB
susceptibles (qλS), exogenous reinfection amongst the exposed sub-population (at rate
pλE), exogenous reinfection of recovered individuals (σθλR) and endogenous reactiva-
tion (kE). The sub-population is decreased by per-capita recovery due to treatment
rI, and by disease induced death at rate µdI. Finally the recovered sub-population
(R) is generated by the recovery of infected individuals and the loss due to exogenous
reinfection (at rate θλR). Note that natural death affects all classes of the population
at the same per-capita rate via the mortality parameter µ.
Note that the proposed model assumes all immigrants are susceptible and enter the
population at rate Λ. While this excludes the realistic possibility of immigration of
infectives (either latent individuals or individuals with active TB), it helps untangle
the conditions that result in backward bifurcation. Previous modelling studies have
already demonstrated that the immigration of infectives is a pathway that can trigger
backward bifurcations [128, 129]. Since the aim of the proposed model is to exclusively
investigate how reinfection after recovery influences TB dynamics, in particular the
phenomenon of backward bifurcation, recruitment of infected individuals is removed.
Otherwise the analysis is mathematically intractable. Moreover, it is important to
justify the choice of a single latent compartment instead of two (i.e., slow and fast
TB progression) as the modelling community is divided on how best to model TB
dynamics. In this chapter the choice of a single latent compartment instead of two
was based on the available literature on TB dynamics. Progression of active TB is
not uniform, as some infected individuals are more likely to progress to active TB
than others. A number of models incorporating long and variable rates of progression
have been constructed and analysed (for instance see [56, 94, 130]). Feng et al. [131]
investigated the impact of variability in latency using arbitrary continuous distributions
and found that such generalization did not result in qualitative differences in terms of
the model dynamics. Before the Feng et al. [56] study, Blower et al. [94] formulated
a differential equation model with two latent cohorts: one cohort consisted of those
who rapidly develop TB after primary infection; while the second cohort involved
individuals who develop the infection slowly through endogenous reactivation. Feng et
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al. [131] also showed that the artificial divisions (as in Blower et al. [94]) play no role
in the qualitative dynamics.
Secondly, a single latent compartment over two latent compartments (fast and slow TB
progression) was chosen for the purpose of mathematical tractability. The increased
number of reinfection pathways needed with two compartments would add a consider-
able degree of model complexity, and become very difficult to analyse. Moreover, the
original study of [56], where the role of reinfection in inducing backward bifurcation
was first identified, consisted of a single latent compartment. The paper [111] that
criticised Feng et al. [56] also had a single latent compartment. The goal of this chapter
is to investigate how recurrent TB (reinfection of recovered individuals) can impact
the backward bifurcation phenomenon found by Feng et al. [56], thus the need to keep
the same single latent compartment structure.
Table 4.1 provides a detailed list and description of the model parameters as well as
typical parameter values used here, as obtained from the literature.
S(t) E(t) I(t) R(t)
(1− q)λS kE rI
qλS
pλE
σθλR
(1− σ)θλR
µS
µEΛ
(µ+ µd)I µR
Figure 4.1: Schematic diagram of the main processes involved in TB infection according
to model equation (4.1). The red dotted curved arrows represent reinfection pathways.
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Table 4.1: Description of variables and parameters of model (4.1).
Variable Interpretation
S Susceptible sub-population
E Asymptomatic and non-infectious individuals
I Symptomatic and infectious individuals
R Recovered individuals
Parameter Interpretation Nominal value Sources Unit
µ Per-capita natural death rate 0.016 [132] year−1
µd Per-capita disease induced death rate 0.1 [56] year−1
θ Recurrent TB due
to reinfection 1.61 [1.61, 7.79] [28, 84, 91]
σ Probability of fast
progression after reinfection 0.05-0.1 [28]
r Per-capita recovery rate 2 [56, 133] year−1
p Exogeneous re-infection 0.25 [0, 1] [56, 132, 134]
q Primary progression proportion
(progress to active TB soon after infection) 0.05 [56, 85, 117]
[83, 94, 132] year−1
k Per-capita endogeneous reactivation rate 0.0002 [28, 91, 97] year−1
β Probability of becoming
infected per contact variable estimated
c Mean number of contacts variable estimated year−1
Λ Recruitment rate 100 [135] year−1
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4.4 Model analysis
4.4.1 Basic properties
Following the methods in [63] (and also the proof in chapter 3), it is not difficult to prove
that when all model parameters are nonnegative the state variables S(t), I(t), E(t)
and R(t) are all positive for all time t provided they are positive initially.
Theorem 4.4.1 The region
ℵ =
{
(S,E, I, R) ∈ R4+ : S + E + I +R ≤
Λ
µ
}
is positively invariant and attracting with respect to the model equation (4.1) with initial
conditions in R4+.
Proof. The proof of Theorem 4.4.1 is similar to the proof of Theorem 3.3.2 in chapter
3 and therefore is not repeated here.
The equilibria of the model are found by setting the rates of all variables in the left-hand
side of equation (4.1) to zero. Clearly the equations have an intrinsic disease-free
equilibrium (DFE) given by
(S¯, E¯, I¯, R¯) = P0 =
(
Λ
µ
, 0, 0, 0
)
.
The stability of the DFE is controlled by the basic reproduction number R0 which
represents the average number of new infections generated by an infected individual
when introduced into an entirely susceptible population. R0 may be determined using
the next generation operator method (see [136]) as shown in Appendix A, where it is
found that
R0 =
cβ(k + qµ)
(µ+ k)(µ+ r + µd)
. (4.3)
It is possible to decouple the expression for R0 to account for slow TB progression and
fast primary progression
R0 =
(
(1− q) cβ
µ+ r + µd
)(
k
µ+ k
)
︸ ︷︷ ︸
Slow TB R0
+
(
qcβ
1
µ+ r + µd
)
︸ ︷︷ ︸
Fast TB R0
.
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The slow TB component of R0 can be obtained by observing that the average infec-
tious period is given as 1
µ+ r + µd
and the probability of progressing from the latent
compartment to the infective class is given as
(
k
µ+ k
)
. Thus, the average time an
individual who starts in the latent compartment is expected to spend in the infectious
compartment is(
1
µ+ r + µd
)
×
(
k
µ+ k
)
. Multiplying this average time by (1− q)cβ yields the slow
TB R0. Moreover, multiplying the mean infectious period
(
1
µ+ r + µd
)
with qcβ
yields the fast TB component of R0.
An important result is the following Theorem 4.4.2:
Theorem 4.4.2 Provided R0 < 1, the DFE of the model (4.1) is locally asymptotically
stable, otherwise it is unstable.
This general result has been reviewed in [25], and hence Theorem 4.4.2 will not be
proved here. The theorem implies that it is possible to eradicate the disease from the
community when R0 < 1 if the initial sizes of the sub-populations of model (4.1) are
in the basin of attraction of the disease free equilibrium.
Interestingly, the formula for the basic reproduction number (4.3) does not include
the reinfection parameters p and θ despite the fact that these terms should contribute
significantly to the emergence of new cases of TB infection. Hence, this already suggests
that R0 alone is unable to completely quantify some key dynamical features of the TB
epidemic, and is in fact the first sign that a backward bifurcation might be involved.
It will emerge that the reinfection parameters p and θ do play an important role and
are responsible for the presence of the backward bifurcation intrinsic to this model.
4.4.2 Endemic equilibria
First the model’s endemic equilibrium points are identified being mindful that there
may in fact be several such points coexisting simultaneously. As before, to find the
endemic equilibria (S∗, E∗, I∗, R∗) the rate equations (4.1) are set to zero and solved
for the equilibrium quantities S∗, E∗, I∗ and R∗ in terms of the force of infection λ.
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This gives
S∗ = Λ
λ+ µ,
E∗ = (1− q)λΛ(µ+ µd)(θλ+ µ) + (1− q)λΛrµ+ (1− σ)θrΛλ
2
ϖ
,
(4.4)
I∗ = qλΛ(θλ+ µ)(pλ+ k + µ) + (1− q)λΛ(θλ+ µ)(pλ+ k)
ϖ
,
R∗ = rqλΛµ+ rλΛ(pλ+ k)
ϖ
,
where
ϖ =(µ+ µd)(θλ+ µ)(λ+ µ)(pλ+ k + µ) + rθλµ(1− σ)(λ+ µ)
+ rµ(λ+ µ)(pλ+ k + µ).
Substituting these equilibrium quantities (i.e., expressions (4.4)) into the force of
infection equation (4.2) yields
P (λ) = λ(a3λ3 + a2λ2 + a1λ+ a0) = 0, (4.5)
where
a3 = θp, a2 = cθp(β0 − β), a1 = c[qθµ+ θk + µp] (β1 − β) ,
a0 = cµ(k + µq)(βR − β), (4.6)
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and
β0 =
θp(µ+ µd) + (1− q)(µ+ µd)θ + (1− σ)θr + θ(k + µq) + p(µ+ r)
cθp
, (4.7)
β1 =
Ξ
c(qθµ+ θk + µp) , (4.8)
βR =
(µ+ r + µd)(µ+ k)
c(k + µq) , (4.9)
(4.10)
where
Ξ = θ(µ+ µd)(µ+ k) + µp(µ+ r + µd) + rθµ(1− σ) + (1− q)(µ+ µd)µ
+ r(µ+ k) + µ(k + µq).
One notes from equation (4.9) that R0 =
β
βR
, and also that the root λ = 0 corresponds
to the DFE, where I∗ = 0. Now the roots of the cubic equation
P1(λ) = a3λ3 + a2λ2 + a1λ+ a0 = 0 (4.11)
substituted in S∗, E∗, I∗, R∗ yield the endemic equilibrium for any specific set of model
parameters.
4.5 No recurrent TB (i.e., θ = 0 ): quadratic P2(λ)
First an important particular parameter subset in which θ = 0 is examined, that is, in
the absence of recovered individuals becoming reinfected. This model has the same
basic reproduction number as for the case σ, θ > 0, as σ and θ do not appear in the R0
expression (4.3). For σ = θ = 0 the third degree polynomial equation (4.11) collapses
to the quadratic
P2(λ) = c2λ2 + c1λ+ c0 = 0, (4.12)
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where
c2 = (µ+ r)p, c1 = cµp(β¯1 − β), c0 = cµ(k + µq)(βR − β),
β¯1 = β1|σ=θ=0 = (µ+ r + µd)µp+ (µ+ k)(µ+ r) + µµd(1− q)
cµp
.
In the above, it is observed that c0 < 0 corresponds to R0 > 1 and vice versa. Thus, in
the absence of recurrent TB it can be deduced that c1 < 0, R0 < 1 and c21 − 4c2c0 > 0
(see Theorem B.2.1 in Appendix B) indicate conditions for the existence of a backward
bifurcation, based on the roots of the quadratic equation (4.12).
Note that case (iii) of Theorem B.2.1 in Appendix B stipulates the condition that
△ = c21 − 4c2c0 > 0 which means there are two real positive endemic equilibria as
required for a backward bifurcation to appear. In fact △ = 0 provides the critical
point for the backward bifurcation where the two positive endemic equilibria collide
and annihilate each other leaving the DFE as the only equilibrium.
By setting △ = 0, the critical value of the transmission coefficient denoted by βc is
obtained. For mathematical convenience let
c1 = ϕ1 − ϕ2β, c0 = ϕ3 − ϕ4β, ϕ1 = (µ+ r + µd)µp+ (µ+ k)(µ+ r) + µµd(1− q),
ϕ2 = cµp, ϕ3 = (µ+ r + µd)(µ+ k), ϕ4 = cµ(k + µq).
Now the discriminant △(β) may be expressed in terms of β. Let βc be the critical
value of β for which the discriminant equals zero i.e.,
△(βc) = ϕ22β2c + 2(2c2ϕ4 − ϕ1ϕ2)βc + (ϕ21 − 4c2ϕ3) = 0.
Some algebraic rearrangement gives
βc =
(ϕ1ϕ2 − 2c2ϕ4) + 2
√
c22ϕ
2
4 + c2ϕ2(ϕ2ϕ3 − ϕ1ϕ4)
ϕ22
. (4.13)
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The critical value of the basic reproduction number denoted by Rc is obtained by
replacing the parameter β in R0 with βc which yields
Rc =
(
c(k + µq)
(µ+ k)(µ+ r + µd)
)(ϕ1ϕ2 − 2c2ϕ4) + 2
√
c22ϕ
2
4 + c2ϕ2(ϕ2ϕ3 − ϕ1ϕ4)
ϕ22
 ,
(4.14)
where the right-hand term in large brackets is just βc.
In fact Rc defines a sub-threshold domain of bistable equilibria of the model system
(4.1) in the sense that within the region Rc < R0 < 1 the model equation (4.1) has
two positive endemic equilibria simultaneously existing with a stable disease free equi-
librium. Thus, the backward bifurcation for equation (4.1) occurs for values of the
basic reproduction number R0 that lie between Rc < R0 < 1. The associated backward
bifurcation for the model without the reinfection pathways A and B (i.e., σ = θ = 0)
shown in Figure 4.2(a) is obtained by plotting λ as a function of β. Figure 4.2(a)
shows that model (4.1) has a disease free equilibrium which corresponds to λ = 0 and
two non-trivial endemic equilibria which, according to numerical simulations, one is
locally asymptotically stable (LAS) and the other is unstable (saddle). Applying the
Center Manifold Theory it is possible to examine the stability and coexistence of these
three equilibria (see proof in Appendix C). Coexistence of two positive equilibria when
R0 < 1 confirms that the model exhibits the phenomenon of backward bifurcation for
R0 < 1.
It can be seen from equations (4.13) and (4.14), that when the exogenous reinfection
parameter p increases, Rc decreases, and when exogenous reinfection parameter de-
creases, Rc increases. Hence, it is deduced from expression (4.14) that Rc is inversely
proportional to the level of exogenous reinfection p. This observation is confirmed by
Figure 4.2(b) which illustrates the effect of increasing exogenous reinfection p on Rc.
That is, with low values of exogenous reinfection the critical value Rc is high implying
that the extent of the backward bifurcation regime becomes smaller as Rc becomes
closer to unity (R0 = 1). The threshold implies that TB can be eliminated from the
community if the basic reproduction number is maintained below Rc (i.e., R0 < Rc).
More formally the following lemma is stated:
Lemma 4.5.1 For model equation (4.1), when σ = θ = 0,
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(i) If R0 > 1 the model has one positive endemic equilibrium point,
(ii) If Rc < R0 < 1 the model has two positive endemic equilibria,
(iii) If R0 < Rc the model has only a disease free equilibrium.
(a) (b)
Figure 4.2: (a) Illustration of backward bifurcation when there is no recurrent TB (i.e.,
θ = 0). Parameters used remain as defined in Table 4.1 except p = 0.09 > pc = 0.0658,
k = 0.0002, q = 0.05, c = 25, β ∈ [0.4, 0.9] and βc = 0.5099 corresponding to
Rc = 0.8852. In the figure the blue solid lines represent the stable equilibria while the
red dotted line represents unstable equilibria. (b) A plot of the critical value of the
basic reproduction number, Rc, as a function of the level of exogenous reinfection p.
NBB and BB respectively denote no backward bifurcation and backward bifurcation
regions. That is, in the region denoted by NBB the level of exogenous reinfection is
too low to induce backward bifurcation while in the region denoted by BB the level of
exogenous reinfection is sufficient to cause multiple positive endemic equilibria.
4.6 Recurrent TB: model with all reinfection path-
ways (A, B and C) θ > 0; cubic P1(λ)
Now returning to the fully general model with all parameters p, σ, θ positive. Recall
that the sign of the roots of the cubic polynomial (equation (4.5)) P1(λ), tell us
the signs of the equilibrium populations for the number of infected individuals (via
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equation (4.2)). Observe that the coefficients in the cubic polynomial a3, a2, a1 and a0
(see equation (4.6)) are all real numbers. For any non-negative model parameters, a3 is
always positive while a2, a1 and a0 can be either positive, zero or negative depending
on β0, β1 and βR, respectively (see equations (4.7)-(4.9)). A comprehensive analysis
of the roots of the cubic (4.11) may be carried out using Descarte’s Rule of Signs
[137] (see Table 4.2). A simpler more intuitive approach is to examine the roots at
the transcritical bifurcation point R0 = 1. Such an analysis gives an understanding of
the type of bifurcation that is likely to occur in the vicinity of R0 = 1, and provides
conclusions that coincide with the more detailed analysis based on Descarte’s Rule
of Signs [137]. Conveniently when R0 = 1 the cubic polynomial (4.11) reduces to the
quadratic equation
f(λ) = a3λ2 + a2λ+ a1 = 0.
A simple study of the roots shows that if a2 < 0 and a1 < 0 (i.e., if β > β0 and β > β1)
or if β1 < β < β0, the quadratic equation has one positive endemic equilibrium. As
seen in Figure 4.3(b), this is the signature of a backward bifurcation. Namely, when
R0 is slightly below unity, the model equation (4.1) has two positive endemic equilibria
but only one when R0 ≥ 1. Furthermore, if a2 > 0 and a1 > 0 (i.e., β < β0 and
β < β1) then at the point R0 = 1, the model has no positive endemic equilibria. This
characteristic is indicative of forward bifurcation as seen in Figure 4.3(a). However,
if R0 is increased slightly above unity then model (4.1) has one positive endemic
equilibrium point. It can be shown that if β0 < β < β1, then the reduced equation has
two positive real roots, indicating that the model equation (4.1) exhibits hysteresis
(see Figures 4.4(a) and 4.4(b)), as will be discussed in detail shortly. This discussion
based on the point R0 = 1 is summarized in Lemma 4.6.1:
Lemma 4.6.1 At the point R0 = 1, where β = βR the model equation (4.1) has:
(i) Two positive endemic equilibria if β0 < βR < β1, which signals hysteresis;
(ii) One positive endemic equilibrium if βR > β0 and βR > β1, or if β1 < βR < β0,
either of which signals backward bifurcation;
(iii) No positive endemic equilibria if βR < β0 and βR < β1, which signals forward
bifurcation.
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Table 4.2: Summary of the model equilibria.
Range of R0 Conditions Equilibria of model system (4.1) Type of bifurcation
R0 = 1 β > β0, β > β1 One positive endemic equilibrium Forward bifurcation
β1 < β < β0 One positive endemic equilibrium Forward bifurcation
β0 < β < β1 Two positive endemic equilibria Associated to hysteresis
R0 > 1 β ≥ β0, β ≥ β1 One positive endemic equilibrium Forward bifurcation
β ≤ β0, β ≤ β1 One positive endemic equilibrium Forward bifurcation
β0 < β < β1 Three positive endemic equilibria Hysteresis
Others
R0 < 1 β > β0, β > β1 Two positive endemic equilibria Backward bifurcation
β1 ≤ β < β0 Two positive endemic equilibria Backward bifurcation
β < β0, β < β1 No positive endemic equilibria Associated to
forward bifurcation
4.6.1 Existence of backward bifurcation reinfection threshold
at R0 = 1
The concept of existence of a critical point at R0 = 1 was fully developed by [58]. For
the general model (4.1), the critical value of exogenous reinfection pc required to allow
the formation of a backward bifurcation at R0 = 1 is determined.
Define
pc =
(
k + µq
µ(1− q)
)(
µ(1− q)(µ+ r + µd) + (µ+ r)(k + µq)
µ(µ+ r + µd)
− Fr
)
, (4.15)
where
Fr =
rθ(k + σµ)
µ(µ+ r + µd)
. (4.16)
The expression Fr (equation (4.16)) is associated with recurrent TB since it is the only
term containing the reinfection parameter θ. In the absence of recurrent TB due to
reinfection (i.e., θ = 0) the expression Fr reduces to zero. Now define the following
Lemma 4.6.2:
Lemma 4.6.2 The model system (4.1) at R0 = 1 exhibits
(i) Backward bifurcation whenever p > pc,
(ii) Forward bifurcation whenever p < pc.
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To see this, first note that referring to Figure 4.3(b), it is apparent that for a model to
exhibit backward bifurcation it is required that, at R0 = 1, there is a single positive
endemic equilibrium. Note again that when R0 = 1 (where a0 = 0), the equilibria
relate to the roots of the quadratic f(λ) = a3λ2 + a2λ+ a1 = 0. The roots are
λ = (−a2 ±
√
a22 − 4a1a3)/2a3 where a3 > 0. (4.17)
The point of interest is the point where the bifurcation structure changes from forward
to backward. But when R0 = 1 (β = βR) this is just the point where the positive
endemic equilibrium vanishes to zero, and from equation (4.17) this must occur when
a1 = 0 (β = β1); or equivalently β1 = βR. Also note that β1 is a function of p (i.e.,
β1 = β1(p)) while βR is not. Hence, equating equations (4.8) and (4.9) for β1(p) and
βR and solving yields the critical value pc for which β1(pc) = βR. After some algebraic
manipulation it is found that the required backward bifurcation reinfection threshold
is given by equation (4.15). A more detailed derivation of pc can be found in Appendix
C, which takes into account the stability of the equilibria through the use of Center
Manifold Theory.
Numerically, Lemma 4.6.2 is illustrated by Figures 4.3(a) and 4.3(b) which respectively
show that the model equation (4.1) has forward bifurcation when p < pc and backward
bifurcation when p > pc.
4.6.2 Relation with models of Lipsitch & Murray 2003 and
Feng et al. 2000
It is interesting to compare the critical point pc for the reinfection threshold given
in equation (4.15) with that found by Feng et al. [56] in their much simpler but still
important model. First note that Feng et al. [56] do not include fast primary progression
which is equivalent to setting q = 0 (see Figure (4.1)). They also assume that the
exogenous reinfection rates are θ = 1, σ = 0 and that the disease induced death rate
is negligible with µd = 0. Under these conditions Feng et al. [56] find that backward
bifurcations occur only if p > PFeng, where
PFeng =
k
µ
(
1 + k
µ+ r
)
≈ k
µ
,
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and the latter approximation assumes that k ≪ r.
In their controversial paper Lipsitch and Murray [111] argued that in the real world
recovered individuals gain immunity to reinfection, and thus reinfection among exposed
individuals must be less than the probability of progressing to the infectious stage of
TB. They showed that this implies
p < PL = k/(µ+ k) ≈ k
µ
given that k ≪ µ. As such, Lipsitch and Murray [111] argued that backward bifurcations
should not be expected in the real world. The extended model has some interesting
insights with regard to these studies. First note that after inclusion of the assumptions
made by Feng et al. [56] in model equation (4.1) (e.g., setting q = 0), the threshold pc
for backward bifurcation (equation (4.15)) simplifies to
pc ≈ PFeng. (4.18)
That is, backward bifurcations are possible only when p > pc ≈ PFeng, and thus the
result of Feng et al. [56] is retrieved.
Consider now the extended model with more realistic infection pathways (q > 0, σ > 0),
but still assuming that µd = 0, k ≪ µ and µ≪ r. For this approximation Fr ≈ σθ,
and the backward bifurcation threshold equation (4.15) simplifies to
pc ≈
(
q + k
µ
)(
1 + k
µ
− σθ
)
≈
(
k
µ
+ q
)
(1− σθ). (4.19)
It is interesting to compare this result to the threshold PL [111] discussed above. If
recovered individuals gain high immunity from having been infected, then the reinfec-
tion pathway R −→ I is relatively small (see Figure 4.1), with σθ ≪ 1. In this case
equation (4.19) shows that pc ≈ PL + q. This is similar to the Lipsitch and Murray
[111] criterion, and suggests that backward bifurcation is unlikely to occur in the
real world, if as Lipsitch and Murray [111] claim that in reality p < PL. However, if
recovered individuals gain only mild immunity against reinfection, then the reinfection
pathway R −→ I and σθ can be relatively large. Note that θ can be greater than unity
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as suggested by Verver et al. [84]. Gomes et al. [91] estimate θ to be in the range
[1.61, 7.79]. In this situation it is quite possible that pc < PL. Hence, with relatively low
immunity amongst recovered individuals [84] backward bifurcation can occur despite
the fact that the Lipsitch and Murray [111] prediction would predict otherwise. This
does not mean that Lipsitch and Murray [111] have erred, but that their result may
need modifications when discussing the presence of more complex reinfection pathways.
In fact even just for the simplified reinfection pathways of the original Feng et al. [56]
model, the validity of the Lipsitch and Murray [111] argument has recently been called
into question given the difficulties of comparisons with real world processes [126].
In the more recent literature, numerous studies have pointed out that initial infection
may not confer protection against exogenous reinfection especially in high-risk popu-
lations [138, 139]. Some studies have demonstrated that it is possible for exogenous
reinfection to outweigh endogenous reactivation [140, 141]. This is supported by the fact
that the majority of new TB cases (about 90%) occur as a result of reinfection rather
than endogenous reactivation [134, 140, 141, 142]. In this situation, pc > k/(µ+ k),
and backward bifurcations can occur even according to the Lipsitch and Murray [111]
criteria. Other distinguished medical research shows that reinfection rates after suc-
cessful treatment are much higher than rates of new TB; sometimes approximately
four times higher [84, 91]. Furthermore, similar to vaccine conferred immunity, the
protection rendered by latent TB infection wanes with time and it is uncertain whether
latent infections would provide a similar immunity decades after the first episode of
TB [134].
4.7 Hysteresis
For the usual forward bifurcation (for example, Figure 4.3(a)), a model has two locally
stable branches at the transcritical point R0 = 1 : i) an infection free equilibrium
that is locally asymptotically stable when R0 < 1; ii) an endemic equilibrium which is
stable for R0 > 1. However, this scenario where there is only one endemic equilibrium
when R0 > 1 may not always be the case. For example, Reluga et al. [39] noted in
their study of epidemic models with structured immunity that it is possible that more
than one endemic equilibria may coexist even though the basic reproduction number is
greater than one. This leads to an unusual phenomenon of forward bifurcation with
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(a) (b)
Figure 4.3: Plots the number of infectives at equilibrium as a function of R0. In
both figures the blue solid lines represents stable equilibria while the red dotted line
represents an unstable equilibrium. (a) Shows forward bifurcation with parameters
p = 0.06 < pc = 0.0647, σ = 0.05, θ = 0.3, µ = 0.0167, µd = 0.1, r = 2, q = 0.05,Λ =
100, c = 60, k = 0.0002, β ∈ [0.3, 0.8]. (b) Shows backward bifurcation with the same
as in (a) except p = 0.09 > pc = 0.0647. For a clear view all bifurcation structures are
plotted with semi-log axes.
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(a) (b)
Figure 4.4: Plots show the infectious population I∗ at equilibrium as a function
of R0. (a) Forward bifurcation with hysteresis where the multiple equilibria are
strictly to the right of R0 = 1. (b) Forward bifurcation with hysteresis where there
are multiple equilibria to the left and to the right of R0 = 1. Parameters used are
µ = 0.0167, µd = 0.1, k = 0.0002, θ = 0.5, r = 2, q = 0.05, σ = 0.2, c = 60,Λ = 100,
β ∈ [0.2, 0.8]. In (a) p = 0.057 < pc = 0.0639 and in (b) p = 0.058 < pc = 0.0639. In
both figures the blue solid lines represent stable equilibria while the red dotted lines
represent unstable equilibria. For a clear view, all bifurcation structures are plotted
with semi-log axes.
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hysteresis, which can be triggered in TB model equation (4.1) when reinfection is taken
into account. Thus equation (4.1) exhibits a hysteresis effect where multiple endemic
equilibria coexist when R0 > 1, as shown in Figure 4.4(a). The two “outer” equilibria
are stable while the interior equilibrium (dotted red line) is unstable. Table 4.2 clarifies
that three endemic equilibria coexist for R0 > 1 if β0 < β < β1. For some parameter
regimes with hysteresis, the endemic equilibria may also be found in the region where
R0 < 1 and where disease is not expected, as shown in Figure 4.4(b). In this scenario,
(similar to a backward bifurcation) TB persists for R0 < 1 even though the bifurcation
at R0 = 1 is a forward bifurcation. So far no other epidemic modelling study is observ-
ing this feature. This feature where hysteresis loops shifts to the left, thus crossing the
epidemic threshold R0 = 1 has epidemiological implications in that, although there
is no backward bifurcation phenomena (as ascertained by the fact that the hysteresis
effect occurs when p < pc) policy makers and clinicians need to reduce the basic
reproduction number below another threshold to eradicate TB. That is reducing R0
below unity will be necessary but not sufficient in eradicating TB within the community.
It is important to note that hysteresis effects appear to occur for a narrow range of
parameters values of R0 when realistic model parameter values are used. However,
the hysteresis effect can be wider for other parameter values. Hence, the occurence
of hysteresis here within a narrow range of R0 values is because the parameter values
selected are within a plausible and realistic range.
4.8 No reinfection path A, (i.e., p = 0, θ > 0)
The case when there is no reinfection among recovered individuals but reinfection of
exposed individuals (i.e., p > 0 and θ = 0) was studied by Kar and Mondal [85], where
an exogenous reinfection threshold was established. Thus, this section focuses on the
scenario when there is no exogenous reinfection among exposed individuals (i.e., p = 0,
reinfection path A is omitted). The goal is to determine whether recurrent TB due
to reinfection of recovered individuals only (θ > 0) can induce the phenomenon of
backward bifurcation.
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In model system (4.1) setting p = 0 yields the following subsystem:
dS
dt
= Λ− λS − µS,
dE
dt
= (1− q)λS + (1− σ)θλR− (µ+ k)E, (4.20)
dI
dt
= qλS + σθλR + kE − (µ+ r + µd)I,
dR
dt
= rI − θλR− µR.
The model system (4.20) has equilibrium points (S∗, E∗, I∗, R∗) that can be expressed
in terms of the force of infection λ∗, obtained by solving
P3(λ∗) = b2λ∗2 + b1λ∗ + b0 = 0, (4.21)
where
b2 =(1− q)(µ+ µd)θ + (1− σ)θr + θ(k + µq),
b1 =θ(µ+ µd)(µ+ k) + rθµ(1− σ) + (1− q)(µ+ µd)µ+ r(µ+ k) + µ(k + µq)
− cβ(qθµ+ θk),
b0 =µ(µ+ r + µd)(µ+ k)(1−R0).
Note that the subsystem (4.20) has the same basic reproduction number as model (4.1).
It is easy to see that R0 = 1 implies b0 = 0. Thus, the following equality is satisfied
when R0 = 1:
(µ+ r + µd)(µ+ k) = βc(k + µq). (4.22)
This combined with the condition b1 < 0, which is necessary for backward bifurcation
to occur, and with some algebraic manipulation leads to
θ >
(1− σ)(µ+ µd)µ+ r(µ+ k) + µ(k + µq)
r(k + µσ) ≜ θc (4.23)
as the required threshold for backward bifurcation.
Theorem 4.8.1 The model subsystem (4.20) at R0 = 1 has:
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(i) Backward bifurcation if θ > θc;
(ii) Forward bifurcation if θ < θc.
Furthermore, a similar condition to (4.23) can be obtained by setting p = 0 in the
Center Manifold results given in Appendix C equation (C2), hence corroborating
Theorem 4.8.1. Thus, if θ > θc = 5 model (4.20) will exhibit backward bifurcation.
However, if θ < θc = 5 model (4.20) does not exhibit backward bifurcation (i.e., has
only forward bifurcation).
With the existing evidence that recovered individuals have increased susceptibility to
reinfection, that is four times higher than that of new TB [28, 84], Theorem 4.8.1 sug-
gests that the contribution of recurrent TB in the general TB burden can significantly
alter TB dynamics, especially in a scenario where recurrent TB independently triggers
the phenomenon of backward bifurcation.
It is important to note that although previous TB models have attempted to incorporate
recurrent TB pathways they do not investigate whether recurrent TB alone can trigger
bi-stability, but rather concentrate on backward bifurcation caused by exogenous
reinfection of exposed individuals (i.e., p > 0). Selecting values of θ from the estimated
interval, i.e., θ ∈ [1.61, 7.79] (see [91]), the threshold given in Theorem 4.8.1 is verified.
Figure 4.5(a) is a bifurcation diagram corresponding to the case θ < θc and indicates a
forward bifurcation, as predicted by Theorem 4.8.1 case (ii). Similarly, Figures 4.5(b)
and 4.5(c) indicate backward bifurcation since θ > θc as predicted by Theorem 4.8.1
case (i).
4.9 Impact of incorporating recurrent TB parame-
ters
Recall that recurrent TB due to reinfection is denoted by reinfection pathways B and
C in Figure (4.1). Given that reinfection path A does induce backward bifurcation
when p > pc it is of interest to investigate how the additional recurrent reinfection
paths B and C can impact the backward bifurcation. In Figure 4.6(a) the force of
infection (λ) is plotted as a function of the basic reproduction number R0 for scenarios
with different recurrent TB contributions. The figure shows that recurrent TB due to
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(a) (b) (c)
Figure 4.5: A scenario where the reinfection path A is omitted (i.e., no reinfection of
exposed individuals, p = 0). Parameters used are µ = 0.0167, µd = 0.1, k = 0.0002, r =
2, q = 0.05, σ = 0.2, c = 60, β ∈ [0.5, 0.65]. (a) A scenario where θ = 4 < θc = 5 and
in this case there is only forward bifurcation at R0 = 1. (b) and (c) show backward
bifurcation and the corresponding θ values are respectively θ = 6 > θc = 5 and
θ = 7.5 > θc = 5.
reinfection among treated/recovered individuals shifts the backward bifurcation to the
left as well as widens the gap between the bifurcation curves. In summary raising the
intensity of recurrent TB leads to:
(i) Widening of the gap between the bifurcation curves (see Figure 4.6(a));
(ii) Reducing the critical value Rc;
(iii) Increasing the number of infected individuals (TB burden) (see Figure 4.6(b));
(iv) Reducing the reinfection threshold pc that induces the phenomenon of backward
bifurcation.
4.10 Summary of the chapter
van Rie et al. [138] wrote: “For decades it has been assumed that postprimary tu-
berculosis is usually caused by reactivation of endogenous infection rather than by
a new, exogenous infection.” Until just before the turn of the century the role of
exogenous reinfection in the transmission of TB was usually believed to be minimal.
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(a) (b)
Figure 4.6: (a) The effect of recurrent TB on backward bifurcation due to the incorpo-
ration of reinfection pathways B and C. Parameter values are µ = 0.0167, µd = 0.1, k =
0.0002, r = 2, q = 0.05, σ = 0.05, p = 0.09, c = 60,Λ = 100, β ∈ [0.45, 0.7]. With no
recurrent TB (θ = 0), p = 0.09 > pc = 0.0659 while with recurrent TB (θ = 0.3)
parameters are the same but pc is altered, i.e., p = 0.09 > pc = 0.0647. The blue
solid lines represent stable equilibria while the red dotted line represent un unstable
equilibrium. (b) Contour plots of force of infection at equilibrium as a function of θ
and p. The figure shows that increasing recurrent TB increases TB prevalence.
However, these views are no longer considered accurate and understanding of the role
of exogenous reinfection has been completely revised. Warren et al. [143] refuted the
unitary concept of pathogenesis of tuberculosis proposed in the 1960s, that tuberculosis
results from a single infection with a single Mycobacterium tuberculosis strain, and
such infections were thought to confer protective immunity against exogenous reinfec-
tion. Thus, exogenous reinfection was thought to be uncommon. Murray and Cohen
[142] found that their data for exogenous reinfection among US immigrants strongly
suggested that reinfection likely plays a major role in high-incidence TB areas.
For the proposed TB model the condition p > pc > q is necessary for backward
bifurcation to occur if reinfection of recovered individuals is not considered (i.e.,
Fr = 0). However, if reinfection of recovered individuals is accounted for the condition
p > pc > q does not necessarily have to hold. This is because reinfection of recovered
individuals can independently induce backward bifurcation phenomenon. Lipsitch
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and Murray [111] argued that backward bifurcation should not occur when taking
into account biologically realistic parameter values. Their argument was built on the
premise that exogenous reinfection among exposed individuals should be less than
the probability of progressing to clinically active TB due to endogenous reactivation,
which translates in mathematics to p < PL = k/(µ+ k). But Feng et al. [56] found that
backward bifurcation can only take place if p > PFeng > PL. For this reason, Lipsitch
and Murray [111] concluded that backward bifurcations are unlikely to be relevant
in the context of TB despite the non-existence of data to support their claim. The
argument of Lipsitch and Murray [111] was based on the Feng et al. [56] TB model
which as mentioned, failed to incorporate key TB pathways such as primary progression
and recurrent TB due to reinfection where some recovered/treated individuals revert
directly to the infective stage. Yet, these pathways are critical to TB epidemiology,
an aspect that was pointed out by Lipsitch and Murray [111] as a weakness of the
Feng et al. [56] model, and they called for further research that would account for
these omitted pathways. However, as has been pointed out, modern research no longer
seems to support the argument developed in Lipsitch and Murray [111] since exogenous
reinfection among individuals with latent TB can outweigh endogenous reactivation
[140, 141]. And this implies that the protection provided by latent TB infection is
not strong enough to prevent individuals becoming reinfected. This is supported by
the fact that the majority of new TB cases (about ninety percent) are a result of
reinfection rather than endogenous reactivation [84, 140, 141, 142]. Moreover, studies
of TB reinfection in high-HIV burden countries have demonstrated the strong negative
impact of HIV on immunity, which is likely to outweigh the possible protection con-
ferred by latent infection [134]. Under this scenario, backward bifurcation is likely to
occur since reinfection will be greater than endogenous reactivation (i.e., p > k/(µ+k)).
The analysis conducted here has shown that when exogenous reinfection is significant
(resulting in a relatively small pc), as is currently understood to be not atypical, back-
ward bifurcation can indeed occur for relatively low values of the reinfection parameter
p. Furthermore, it is observed that if the exogenous reinfection path A is ommited,
which is required to cause backward bifurcation in the study of Feng et al. [56], then
recurrent TB alone (i.e., paths B and C in model equation (4.1)) may still yield
backward bifurcations. For instance, if p = 0 (thereby omitting pathway A), and the
recurrent TB rate parameter θ exceeds a certain threshold θ > θc, backward bifurcation
can occur (see Figures 4.5(b) and 4.5(c)). According to the available literature on
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TB, this result has not been observed in previous TB modelling studies. In addition,
recurrent TB can induce forward bifurcation with hysteresis, rather than just the
usual forward bifurcation. Interestingly, the hysteresis loop depends on reinfection
parameters, and this may lead to an unusual scenario where the hysteresis crosses
the threshold R0 = 1 thus entering the region where only backward bifurcation is
expected (see Figure 4.4(b)). Epidemiologically this implies that TB can persist in the
community when R0 < 1 even though there is only a forward bifurcation.
In the literature it has been observed that individuals who previously have had active
TB and who were successfully treated are more likely to gain active TB another time
[84]. However there is little understanding as to why this occurs. Gomes et al. [91]
suggested two alternative mechanisms a) previous infection increases susceptibility of
individuals to reinfection; b) population heterogeneity, in which some individuals are
more at-risk than others, might lead to this conclusion. In this chapter, the former
possibility is almost exclusively explored. However the latter possibility may also be
at play as examined by Gomes et al. [91]. In the latter case, heterogeneity would be
less likely to create changes in reinfection parameters such as θ, and thus might not
lead to the same bifurcation phenomena found in this study. Nevertheless, a wealth of
theoretical studies suggest that heterogeneous infection processes are often involved
in creating backward bifurcations, and thus complex dynamical phenomena can be
expected as exhbited in [31, 55, 144].
In future work, it would be interesting to consider the possibility that some infected
individuals who are treated do not become completely cured. This situation would lead
to another cohort of individuals characterised by the fact that treatment has failed,
and thus require adding an extra compartment which distinguishes complete recovery
and incomplete recovery (of individuals who are infectious). The extra infectives
from the latter compartment will tend to increase TB prevalence and thus widen the
bifurcation curves. While this possibility is of importance, it falls outside the main
scope of the present chapter, and would lead to a model that is very difficult to analyse
mathematically.
Chapter 5
Heterogeneity in host susceptibility
to tuberculosis and its effect on
public health interventions
5.1 Chapter overview
In this chapter a tuberculosis (TB) model that accounts for heterogeneity in host
susceptibility to tuberculosis is proposed, with the aim of investigating the implications
this may have for the effectiveness of public health interventions. The model exam-
ines the possibility that recovered individuals treated from active TB and individuals
treated with preventive therapy acquire different levels of immunity. This contrasts
with recent studies that assume the two cohorts acquire the same level of immunity,
and therefore both groups are reinfected at the same rate. The analysis presented
here examines the impact of this assumption when designing intervention strategies.
Comparison of reinfection rates between cohorts treated with preventive therapy and
recovered individuals who were previously treated for active TB provides important
epidemiological insights. It is found that the reinfection rate of the cohort treated
with preventive therapy is the one that plays the key role in qualitative changes in TB
dynamics. By contrast, the reinfection rate of recovered individuals (previously treated
from active TB) plays a minor role.
Moreover, the study shows that preventive treatment of individuals during early
latency is always beneficial regardless of the level of susceptibility to reinfection; the
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only notable difference being the magnitude of reduction in the TB burden. Greater
impacts occur when the risk of reinfection is relatively low. Further, if patients have
greater immunity following treatment for late latent infection, then treatment is again
beneficial. However, if susceptibility increases following treatment for late latent
infection, the effect of treatment depends on the epidemiological setting. That is:
(a) in (very) low burden settings, the effect on reactivation predominates and the
burden declines with treatment; (b) in moderate to high burden settings the effect
of reinfection predominates and burden increases with treatment. The effect is most
dominant between the two reinfection thresholds, RT2 and RT1, respectively associated
with individuals being treated with preventive therapy and individuals with untreated
late latent TB infection, as explained in more detail below.
5.2 Introduction
After coming into contact with Mtb, individuals may progress directly to active infec-
tious disease (primary progression) or enter a state of latent Mtb infection (LTBI) from
which they may develop active disease after a variable period of time through “reactiva-
tion”. This pattern is consistent with epidemiological evidence indicating that the risk
of active TB is highest in the first five years from exposure and declines thereafter, with
the highest risk period being immediately after infection [134]. The risk of reinfection or
superinfection with further episodes of exposure to Mtb is unclear, and although there
is likely to be some degree of immunity to subsequent infections, little is known about
the extent of protection [77, 145]. Models emphasize that understanding the degree of
reduction of TB risk following previous infection in comparison to primary infection
is critical to understanding the epidemiology of TB [134]. For example, following the
introduction of a drug-resistant Mtb strain into a population where TB burden is high,
the proliferation of the strain may be hampered by the size of the effective suscep-
tible population, which may be largely determined by the level of immunity among
individuals with LTBI [146]. As a consequence, if latent infection provides sufficient
protection against future infection, then the rate of infection with the resistant strain
will fall, markedly curtailing the TB epidemic. However, issues such as disparities in
infection rates between communities burdened with human immuno-deficiency virus
(HIV) make it difficult to study reinfection directly, as the detrimental impact of HIV
on immunity surpasses immunity provided by latent infection [134]. There have been
past attempts to estimate the risk of reinfection amongst latently infected individuals,
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including through population models such as [140, 147, 148, 149], which have shown
risk reductions ranging from 41% to 81%. Together, these studies suggest that partial
protection (from TB) is provided against future episodes of disease.
Besides reinfection of LTBI, individuals who have had active TB but have recovered,
are also at risk of reinfection. For this reason, many models incorporate a compartment
accounting for recovered individuals who remain susceptible to further episodes of
TB (recurrent TB). It is important to note that there are two mechanisms by which
recurrent TB can occur: (i) relapse with the previously responsible strain or (ii) re-
infection from a new strain of TB. The latter contribution of exogenous reinfection
with Mtb (in comparison to the endogenous reactivation of LTBI) to recurrent TB is
a subject that is still debated as the two mechanisms cannot be easily disentangled
[91]. However, advances in clinical medicine and gene technology, such as DNA fin-
gerprinting techniques, can now distinguish the first episode of TB from the second
[78, 79, 80, 81]. Further, these techniques can determine whether a new episode of TB
is caused by infection with the same strain as previously or a newly encountered strain,
enabling classification of TB episodes as either relapse or reinfection, respectively.
However, there is no consensus on whether recovered/treated individuals should be
assigned a higher, lower or equivalent rate of infection in comparison to either latently
infected or to uninfected individuals (susceptible). This raises the important question
of how different levels of susceptibility across a population may interact to affect Mtb
transmission dynamics. Some different approaches to exploring the impact of rates
of recurrent TB adopted in the past include: assuming recovered individuals have no
risk of reinfection [130, 150]; assuming relapse is responsible for all recurrent cases [94];
assuming equal risk of reinfection as for latently infected individuals [151]; assuming
recovered individuals have equal rates of reinfection as for susceptible individuals [152];
incorporating both reinfection and relapse pathways after treatment [153]. Therefore,
there is no consensus on whether recovered individuals have no risk of future infection,
reduced risk, equal risk, or increased risk.
A previous review of recurrent TB episodes revealed that the proportion of recurrent
cases that were due to subsequent infection with a new strain as opposed to relapse
with the same strain varied markedly from 0% to 100% [119]. The review emphasized
that relapse and reinfection should be treated as separate mechanisms and the two
mechanims are likely to be responsible for the extent of variability in results. According
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to [138, 154, 155, 156], rates of reinfection after successful treatment have been found
to be variable in highly endemic regions, which likely reflects the degree of continuing
exposure after treatment. Estimates of rates of recurrent TB in various settings often
reach several thousand per 100,000 person-years, including estimates as high as 7850
per 100,000 persons-years [92]. A meta-analysis of such studies found that reinfection
rates after successful treatment are higher than the background rate of TB in the
community [84].
Currently, drugs are available that can be used to treat both individuals with LTBI
and individuals with active TB, with the two most important first-line drugs being
isoniazid and rifampicin. These two medications are effective in the treatment of active
TB disease and as preventive therapy for patients who have previously been infected
but are yet to manifest symptoms. Isoniazid preventive therapy (IPT) is the most
commonly used preventive regimen globally and has established efficacy in dramatically
reducing a patient’s future risk of progression to active TB [157]. Past case studies of
isoniazid preventive therapy (IPT) among latently TB infected individuals (conducted
in South Africa gold mines) suggested that IPT is effective at the individual level,
significantly reducing the risk of subsequent disease. However, the effect of IPT may
be lost immediately when treatment is discontinued, which led the authors to conclude
that the role of IPT at the population level is unclear. However, they also called
for further research, since the effectiveness at the population level may have been
compromised by a number of factors, such as post-treatment reinfection of miners or
inadequately treated LTBI [158]. Other factors such as a high prevalence of HIV and
silicosis, which are known to be strong risk factors for tuberculosis, may have also
influenced the population level effect of IPT. Therefore, for IPT to be effective, it may
need to be administered continuously amongst individuals at highest risk of TB.
Although, previous studies have considered population-level heterogeneity in susceptibil-
ity to reinfection between previously treated and latently infected persons [91, 97, 159],
no previous work has considered differential susceptibility across all four possible
exposure and treatment histories (i.e., fully susceptible, LTBI, treated LTBI and
treated TB disease), together with the population level impact of all relevant public
health interventions. Moreover, it is highly likely that the levels of susceptibility of
the two previously treated populations differ considerably, given the likelihood that
those treated for latent infection may retain some of the considerable immunological
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protection conferred by this infection, whereas the level of protection conferred by
previous active TB is highly uncertain. In this chapter a TB model is presented with
the aim of investigating: (i) how variability in risk of reinfection alters TB dynamics
in a model accounting for heterogeneity in host susceptibility; (ii) how this variability
in risk of reinfection influences the effectiveness of public health interventions.
5.3 Model description
Following contact with Mtb an individual may develop TB disease as a result of one
of three possible routes. These are fast primary progression after a recent infection,
endogenous reactivation of LTBI and exogenous reinfection of a previously infected
individual [160]. Here a deterministic mathematical model of the transmission of
Mtb, taking into consideration the treatment of latently infected individuals with IPT
is developed. Numerous infectious diseases demonstrate considerable latent periods
during which an individual harbours the disease but does not manifest symptoms and
is not infectious. A key feature of TB is its long latency period. This characteristic
has crucial epidemiological implications [94], and thus most mathematical models of
Mtb transmission in the literature incorporate latent compartments [161]. Through
clinical observation it has been noted that following infection with TB, different rates
of progression to active TB exist and that these rates decrease with time from infection.
For example, 12.9% of patients with infection confirmed with interferon-gamma release
assays following exposure to a smear-positive index case progressed to active TB in
23 months [162]. By contrast, after the initial high risk period, the rate at which
reactivation TB occurs is relatively low and is estimated at 5-10% over 20 years [94]. To
account for these marked differences, past mathematical models devoted to tracking TB
dynamics have incorporated two major pathways from susceptible to actively infected:
fast and slow TB progression. In such models, a fraction of exposed susceptibles
progresses directly to active TB, bypassing the latency compartment [56, 94, 146, 163].
This modelling method enables a slight modification of the standard exponential func-
tion that governs time spent in the exposed compartment [164]. Other approaches
include employing a stepwise reduction in the rate of progression occurring five years
after exposure [140] or an arbitrary distribution of the latent period [56].
In recent TB transmission models, compartments for both early and late latency
are increasingly utilized to account for high and low risk periods following infection
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[91, 97, 165, 166, 167]. In such compartmental configurations all individuals progress
to the early latent compartment following infection, after which a fraction may progress
to infectious TB while the remainder transit to the low-risk late latent compartment
[150, 167, 168, 169]. In consideration of the above discussion, the present study strati-
fies latent Mtb infection into two cohorts: a cohort at high risk of developing active
TB, which is referred to as early LTBI, and a later stage of individuals with low
risk for developing active TB, which shall be referred to as late LTBI. Therefore, the
overall population is partitioned into six mutually exclusive classes: susceptible S
which comprises individuals who have not come into contact with tuberculosis; early
latently infected L1 which represents individuals who have recently been infected with
Mtb (generally within a period of less than two years); late latently infected L2 which
represent individuals with persistent latent TB who have contained TB infection and
whose TB infection remains inactive; infectives I which represents individuals with
active TB and are capable of infecting others; P which represents individuals who are
being or who have been treated with isoniazid preventive therapy; recovered R which
represents individuals who were previously infected and have been successfully treated.
The total population is assumed to be large enough to be modelled deterministically
and random mixing is assumed.
For the sake of mathematical tractability, here it is assumed that the birth rate
compensates for TB-induced and background mortality (similar to the simplification
used in some of the classical studies in the field, as for example in some of the key
studies of Blower et al. [94, 117, 130, 167] and Dye et al. [170]). Thus, λ = µ + dI
is the recruitment rate and all state variables are expressed as a fraction of the total
population. The susceptible population comprises of individuals who enter into this
compartment at a rate λ and they diminish as individuals are infected with Mtb at a
density-dependent infection rate βI, where β is the transmission coefficient. Newly
infected individuals enter the early latent compartment L1 and it is assumed that
a proportion of individuals in the early latent compartment are detected following
screening for TB and are treated with IPT at rate θ, progressing to compartment P. A
proportion of individuals in the early latent compartment progress to the active TB
compartment I at a rate fϕ, while the remaining proportion proceeds to the late latent
compartment at a rate (1− f)ϕ.
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Individuals in the late latent compartment may also receive IPT and thus progress to
compartment P at a rate ρ. Furthermore, individuals in the late latent compartment
can transit into the infectious compartment I due to endogenous reactivation of their
latent TB at a rate η.
Only persons in the I compartment are infectious, and as such compartments L1, L2
and P do not contribute to the force of infection. Therefore, the infectious compartment
is generated by fast progression of TB, endogenous reactivation from late latency and
relapse of recovered individuals at a rate ω. The subpopulation is diminished when
individuals are successfully treated at rate τ or as a result of spontaneous recovery
(self cure) at a rate α.
Previously infected individuals may be fully susceptible to exogenous reinfection and
infected at the same rate as the susceptible population (S(t)), or partially immune
or have no immunity against reinfection. Consequently, late latently infected individ-
uals, individuals treated with IPT and recovered individuals are reinfected at rates
σiβ (where i=1,2,3), respectively, with σi ∈ [0, 1] (i = 1, 2, 3) accounting for partial
immunity against exogenous reinfection. Note that σi = 1 (i = 1, 2, 3) corresponds
to a scenario where late LTBI, treated LTBI and recovered individuals are infected
at the same rate as susceptible individuals, while σi > 1 (i = 1, 2, 3) implies that all
post-infection cohorts have increased susceptibility to reinfection in comparison to
susceptible individuals. This would also correspond to some past studies which have
shown that individuals who have recovered from TB infection are more susceptible to
future infection and in such a scenario σi > 1, i = 1, 2, 3 [84].
All individuals experience natural death at a constant rate µ, except infectious in-
dividuals who suffer an additional TB-induced death at rate d. Transitions between
compartments are shown diagrammatically in Figure 5.1. Combining the aforemen-
tioned assumptions, the following system of nonlinear ordinary differential equations
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S(t) L1(t) L2(t) I(t)
R(t)P (t)
βIS (1− f)ϕL1 ηL2
θL1
fϕL1
σ3βIR
σ1βIL2
σ2βIP ρL2 (τ + α)I ωR
λ
µS µL1 µL2 (µ+ d)I
µRµP
Figure 5.1: Schematic representation of the model. The square boxes represent
classification of the general population into six mutually exclusive subpopulations,
i.e., susceptibles S(t), early latents L1(t), late latents L2(t), individuals treated with
isoniazid preventive therapy P (t), individuals with active TB I(t), and recovered
individuals R(t). All arrows indicate either inflow or outflow or transition between
compartments. Blue arrows illustrate transition of latently infected individuals as
a result of treatment with IPT. Red dashed arrows show reinfection of late latently
infected individuals, individuals treated with IPT and recovered individuals, respectively
represented by σi, i = 1, 2, 3.
govern the model:
dS
dt
= λ− µS − βIS,
dL1
dt
= σ1βIL2 + σ2βIP + σ3βIR + βIS − (θ + µ+ ϕ)L1,
dL2
dt
= (1− f)ϕL1 − (µ+ η + ρ+ σ1βI)L2, (5.1)
dI
dt
= ϕfL1 + ηL2 + ωR− (µ+ d+ τ + α)I,
dP
dt
= θL1 + ρL2 − (µ+ σ2βI)P,
dR
dt
= (τ + α)I − (µ+ ω + σ3βI)R.
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The proposed model equations are different from the recently published model by
Ragonnet et al. [166], in that each reinfection pathway is explicitly distinguished
and individuals treated with IPT are not distinguished according to their time since
infection. Moreover, since both early and late latently infected individuals are treated
with isoniazid preventive therapy, instead of having two compartments for each as in
[166], in this study the two compartments are coalesced into a single compartment
for parsimony. Another important paper [97] incorporated treatment of early and
late latent individuals but assumed that individuals treated with IPT and recovered
individuals have identical risks of reinfection after recovery (i.e., σ2 = σ3). In the
present study this assumption is relaxed by adding another compartment of indi-
viduals treated with IPT, so that the risk of exogenous reinfection can be varied
between late latently infected individuals, individuals treated with IPT and recov-
ered individuals. The motivation behind this is that there is a reasonable estimate of
the value of σ1 (see [91, 97, 121, 134, 171, 172]), whereas σ2 and σ3 are highly uncertain.
The parameter values used in investigating the aforementioned objectives are selected
from the relevant literature on TB epidemic models. The natural death rate µ is set to
correspond to an average lifespan of 70-80 years [97]. From [173], the duration of TB
from the first onset of TB symptoms to treatment or death is approximately three years.
Consequently, both parameter d and α are estimated by assuming that d+ α = 1/3
and 2d ≈ α. Thus, d is taken as d = 1/9 ≈ 0.1. From evidence that about 5-10 % of
the infected population manifest active TB shortly after infection [82, 174], parameter
f is set to 0.05-0.1. Parameter ϕ is selected from a range of values ϕ ∈ [1.5, 12]
[82, 91, 97, 166, 167]. The rate of endogenous reactivation among untreated late latent
individuals is taken as η = 0.0002 per year, relapse among those who were previously
cured through either therapeutic interventions or spontaneous cure is set to ω = 0.00002
per year; both adopted from [140, 147]. The relative risk of reinfection among untreated
late latent individuals, σ1 is fixed at 0.25 as in [97, 121], with the justification that
it agrees with the maximum level of immunity rendered by BCG (Bacille Calmette-
Guérin) vaccination [175] (although the effects of varying this parameter from its
baseline value are explored in detail below). The parameter σ2 corresponds to the
relative risk of reinfection among individuals treated with IPT, while σ3 corresponds
to the relative risk of reinfection among recovered individuals. Exploring the effects
of varying these highly uncertain parameters (including their epidemiological effects
and their influence on the effectiveness of public health interventions) is the primary
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purpose of this study. The baseline parameter value for therapeutic intervention among
individuals manifesting TB symptoms is set at τ = 2 per year, which corresponds to
a mean duration of infectiousness of six months [97] (which implicitly assumes that
the R compartment incorporates those currently under treatment for active disease).
Last, the transmission coefficient β is varied over a wide range. A summary of the
parameters and their respective values are shown in Table 5.1.
Table 5.1: Parameters and definitions for model equation (5.1).
Parameter Definition baseline value range References
β Transmission coefficient – 0-500 yr−1 [91, 97]
µ Natural death rate 1/70 yr−1 – [91, 97, 166, 167]
d TB-induced death rate 0.1 yr−1 - - [56, 173]
ϕ Rate at which infected individuals exit
early latent compartment L1 12 yr−1 1.5-12 [91, 97, 166, 167]
f Fraction of TB infected population that
progress to active TB soon after infection 0.05 0.05-0.1 [174]
η Rate of endogenous reactivation for late latents 0.0002 yr−1 - - [151, 176]
τ Treatment rate of active TB 2 yr−1 - - [91, 97, 177]
α Spontaneous cure/self cure 2/9 yr−1 - - -
θ Treatment rate of LTBI L1 with IPT 1 variable [97]
ρ Treatment rate of LTBI L2 with IPT 0.1 variable [97]
ω Rate of relapse following recovery 0.00002 yr−1 - - [140, 147]
Levels of susceptibility
σ1 Multiplier for exogenous reinfection
for latent L1 0.25 0.25-1 [91, 134]
σ2 Multiplier for exogenous reinfection
for population treated with IPT 0.5 0.25-2 [84, 91, 134]
σ3 Multiplier for exogenous reinfection
for recovered population 0.5 0.25-2 [84, 91, 134]
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5.4 Basic reproduction number R0
In epidemic theory the basic reproduction number, denoted by R0, is one of the
most important model quantities, given its ability to predict the triggering of an
epidemic. R0 is defined as the number of secondary infections that would occur when
a single infectious individual is introduced into an entirely susceptible population, and
considered over the lifetime of the disease. Following the method in [25] the basic
reproduction number for the model system (5.1) as computed in Appendix D is given
as:
R0 =
β(µ+ ω)ϕ(f(µ+ ρ) + η)
((µ+ d)(µ+ ω) + µ(τ + α))(µ+ η + ρ)(θ + µ+ ϕ) . (5.2)
(See Appendix E for biological interpretation of this expression (5.2) for R0.) In general
it is known that a value of R0 < 1 implies that each individual is only able to infect
less than one individual on average, such that the disease will die out, whereas a value
of R0 > 1 implies that each individual is able to infect more than one individual and
that endemic disease will persist within the population. Hence, R0 = 1 is a crucial
epidemic threshold in determining the epidemic trajectory.
Figure 5.2(a) illustrates that in the complete absence of reinfection pathways (σ1 =
σ2 = σ3 = 0), the model dynamics are quite simple. When R0 < 1 there is a disease
free equilibrium (I∗ = 0), or DFE, and when R0 > 1 there is one endemic equilibrium.
(Note the logarithmic scale in the Figure which hides the DFE). For this scenario (i.e.,
no reinfection pathways), the DFE is shown in Appendix F to be globally asymptotically
stable (g.a.s). The epidemiological implication of DFE being g.a.s is that TB will
be eliminated from the community if the threshold quantity R0 is maintained (or
decreased) to a value below unity.
5.5 Reinfection threshold
With the introduction of reinfection pathways, the non-linear dynamics of model
equation (5.1) yield a different bifurcation structure (see [121]). Figure 5.2(b) which is
obtained by plotting I∗ versus the transmission coefficient β for the full model (equation
(5.1)), illustrates the existence of a low endemic region (low I∗ for β < 200) and a high
endemic region (high I∗ for β > 200). The red dotted line marks the endemic threshold
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which occurs at the point R0 = 1. However, besides the endemic threshold at R0 = 1,
there are other “reinfection thresholds” (here when β ≈ 200) which play a critical role
in determining endemic equilibria [97, 121]. A reinfection threshold is said to occur in
a model when rates of reinfection are just sufficient to maintain an endemic disease in
the absence of contributions from other pathways (i.e., primary infection, βIS = 0 and
reactivation mechanims, η = ω = 0). Often, disease prevalence increases by two orders
of magnitude when transmission increases across the reinfection threshold [121, 171], as
seen in Figure 5.2(b). The reinfection threshold partitions the transmissibility axis into
two regions: the low and high endemic regions. The studies of [121, 171] introduced
a technique that is helpful for mathematically identifying reinfection thresholds (see
Appendix H).
(a) (b) (c)
Figure 5.2: Bifurcation diagrams of equilibrium TB prevalence as a function of the
transmission coefficient β. (a) In the absence of reinfection the epidemic threshold
occurs at R0 = 1. (b) In the presence of reinfection four thresholds emerges. That is
the threshold that occurs at R0 = 1 and the reinfection thresholds RT1, RT2 and RT3.
(c) Bifurcation diagram of the reinfection submodel (5.3). The red dotted vertical line
marks the transcritical bifurcation point R0 = 1, that is the endemic threshold, while
the black vertical dashed lines mark the points where reinfection thresholds RT1, RT2
and RT3 converge. Parameters used are the baseline values in Table 5.1. Reinfection
susceptibility parameters are shown in the figures. In all figures a semi-logarithmic
scale is used for a clear view.
The reinfection thresholds of model (5.1) are approximated by analysing special sub-
models that distinguish reinfection from other transmission processes such as primary
infection, reactivation and relapse [178]. The first step is to set primary infection,
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endogenous reactivation and relapse to zero (i.e., βIS = 0 and η = ω = 0). It is
then possible to approximate three reinfection thresholds from the following respective
submodels:
(i) RT1: The threshold due to reinfection during late latency (L2). In this scenario
reinfection of recovered individuals and those previously treated for latent infection
are switched off (i.e., R(t) = P (t) = 0);
(ii) RT2: The threshold due to reinfection of individuals previously treated for LTBI
(P ). In this scenario, reinfection of recovered individuals and those with latent
infection are switched off (i.e., R(t) = L2(t) = 0);
(iii) RT3: The threshold due to reinfection of recovered individuals (R). In this
scenario, reinfection of latently infected individuals and those previously treated
for LTBI are switched off (i.e., L2(t) = P (t) = 0).
The following example gives calculations for finding the first reinfection threshold RT1
in model (5.1) using the procedure outlined in [178] (see Appendix H). As mentioned,
reactivation and primary infection mechanisms are set to zero (βIS = 0 and η = ω = 0),
and post-infection levels of population immunity risk are assumed to be homogeneous
or equal (that is σ1 = σ2 = σ3). In this configuration, the rates of infection of
compartments L2,P and R become equivalent, so that it is possible to merge these
three compartments. The reinfection submodel is
d(L2 + P +R)
dt
= λ+ (1− f)ϕL1 + (τ + α)I + θL1
− µ(L2 + P +R)− σ1βI(L2 + P +R),
dL1
dt
= σ1βI(L2 + P +R)− (θ + µ+ ϕ)L1, (5.3)
dI
dt
= ϕfL1 − (µ+ d+ τ + α)I.
The Jacobian matrix of the reinfection submodel (5.3) evaluated at the disease free
equilibrium (1, 0, 0) is then
JR =

−µ (1− f)ϕ+ θ (d+ τ + α)− σ1β
0 −(θ + µ+ ϕ) σ1β
0 ϕf −(µ+ d+ τ + α)
 . (5.4)
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Setting the determinant of the Jacobian matrix (5.4) to zero and evaluating β in terms
of model parameters yields the critical value of the first reinfection threshold,
β = 1
σ1
(θ + µ+ ϕ)(µ+ d+ τ + α)
ϕf
= RT1. (5.5)
Parameters are taken to be ϕ = 12 and θ = 1 while others remain as shown in Table
5.1. This yields RT1 ≈ 201 (see Figures 5.2(b) and 5.2(c) where RT1 is marked with a
black dotted line). The reinfection threshold expressed in terms of R0 (this is R0 for
the full model) is obtained by substituting (5.5) into equation (5.2), leading to
RRT10 =
1
σ1
(µ+ d+ τ + α)(µ+ ω)(fϕ(µ+ ρ) + ηϕ)
fϕ((µ+ d)(µ+ ω) + µ(τ + α))(µ+ η + ρ) . (5.6)
Note that, if the reactivation and relapse mechanisms are now set equal to zero
(ω = η = 0) then expression (5.6) reduces to R0 ≈ 1/σ1 which is equivalent to the
simplest form of reinfection threshold in terms of R0, as originally obtained by [121].
The other reinfection thresholds RT2 and RT3 are computed similarly as shown in
Appendix I. The equilibrium of the reinfection submodel (5.3) can be easily obtained
by setting the right-hand terms to zero and evaluating for I∗ as
I∗ =
fϕ
[
β − (θ+µ+ϕ)(µ+d+τ+α)
σ1fϕ
]
β[fϕ+ (µ+ d+ τ + α)] . (5.7)
(See Appendix J for other steady states.)
It is interesting to see how well the submodel approximates the behaviour of the
full model in the vicinity of the reinfection threshold RT1. Figure 5.2(c) plots the
equilibrium I∗ for the submodel equations as a function of β. Above β = 201 there is
a positive endemic equilibrium but below this value only the disease-free equilibrium is
present. Thus, the theoretically predicted reinfection threshold for the submodel is
confirmed to be RT1 = 201.
The success of the prediction for RT1 can be gauged by returning to Figure 5.2(b).
The high endemic zone occurs when β ≳ 200, that is there is a transition from low to
high TB burden with the proportion of active TB increasing by about two orders of
magnitude when β ≳ 200 (as can also be observed in [97, 121]). That is, there is a
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100-fold change in prevalence associated with a very small change in β value.
5.5.1 Homogeneous reinfection risk (σ1 = σ2 = σ3 < 1)
First, it is useful to reflect on how the reinfection parameters σi (i = 1, 2, 3) should
be interpreted by re-examining a typical infection term σiβ in equation (5.1). Note
that when the risk of reinfection parameter σi < 1 (i = 1, 2, 3), it corresponds to a
scenario where individuals susceptible to reinfection have partial immunity, while σi = 1
(i = 1, 2, 3) corresponds to susceptibility to infection being the same as for a typical
susceptible individual. Shortly a scenario where the risk of reinfection parameters can
in some cases be greater than unity σi > 1 will also be discussed. That is, individuals
who have already been infected have the same or even higher risks of reinfection, when
compared with a typical susceptible individual who has never been infected. This
indicates that individuals may have increased susceptibility to tuberculosis and is
biologically plausible, e.g., due to local tissue damage to the respiratory tract impairing
innate immunity. Supposing σi < 1 (i = 1, 2, 3), the bifurcation diagram in Figure
5.2(b) indicates a scenario where all cohorts susceptible to reinfection have equal risk of
reinfection (that is reinfection risk parameters are set to σ1 = σ2 = σ3 = 0.25). When
interpreting Figure 5.2(b) recall that the vertical axis representing I∗ has a logarithmic
scale. The reinfection thresholds RT1 = RT2 = RT3 ≈ 200 divide the transmissibility
axis into low and high endemic regions. For β ⪅ 50 (equivalently R0 < 1), I∗ = 0. For
50 ⪅ β ⪅ 200 then I∗ ≈ 10−3, when β ≈ 200 then I∗ ≈ 10−2 and when β > 200 then
I∗ → 10−1.
5.6 Heterogeneity in susceptibility to reinfection
Now the effects of reinfection parameters σ2 and σ3 on TB dynamics are investigated.
Suppose that σ1 is fixed to 0.25 while either σ2 or σ3 are selected such that they are
equal or greater than σ1. Letting σ1 = 0.25, σ2 = 0.5, σ3 = 0.25 results in Figure 5.3(a)
which shows that increasing σ2 results in an increase in TB prevalence. However, by
setting σ1 = 0.25, σ2 = 0.25 and σ3 = 0.5 results in Figure 5.3(b) which shows that σ3
has little effect on TB prevalence in comparison to the same increase in σ2 (see Figure
5.3(a)).
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(a) (b)
Figure 5.3: Illustration of the relative importance of σ2 and σ3 to equilibrium dynamics.
Parameters used are the baseline parameters in Table 5.1. (a) Impact of increasing σ2
while both σ1 and σ3 are fixed. (b) Effect of increasing σ3 while both σ1 and σ2 are
fixed.
Further, model dynamics are explored over a wider range of reinfection parameters
by again modifying the relative risks of reinfection among individuals treated with
IPT (σ2) and those previously recovered from active TB (σ3). The relative rate of
reinfection among LTBI is fixed to σ1 = 0.25, consistent with the pertinent literature
described above and with [97, 121, 171]. The remaining two risk of reinfection pa-
rameters, (σ2 and σ3) are varied and may take values of 0.125, 0.50 and 1.5, thereby
creating heterogeneity in susceptibility to TB transmission. From left to right the three
columns of panels in Figure 5.4 show an increasing risk of reinfection among recovered
individuals (σ3) while from top to bottom each row of the figure shows an increasing
risk of reinfection among individuals treated with IPT (σ2).
It is observed that as σ2 increases (i.e., moving from top to bottom of each column
in Figure 5.4), there is a structural change in the bifurcation curve. As σ2 increases
(from top to bottom) TB prevalence rises. In contrast, within each row of panel 5.4
there is no significant qualitative change in the bifurcation structure as σ3 is varied
(parameter values σ3 = 0.125, 0.50, 1.50) i.e., moving from left to right.
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Moreover, considering a scenario where either individuals treated with IPT or recovered
individuals (or both) have a significant loss of immunity by readjusting σ2 and σ3 such
that they can take values greater than one, results in bi-stability phenomena whereby
TB can be endemic below the threshold R0 = 1. However, the occurrence of backward
bifurcation is attributed to σ2 and not σ3 as illustrated in the last row of panels of
Figure 5.4 where backward bifurcation sets in when σ2 is greater than one. Further
simulations show that σ3 has minimal effect as can be observed in Figures 5.4(c) and
5.4(f) appearing in the last column of panel Figure 5.4. However, it is important to
note that at the present time, the lack of sensitivity of model dynamics to σ3 is unclear
and is a subject that will be examined in future research.
The observation made here regarding σ2 implies that the reinfection parameter account-
ing for reinfection among individuals treated with IPT plays a key role in determining
TB dynamics.
5.6.1 Other features: hysteresis
Besides the backward bifurcation phenomena observed in the last row of Figure 5.4, the
proposed model equation (5.1) exhibits hysteresis effects. Hysteresis is a phenomenon
whereby multiple equilibria, both stable and unstable occur simultaneously above the
epidemic threshold R0 = 1 (see [39]). Selecting a set of parameters such that both
σ2 = σ3 = 0.125, and σ1 = 0.25 while other parameters remain as the baseline values
shown in Table 5.1, results in Figure 5.5(a) which shows a hysteresis phenomenon. In
Figure 5.5(a) the unstable equilibrium is marked by a red dotted line that separates
two stable equilibria: low endemic and high endemic. Rather similar to a backward
bifurcation, there can be jumps between the two stable equilibria. In the regime where
the contact rate is approximately β = 253 there is a low endemic equilibrium. A small
epidemiolgical change, such as a slight rise in β, (which pushes I above the unstable
equilibrium marked by the red dashed line) may trigger a jump to the high endemic
equilibrium.
5.6.2 No partial immunity
As discussed, the degree of protection conferred by initial infection with TB is still
controversial. Gomes et al. [91] and Verver et al. [84] suggest that the risk of reinfection
parameters σ1, σ2, σ3 can in some cases be close to or greater than unity, so that
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(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
Figure 5.4: Exploration of the full range of plausible values of the relative risk of
reinfection parameters. All panels show equilibrium prevalence as a function of the
transmission coefficient β. From left to right, each column shows an increase in the
relative risk of reinfection among recovered individuals σ3, while from top to bottom
each row shows increasing risk of reinfection among individuals treated with IPT σ2.
Other parameter values remain at baseline values in Table 5.1. The red dotted vertical
lines mark the point where R0 = 1. The dotted red segments of the endemic curves
represent the unstable equilibria while the blue lines represent stable equilibria.
individuals who have already been infected may have the same or even higher risks
of reinfection as compared to typical susceptible individuals who have never been
infected. As discussed above, this situation seems less intuitive, but remains plausible.
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(a) (b) (c)
Figure 5.5: Emergence of hysteresis and backward bifurcation effects with changes
to reinfection parameters. Parameters used are the baseline parameters in Table
5.1. (a) Occurrence of a hysteresis effect. (b) A scenario where all cohorts subject
to reinfection have no immunity and are therefore infected at the same rate as the
susceptible population. (c) A scenario where all post-infection cohorts have no partial
immunity and have increased susceptibility to reinfection.
For example [91] estimated σ3 = 0.51 with a confidence interval of [0.00, 2.37] for a
heterogeneous model, while for a homogeneous model to be about σ3 = 3.87 with a
confidence interval of [1.61, 7.79].
Consider now a scenario in which all cohorts subject to reinfection have equal suscepti-
bility to infection as susceptible individuals (note that this is equivalent to a classic
SEIS model). That is, σ1 = σ2 = σ3 = 1. This leads to the bifurcation diagram in
Figure 5.5(b) and demonstrates that TB will jump to a high endemic level immediately
after the basic reproduction number exceeds R0 = 1. Moreover, if all cohorts subject
to reinfection have higher rates of infection than susceptible individuals, then the
phenomenon of backward bifurcation appears to occur as shown in Figure 5.5(c) and
TB can exist in a high endemic state on either side of the threshold R0 = 1.
5.7 Interventions that impact reinfection
5.7.1 Effect of treating early LTBI
The effect of treating early LTBI for different levels of susceptibility to reinfection is
examined. Recall that treatment of early latent TB with preventive therapy (IPT)
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is modelled by the parameter θ which is the treatment rate of early LTBI L1. First,
assume that the relative rate of reinfection among late LTBI (σ1) is less than the
levels of reinfection of both recovered individuals (σ3) and individuals treated with
IPT (σ2). Consider risk of reinfection parameters σ2 = σ3 = 0.5 and σ1 = 0.25. Figure
5.6(a) illustrates model dynamics for different values of the treatment parameter θ,
and shows that treatment of early latent TB decreases TB prevalence regardless of
the higher risk of reinfection (i.e., σ2 > σ1 and σ3 > σ1). Now consider a scenario
where the level of susceptibility to reinfection of late LTBI is high in comparison to
the levels of susceptibility to reinfection of both recovered and individuals treated with
IPT. Selecting σ2 = σ3 = 0.125 and σ1 = 0.25, yields the bifurcation diagram seen
in Figure 5.6(b). Again it is observed that treatment of early LTBI via θ decreases
TB prevalence. Note that the magnitude of TB reduction is relatively stronger when
θ > 1. These same results are plotted with linear scales in Figures 5.6(c) and 5.6(d).
5.7.2 Effect of treating late LTBI
It is importnat to note that Gomes et al. [97] investigated a scenario where intervention
(i.e., treatment of late LTBI) is assumed to increase or decrease risks of reinfection i.e.,
the values of σi. However, their study did not distinguish between individuals treated
with IPT and individuals previously assumed to have recovered due to antibiotic
treatment or self-cure. As stated above, the present study distinguishes individuals
who have recovered from active TB from those who are being or have been treated
with IPT. Thus, contrary to Gomes et al. [97] where only two groups that were subject
to reinfection were considered, the model presented here has three such cohorts. Distin-
guishing between individuals treated for active TB and individuals treated with IPT
provides a more comprehensive analysis of treating late LTBI when the population is
subjected to different levels of reinfection.
Recall that the parameter ρ represents treatment of late LTBI with IPT. Thus, bi-
furcation diagrams obtained for different levels of reinfection of individuals treated
with IPT (modified by σ2) and recovered individuals (modified by σ3) to reinfection
of late LTBI (modified by σ1) are compared. Panels are again presented with σ2
increasing from top to bottom while σ3 increases from left to right (see Figure 5.7).
First assuming intervention decreases the level of susceptibility to reinfection it is
assumed that both recovered individuals and individuals treated with IPT have a
lower rate of reinfection in comparison to late LTBI. By letting σ2 = σ3 = 0.125 while
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(c) (d)
Figure 5.6: Impact of treating early latent individuals under different risks of suscep-
tibility to reinfection. (a) Treatment of early LTBI (and of active disease) leads to
increased susceptibility to reinfection compared to late latent infection. (b) The level
of susceptibility to reinfection among late LTBI is lower than for both individuals
treated with IPT and recovered individuals treated from active TB. Figures (c) and
(d) respectively represent figures (a) and (b) with a linear scale y-axis. Treatment of
late LTBI and individuals with active TB are respectively set at ρ = 0.1 and τ = 2
while other parameters are as shown in Table 5.1.
σ1 = 0.25, Figure 5.7(a) is obtained. The baseline scenario is obtained by setting ρ = 0
while the extreme case is illustrated by assuming ρ → ∞. Figure 5.7(a) illustrates
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that in a scenario where σ2, σ3 < σ1 treatment of late LTBI reduces TB prevalence.
This decrease in TB prevalence is largely attributable to the general reduction in
susceptibility to reinfection (small σ2 and σ3). In addition, Figure 5.7(a) indicates
the existence of bi-stable equilibria (hysteresis effect) in which stable equilibria are
separated by an unstable equilibrium (dashed red line). Performing another sim-
ple numerical experiment can shed some light on the differences between reinfection
parameters σ2 and σ3. Hence, assuming σ2 < σ1 and σ3 > σ1, and plotting TB preva-
lence as a function of β results in Figure 5.7(b), which is almost the same as Figure
5.7(a). That is, treatment of late LTBI is beneficial despite σ3 = 0.5 being double
σ1. These results imply again that σ3 is unimportant, while σ2 is the main parameter
of interest. The respective reinfection thresholds associated with individuals treated
with IPT (RT2), recovered individuals (RT3) and late LTBI (RT1) are marked on
Figure 5.7 with black dotted lines. Considering the regions bounded by reinfection
thresholds, it is clear from Figure 5.7(b) that treatment has the most beneficial impact
within the region bounded by RT1 and RT2, and the position of RT3 has little influence.
Secondly, another set of risk of reinfection parameters is considered such that the rate
of reinfection among recovered individuals (σ3) is less than the rate of reinfection of
late LTBI (σ1) while the level of reinfection among individuals treated with IPT (σ2)
is relatively high (σ1 = 0.25, σ2 = 0.5 and σ3 = 0.125). This set of parameters leads
to Figure 5.7(c) which shows that treatment of late LTBI now leads to an increase in
TB prevalence. It is evident from Figure 5.7(c) that the reinfection thresholds RT2
and RT1 bound the parameter space where treatment of late LTBI has most impact.
Outside this region treatment has a minor effect.
Finally, assuming susceptibility to reinfection among individuals treated with IPT and
recovered individuals increases after treatment, results in the findings presented in
Figure 5.7(d) where σ2 = σ3 = 0.50 while σ1 = 0.25. Figure 5.7(d) again shows that
increasing treatment of late LTBI may lead to an increase in TB prevalence when
σ2, σ3 > σ1. Note that the greatest increase in TB prevalence also occurs between the
reinfection thresholds RT2 (=RT3) and RT1. This implies that the relative magnitude
of risk of reinfection, σ1 compared to σ2, is vital in determining whether treatment will
increase or decrease TB prevalence.
5.7 Interventions that impact reinfection 96
The previously described study [97] investigated the effect of treating late latent TB
under two assumptions: a) susceptibility to reinfection increases after treatment of
late LTBI, and b) susceptibility to reinfection decreases after treatment of late LTBI.
They found that if treatment of late LTBI increases the risk of reinfection of recovered
individuals σ2 then TB prevalences increases, while if treatment of LTBI is assumed to
decrease risk of reinfection of recovered individuals σ2, then TB prevalence decreases
[97]. As mentioned above, in Gomes et al. [97] both individuals treated for active TB
and individuals treated with preventive therapy were assumed to be indistinguishable
and therefore classified as one cohort of recovered individuals.
However, it is important to identify the precise epidemiological parameter responsible
for the observed changes in qualitative dynamics. The findings in Figure 5.7 suggest
that distinguishing the relative susceptibility to reinfection between individuals treated
with IPT from those who have been cured from active TB is important to elucidate the
complex dynamics of TB. As observed in the formulated model (5.1), σ3 is essentially
redundant when it comes to predicting whether treatment will decrease or increase the
prevalence of TB. Hence, epidemiological studies interested in understanding the impact
of preventive therapy (IPT) should focus on quantifying the risk of reinfection among
persons treated with IPT in comparison to latently infected individuals (modified by σ2).
Further, it is important to investigate a scenario where late latently infected individu-
als have the same level of reinfection as individuals treated with IPT and recovered
individuals. Thus, considering σ1 = σ2 = σ3 = 0.25 while varying treatment results in
Figure 5.8(a) which depicts that treatment has a positive impact between the region
bounded by R0 = 1 and RT1 (=RT2=RT3) and minimal impact above the reinfection
thresholds RT1 (=RT2=RT3). Figure 5.8(b) is obtained using the same parameter
values as Figure 5.8(a) except that the reactivation mechanisms are switched off (i.e.,
ω = η = 0). It is observed that all the endemic curves under different treatment values
merge. However, further exploration of a scenario where reactivation mechanisms are
neglected while levels of reinfection are unequal (i.e., σ1 < σ2 = σ3) results in Figure
5.8(d) which is qualitatively similar to when reactivation mechanisms are included (see
Figure 5.8(c)). This observation suggests that reactivation pathways do not play a
significant role when it comes to determining the outcome of treatment of late LTBI;
rather it is the rate of reinfection and particularly reinfection of individuals treated
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with IPT that greatly influence treatment outcome.
Within the medical literature the endogenous reactivation mechanism (i.e., parameter
η) is well known to be very small as it takes over 20 years for an individual with latent
TB to develop active TB following initial infection [118]. Moreover, the lifetime risk
of a latently infected individual to progress to the infectious stage is approximately
5-10% [118]. Thus the choice of parameter η = 0.0002yr−1 is in line with the current
TB literature (see [97, 140, 147, 177]). Hence, in a scenario where I compared η =
0.0002yr−1 with η = 0 it is because selecting a value that is above 0.0002yr−1 would be
choosing a value that is outside the estimated range. See also Gomes et al. [97] where
they considered different levels of reinfections under two scenarios: η = 0.0002yr−1
and η = 0. On the other hand reinfection is known to be much higher in comparison
to endogenous reactivation. The available literature on TB supposes that the majority
of new TB cases (about 90%) occur as a result of reinfection rather than endogenous
reactivation [134, 140, 141, 142]. Thus, reinfection is the process that has most
influence on TB dynamics. Moreover, setting η = 0 was a simplfying assumption to
check whether the results deduced regarding impact of reinfection in the presence of
preventive treatment hold.
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Figure 5.7: Effect of treatment for late latent infection under the assumption that
treatment decreases (panels (a) and (b)) and increases (panels (c) and (d)) susceptibility
to reinfection, and assuming that treatment for active disease decreases (panels (a)
and (c)) and increases (panels (b) and (d)) susceptibility to reinfection. Treatment of
individuals with active TB is fixed to τ = 2, and treatment of individuals with early
latent TB is fixed to θ = 1, while treatment of late latent individuals is introduced at
different rates; ρ = 0, 0.1, 1, 10 and the limit as ρ→∞. Other parameters used are as
shown in Table 5.1. (a) σ2, σ3 < σ1. (b) σ2 < σ1 < σ3. (c) σ3 < σ1 < σ2. (d) σ1 < σ2, σ3.
In the figures the black dashed endemic lines represent the baseline case where there is
no treatment of late LTBI (i.e., ρ = 0) while the blue dashed endemic lines represent
immediate treatment for the entire population (ρ→∞). In both figures (a) and (b)
the dashed red lines of the endemic curves represent unstable equilibria while blue solid
lines represent stable equilibria. All figures are plotted using a semi-logarithmic scale.
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(c) (d)
Figure 5.8: Treatment of late latent infection under the assumption of no effect on
susceptibility to reinfection (panels (a) and (b)) and increased susceptibility (panels
(c) and (d)), with reactivation mechanisms present (panels (a) and (c)) and removed
(panels (b) and (d)). Parameters are τ = 2, θ = 1, ρ = 0, 0.5, 1 and ρ → ∞ while
other parameters remain as in Table 5.1. The risks of reinfection are shown in each
sub-figure.
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5.8 Summary of the chapter
In this chapter, a mathematical TB model accounting for heterogeneity in susceptibility
to reinfection has been proposed. Analysis of the model yielded the following results:
(i) It was found that the risk of reinfection among individuals treated with IPT (i.e.,
σ2) plays a central role in qualitative changes in model dynamics, particularly in
shifting TB prevalence between low and high burden values. In contrast, the risk
of reinfection (i.e., σ3) among the recovered cohort who were previously treated
from active TB (or self-cure) plays an insignificant role in terms of the qualitative
dynamics of the model. See Figure 5.4;
(ii) Treatment of early latent infection is shown to be always beneficial irrespective
of the level of reinfections among cohorts subject to reinfection. The benefit is
strongest if individuals treated with IPT and recovered individuals previously
treated from active TB, have a relatively low risk of reinfection i.e., compared to
late LTBI. That is, when σ2 < σ1 and σ3 < σ1; see Figure 5.6(b) or Figure 5.6(d)
(given in linear scale);
(iii) Similar to previous findings [97], the assumption that treatment decreases the
risks of reinfection among both cohorts of individuals treated with IPT and
individuals recovered from active TB was considered. Under this assumption,
treatment of late latency TB individuals has a positive impact (see Figure 5.7(a))
and therefore may be highly synergistic with other interventions;
(iv) Alternatively, the assumption that treatment of late latent infection increases the
risk of reinfection among individuals treated with IPT and recovered individuals
was also considered. This yields contrasting results to case (iii) above. That
is, treatment of late LTBI increases TB prevalence, although treatment is more
detrimental above the reinfection threshold, particularly in an intermediate
prevalence zone lying between RT2(=RT3) and RT1. See Figure 5.7(d);
(v) Assume now that treatment of late latently infected individuals increases the risk
of reinfection of individuals treated with IPT (i.e., σ2 > σ1) but decreases the
risk of reinfection among recovered individuals (i.e., σ3 < σ1). The results still
show that increasing treatment of late LTBI increases the prevalence of active TB
(see Figure 5.7(c)). This observation suggests that the parameter σ2 associated
with reinfection of individuals treated with preventive therapy is the one that
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determines whether treatment of late latency will decrease or increase prevalence
of active TB. Hence, σ2 is a key epidemiological parameter;
(vi) It is observed that reactivation mechanisms (in particular reactivation from late
latent infection (η) and from recovered individuals (ω)) play a minimal role in
determining treatment outcomes. See Figures 5.8(a) and 5.8(b);
(vii) Finally, reinfection of previously infected persons can lead to unusual dynamics,
such as backward bifurcation and hysteresis effects. This is epidemiologically
important because it could lead to extreme changes in disease burden following
relatively minor epidemiological changes.
The conclusions made in this chapter show differences to previous work [97] because of
the different form of the proposed model and its more realistic structure. This previous
study, Gomes et al. [97], assumed that individuals who were previously treated for
active TB and individuals treated with preventive therapy are not differentiable and
therefore they can be treated as a single group. In particular, σ2 and σ3 were coupled as
a single parameter, obscuring the understanding of the role of each individual parameter.
However, this study shows that relaxing this assumption yields new epidemiological
findings. This follows from the fact that it is impossible to tell from Gomes et al. [97]
whether an increase in prevalence of active TB is attributed to reinfection of individuals
being treated or who have been treated with IPT, or due to reinfection of individuals
treated from active TB. Consequently, this study refines the results of Gomes et al.
[97] by pointing out the precise parameter attributed to an increase or decrease in
prevalence of active TB as treatment increases. Thus, epidemiological studies with the
ability to quantify σ2 accurately would be important in shedding light on TB dynamics.
Currently little is known about the true value of σ2 which is associated with reinfection
of individuals being treated or who have been treated with preventive therapy (IPT).
5.8.1 World Health Organization (WHO) TB burden esti-
mates
TB is present in every region and country of the world but its distribution varies greatly
with the most highly endemic countries reporting rates of disease around 1000 per
100,000 per year, while the least endemic countries have rates as low as 5 per 100,000
per year. There can be little doubt that this observation of 200-fold differences in
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disease burden relates in part to heterogeneity in socio-economic development, living
conditions, prevalence of comorbidities and the strength of health systems. However,
given such a huge gulf in disease rates, additional factors may well be at work. Here it
is postulated that decreased susceptibility to reinfection in comparison to first infection
acts to create a threshold effect, which can lead to a 100-fold increase in burden once
crossed. Similarly, disease may be considerably easier to control once prevalence has
dropped below the reinfection threshold and entered the low endemic, controllable zone.
That is, while socio-economic development and improvements in treatment programs
could explain gradual decreases in burden, this additional phenomenon may help to
explain more dramatic shifts. For example, the recent rapid declines in TB burden in
China and other countries of East Asia could be partly attributable to this threshold
effect.
Empirical evidence for the role of reinfection heterogeneity is difficult to find, given
the difficulty in obtaining high-quality data on TB burden relative to the slow speed
with which the epidemic evolves. However, many regions of the world appear to show
significant divides between high and low burden countries (Figure 5.9). Although, this
is not clearly apparent in all regions and an overall threshold is not evident (Figure
5.10), this grouping of countries is arguably seen in current WHO data [1]. The absence
of a clear divide could relate to factors such as comorbidities (e.g., HIV infection),
differences in health systems and socio-economic development, as well as the fact
that TB transmission frequently occurs over a much smaller scale than a nation state.
Therefore, the reported overall burden for individual countries actually represents the
summation of many heterogeneous sub-epidemics, particularly for large countries such
as China and India.
5.8.2 Limitations and conclusion
Mathematical modelling is an important tool for epidemiologists since it provides in-
sights into underlying processes where empirical epidemiological observations generally
cannot. With the proposed model, the key parameter influencing preventive treatment
outcomes is identified. It was found that the reinfection parameter accounting for
reinfection of individuals treated with IPT (σ2), and not the parameter accounting for
reinfection of recovered individuals (σ3), alters treatment outcome. Further, changes in
σ2 can either be beneficial or detrimental when there are treatment programs. The need
to quantify the parameter is important if epidemiologists are to accurately estimate
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its effect on TB dynamics. Moreover, it is observed that reactivation mechanisms (in
particular reactivation from late latent infection and from recovered individuals) play
a minimal role in determining treatment outcomes.
Moreover, it is imperative to emphasize that the result obtained regarding unimpor-
tance of σ3 is not related to relative equilibrium sizes e.g., R∗ and P ∗. Reason being that
different parameter sets were explored and results deduced lead to the same conclusion.
A clear illustration can be observed in the Figure 5.3 where the relative importance
of σ2 and σ3 on equilibrium prevalence are compared by the equilibrium prevalence
curve where σ1 = σ2 = σ3 = 0.25. In Figure 5.3(a) σ2 is increased to 0.5 while both
σ1 and σ3 are fixed to 0.25. In such set of parameters σ2 is observed to increase the
equilibrium prevalence I∗ relative to the baseline curve. On the other hand when σ3
is increased to 0.50 while both σ1 and σ2 are fixed to 0.25 the equilibrium curve is
almost merging with the baseline curve (see Figure 5.3(b)). This stresses that, the
unimportance of σ3 is not driven by different choice of parameter values. Furthermore,
a broad range of parameter values for both σ2 and σ3 were also considered. In the
panel Figure 5.4, parameter σ3 was assumed to increase from left to right taking values
0.125, 0.50 and 1.50. And it is clearly observed that, there is no significant change in
bifurcation structure as σ3 is varied from left to right. This is contrary to when σ2
is varied through similar values, where it is observed that the bifurcation structure
changes from hysteresis to forward and finally to backward.
The proposed model has some limitations that can be addressed in future studies. In the
proposed model, individuals being treated from early and late latent compartments are
coalesced into a single compartment so as to simplify the model (although the effect of
distinguishing these groups following preventive treatment has been previously explored
[166]). This could be addressed in conjunction with the approach for distinguishing
four susceptibility categories as studied here. Finally, incomplete efficacy of preventive
treatment could be reasonably considered and explored with the proposed model as a
simple reduction in treatment rates.
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Figure 5.9: Illustration of world TB burden by regions across the world obtained using
global TB data [1]. Note that the size of the circle is proportional to the population
size of the country.
5.8 Summary of the chapter 105
1
10
10
0
10
00
In
ci
de
nc
e
1 10 100
Mortality
Western Pacific
African
Americas
European
South-East Asia
Eastern Mediterranean
Figure 5.10: Illustration of global TB burden by country using global TB report data
[1].
Chapter 6
Other related work: analysis of a
heroin epidemic model with
nonlinear treatment function
6.1 Chapter overview
A mathematical model is developed that examines how heroin addiction spreads in
society. The model has similarities to epidemic equations that study the spread of
infectious diseases. The model takes into account the treatment of heroin users by
incorporating a realistic functional form that “saturates” representing the limited
availability of treatment. In these circumstances, bifurcation analysis reveals that
the model has an intrinsic backward bifurcation whenever the saturation parameter
is larger than a fixed threshold. Since the objective of this chapter is to study the
proposed model’s global stability it is important to note that in the absence of backward
bifurcations, Lyapunov functions can often be found and used to prove global stability.
However, in the presence of backward bifurcations, such Lyapunov functions may not
exist or may be difficult to construct. In this chapter a geometric approach to global
stability is applied to derive conditions that ensure the system is globally asymptotically
stable. Numerical simulations are also presented to give a more complete representation
of the model dynamics. Sensitivity analysis performed by Latin hypercube sampling
(LHS) suggests that the effective contact rate in the population, the relapse rate of
heroin users undergoing treatment, and the extent of saturation of heroin users are
mechanisms fuelling heroin epidemic proliferation. However, in the long term relapse
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of heroin users undergoing treatment, i.e., going back to a heroin using career, has
slightly higher impact on heroin usage than effective contact rate.
6.2 Introduction
In 1897, Germany’s Bayer pharmaceutical company synthesised heroin, and soon after
marketed the product as a non-addictive miracle drug, for use as a cough syrup and
pain reliever [179]. Cough medicine was in fact in high demand, since tuberculosis and
pneumonia were fast-spreading diseases of the time. As such, the miracle drug heroin
was rapidly disseminated across the globe. Fast forward to today, it is known that
addiction to heroin is an extremely common phenomena among heroin users; some 23
% of individuals who consume the drug become dependent on it. World wide, many
countries are affected by the heroin drug-trafficking industry and its growing number
of users. America is currently in the midst of another heroin epidemic [180] with
approximately 700,000 Americans using heroin in the past year [180]. The number of
people using heroin for the first time is increasing at an alarming rate, with > 150, 000
Americans engaging in heroin use in 2012, which is almost double that recorded in 2006
[180]. Heroin also leads to other diseases and is considered a major pathway responsible
for fuelling proliferation of Human immunodeficiency virus (HIV) and Hepatitis B and
C virus (HBV, HCV) [181, 182].
The development of heroin habituation and addiction has similar characteristics to
an epidemic, in terms of its disturbingly contagious spread through a susceptible
population. In the last decades, a whole range of mathematical models have been
developed to forecast how diseases spread in time and space, and how they can be
controlled. Recently, the same mathematical modelling techniques have been extended
for the purpose of understanding and combating drug addiction problems. The aim
of the present study is to propose a novel heroin epidemic model and make use of it
to study issues arising with treatment as well as establish conditions that may signal
heroin persistence within the community.
The ultimate goal of mathematical epidemiology is to understand how to control and
eliminate infectious diseases and these ideas have a place for also dealing with social
problems. In epidemic theory the basic reproduction number, usually denoted by R0 is
one of the most important concepts, given its ability to predict the course of an epidemic.
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It will also prove invaluable in the study of heroin dynamics in society. R0 is defined
as the number of secondary infections that are likely to occur when a single infectious
individual is introduced into an entirely susceptible population [183]. Until recently, it
has been widely accepted that the condition R0 < 1 is an essential requirement for the
eradication of a disease. However, this viewpoint has been challenged with a number
of theoretical studies demonstrating that this criterion may not always be sufficient.
Instead, the phenomenon of backward bifurcation offers a different interpretation since
it shows that although the basic reproduction number is below unity and the infection
free equilibrium is stable, there might still be another stable endemic equilibrium and
unstable endemic equilibrium coexisting simultaneously. Thus even though R0 < 1,
a population may still reside at an endemic equilibrium in which the disease persists
indefinitely. In a scenario where multiple equilibria concurrently exist the extinction or
persistence of an epidemic is dependent on the initially infected size of subpopulations.
The qualitative features of backward bifurcation are illustrated by Figure 6.1.
A variety of behavioural and pharmacological medications can be administered to effec-
tively treat heroin addiction. The side effects associated to quitting using heroin (such
as pain, diarrhoea, nausea and vomiting) are very severe and very often compel heroin
addicts to relapse. To prevent such cases there are available medications that can be
administered during the detoxification stage to relieve craving and physical symptoms.
A number of studies have established that pharmacological therapy has positive impact
in facilitating drug addicts to remain in treatment programs. Furthermore, it has been
noted that during addiction treatment there is a decline in drug consumption, infectious
disease transmission and crime rates [180]. In this chapter a model incorporating a
saturated treatment function is proposed and threshold conditions that indicate when
heroin is able to persist within a community are derived. Besides incorporation of a
saturated treatment function, the proposed heroin model will also include an extra
class of individuals, namely those who have been successfully treated. This class has
been neglected in previous heroin epidemic models [184, 185, 186, 187]. Much of the
work in this chapter will focus on exploring the conditions for global stability of the
heroin model with treatment. The analysis deals with global stability of a heroin model
with a density-dependent incidence rate, “self cure”, relapse and saturated treatment
function using the Bendixson criterion.
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With this in mind, the SIR (Susceptible-Infectives-Recovered) model by Wang et al.
[186] is extended to represent a heroin epidemic model for which global stability proper-
ties are investigated. The proposed model will be used to study global stability for the
non-trivial equilibrium states by using two distinct approaches: The Lyapunov direct
method and Li and Muldowney’s [188, 189] geometric approach to global stability. It is
with no doubt that the famous Lyapunov direct method is a powerful tool for nonlinear
stability analysis [190]. One of the main advantages of Lypunov’s direct technique is
that it is directly applicable to nonlinear systems [191]. However, a major challenge is
that it requires an auxiliary function which is often hard to construct. And this difficulty
is exacerbated especially if the model exhibits backward bifurcation phenomena because
Lyapunov functions for such models may not exist. To address these difficulties another
powerful tool; the geometric technique due to Li and Muldowney was developed in
the mid nineties [98, 191, 192]. Their method involves a generalization of Bendixson’s
criterion to systems of any finite dimension and applies compound matrices. Presently,
this method has gained popularity due to its vast range of applications, in particular
to mathematical models that are of biological interest. Although this method is mainly
applied in epidemic models (for instance see [188, 189, 193, 194, 195, 196]) its use can
be found in other population dynamics contexts (see [197]). It has been shown in
[189] that the geometric technique is more appropriate for mathematical models of
SEIR-like structure since their analysis can be easily reduced to a three dimensional
system. Nevertheless, the method has been extended to four dimensional systems that
may be difficult to reduce, though applications to four dimensional systems are rare
because the procedure becomes mathematically involved when n ≥ 4. Examples can
be found in the work of Ballyk and coworkers who applied compound matrices to a
four dimensional population model [198] and also by Gumel and coworkers [199] who
studied a SVEIR (Susceptible-Vaccinated-Exposed-Infected-Recovered) model of severe
acute respiratory syndrome (SARS) epidemic spread.
The four dimensional model studied here can be reduced to a three dimensional system.
Both the Lyapunov direct method and the geometric approach are applied to investigate
global properties of a four dimensional heroin epidemic model. The Lyapunov direct
method will be applied in a special case, where the parameter that triggers bi-stability
phenomena is switched off. On the other hand the geometric approach will be applied
in the general model where all parameters are present including the one that causes
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bi-stability. Here the procedure in [189, 191] is followed to obtain sufficient conditions
for global stability.
(a)
Figure 6.1: Illustration of the qualitative features of backward bifurcation. The red
dotted line represents the unstable equilibrium (i.e., unstable endemic equilibria and
unstable heroin-free equilibrium) while the blue solid lines represent stable equilibria
(i.e., stable endemic equilibria and stable heroin-free equilibrium).
6.3 Model formulation
In the spirit of the SIR (Susceptible-Infected-Recovered) model in the literature (i.e.,
[88]), a heroin epidemic model is formulated based on the assumption that heroin use
follows a process that can be modelled similarly to infectious diseases [200, 201]. The
general population is stratified into four mutually exclusive classes, namely susceptibles
(S), individuals successfully treated from heroin use (U3), heroin users undergoing
treatment (U2) and heroin users not in treatment (U1). The proposed heroin epidemic
model is based on key assumptions which include:
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• Uniform mixing: individuals in the above mentioned classes freely interact with each
other;
• Individuals undergoing treatment are still often using drugs [202];
• Heroin users in treatment relapse to heroin users not in treatment as a result of the
self decision to terminate treatment [203];
• Heroin users in treatment do not infect susceptibles;
• Individuals who have been successfully cured are not susceptible to relapse, either
through a simple per-capita flow or as a result of an interaction with existing heroin
users.
These are simplifying assumptions that are made largely to make the model analytically
tractable. Given these assumptions the heroin model may be described by the processes
illustrated in Figure 6.2, which can be written in terms of the following set of equations:
dS
dt
= Λ− βU1S − µS,
dU1
dt
= βU1S + pU2 − (µ+ δ1 + ξ)U1 − T (U1),
dU2
dt
= T (U1)− (p+ σ + δ2 + µ)U2, (6.1)
dU3
dt
= σU2 + ξU1 − µU3.
In brief, the susceptible sub-population S(t) is generated at a constant rate through
immigration and birth at rate Λ. Some susceptible individuals who come into contact
with heroin users U1(t) may begin to use heroin. Hence, the susceptible population is
diminished due to contact with heroin users at rate βU1S, while heroin users increase
at the same rate. Heroin users also increase when those undergoing treatment relapse
at rate pU2, and return to their heroin using lifestyle. Heroin users reduce in number as
a result of treatment which is represented by the treatment function T (U1). Moreover,
the user subpopulation is reduced by heroin-induced death at rate δ1U1 as well as a
result of the self decision to cease using heroin (also referred as “self-cure”) at rate ξU1.
Individuals undergoing treatment are diminished through relapse to heroin using at
rate pU2, heroin-induced death at rate δ2U2 and successful treatment at rate σU2. Fi-
nally, the recovered/successfully treated subpopulation U3(t) is generated when heroin
users undergoing treatment are successfully cured and also through “self-cure”. All
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subpopulations are decreased by natural death via the background mortality parameter
µ.
Heroin epidemic models studied to date [184, 185, 186, 187] assume the classical view
that the treatment rate of the infective population should be proportional to the
number of infective individuals [23]. This view was criticised during the SARS (Severe
Acute Respiratory Syndrome) outbreaks in 2003. The dramatic increase of SARS cases
in Beijing challenged the normal public-health system because it was only possible
to treat a limited number of SARS patients at a given time. The experience with
SARS sparked a renewed interest among modellers to investigate the implication of the
capacity of the health-care system. Wang and Ruan [204] considered an SIR epidemic
model and assumed a Heaviside treatment function while Wang [205] restudied the
same SIR model but assumed a piecewise linear treatment function. Here it is assumed
that the heroin users U1(t) receive treatment based on the following more general
saturated treatment function:
T (U1) ≜
αU1
1 + ωU1
,
where α is positive and ω is nonnegative. In the proposed model the parameter ω ac-
counts for the extent of saturation of heroin users. Note that for small U1 the treatment
function reduces to T (U1) ≈ αU1 while for large U1 it reduces to T (U1) ≈ α/ω which
actually characterizes the saturated phenomena of the treatment. Further, if ω = 0,
the treatment function becomes T (U1) = αU1 which is the usual linear treatment rate.
1/(1 + ωU1) is a measure of inhibition due to a saturation of heroin users who are
usually too many to be dealt with given the limited available treatment.
A summary of the model variables and parameters is given in Table 6.1.
6.4 Basic properties and basic reproduction num-
ber
Since the proposed model involves a human population, the model must be able to
ensure that all the associated parameters and the state variables S, U3, U2, U1 are
nonnegative for all time t > 0. Hence, the following result:
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Figure 6.2: A heroin epidemic model with a density-dependent incidence rate and a
saturated treatment function. The blue solid arrows represent deaths either due to
heroin or natural causes while the black solid arrows represent change of status from
one compartment to another.
Table 6.1: Description of variables and parameters of model (6.1).
Variable description
S Number of susceptible individuals at time t
U3 Number of heroin users who have been successfully treated from heroin
use, as well as individuals who have voluntarily stopped using heroin
(and have withdrawal symptoms) at time t
U2 Number of heroin users undergoing treatment at time t
U1 Number of drug users not undergoing treatment at time t
i.e., the initial and relapsed heroin users
N Total population at time t (N = S(t) + U3(t) + U2(t) + U1(t))
Parameter description
Λ Recruitment rate of individuals in the general population entering the susceptible population
β Effective contact rate
µ Death rate due to natural causes
p Rate at which individuals undergoing treatment relapse to heroin use
ξ “Self cure” rate at which heroin users stop using heroin and join the successfully cured class
of individuals not taking heroin
δ1 Heroin-related death rate of heroin users not in treatment
δ2 Heroin-related death rate of individuals undergoing treatment
σ Rate at which heroin users in treatment are successfully
cured (i.e., completely detoxicated) from heroin use
α Rate at which heroin users are treated
ω The extent of saturation of heroin users within the community
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Theorem 6.4.1 Let the initial conditions supplied to model (6.1) be such that S(0) >
0, U3(0) > 0, U2(0) > 0 and U1(0) > 0. Then the trajectories (S(t), U3(t), U2(t), U1(t))
of the model (6.1), with nonnegative initial conditions, will remain nonnegative for all
time t.
Proof . Let t1 = sup{t > 0 : S(t) > 0, U3(t) > 0, U2(t) > 0, U1(t) > 0} > 0. Now from
the first equation of model (6.1) it follows that
dS
dt
= Λ− βU1S − µS = Λ− ΦS − µS (where Φ = βU1),
which can be written as
d
dt
{
S(t) exp
[
µt+
∫ t
0
Φ(τ)dτ
]}
= Λ
{
exp
[
µt+
∫ t
0
Φ(τ)dτ
] }
.
Hence,
S(t1) exp
[
µt1 +
∫ t1
0
Φ(τ)dτ
]
− S(0) =
∫ t1
0
Λ
{
exp
[
µx+
∫ x
0
Φ(τ)dτ
]}
dx,
so that
S(t1) =S(0) exp
[
−µt1 −
∫ t1
0
Φ(τ)dτ
]
+
{
exp
[
−µt1 −
∫ t1
0
Φ(τ)dτ
] }
×
∫ t1
0
Λ
{
exp
[
µx+
∫ x
0
Φ(τ)dτ
] }
dx > 0.
Following a similar procedure it can be shown that U3(t) > 0, U2(t) > 0, U1(t) > 0 for
all time t > 0. Thus, all trajectories of model (6.1) remain positive for all non-negative
initial conditions, as required. □
Now the region where model (6.1) is considered to be biologically feasible is established.
Summing all the equations of the basic model (6.1) yields
dN(t)
dt
= Λ− µN(t)− δ1U1(t)− δ2U2(t). (6.2)
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Considering that 0 < U1(t) < N(t), 0 < U2(t) < N(t) and letting δ¯ = max{δ1, δ2}, it
follows from equation (6.2) that
Λ− (µ+ 2δ¯)N(t) ≤ dN(t)
dt
≤ Λ− µN(t).
Therefore
Λ
µ+ 2δ¯
≤ lim inf
t→∞ N(t) ≤ lim supt→∞ N(t) ≤
Λ
µ
such that lim sup
t→∞
N(t) ≤ Λ
µ
.
Theorem 6.4.2 The closed set
℧ =
{
(S, U3, U2, U1) : 0 ≤ S, U3, U2, U1;S + U3 + U2 + U1 ≤ Λ
µ
}
is positively invariant and absorbing with respect to the set of nonlinear differential
equations (6.1).
Proof. Here it is shown that the feasible solutions of model (6.1) are uniformly
bounded in the region ℧. Suppose S, U3, U2, U1 is any solution of the system (6.1)
supplied with nonnegative initial conditions. Then it is straightforward to note that
the total population N satisfies the inequality
dN
dt
= Λ− µN − δ1U1 − δ2U2 ≤ Λ− µN. (6.3)
From (6.3) it follows that dN
dt
≤ Λ− µN which implies dN
dt
≤ 0 if N ≥ Λ
µ
. The standard
comparison theorem [106] can be used to deduce that N(t) ≤ N(0)e−µt + Λ
µ
(1− e−µt).
In particular N(t) ≤ Λ
µ
if N(0) ≤ Λ
µ
for all t > 0. Thus, under the flow induced by
system (6.1), the region ℧ is positively invariant. Furthermore, for N(0) > Λ
µ
the
trajectory solution N(t) enters either in the region ℧ in finite time or asymptotically
approaches Λ
µ
. Thus, in the region ℧, model (6.1) is said to be mathematically and
epidemiologically well posed [20] and the solution of all the trajectories generated by
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model (6.1) are considered to be in the biologically feasible region ℧. □
Clearly system (6.1) has an intrinsic heroin free equilibrium (HFE) given by D0 =
(S0, 0, 0, 0), a scenario representing a heroin free state in the community. S0 = Λµ
represents the number of susceptibles when no one is using heroin. The basic reproduc-
tion number denoted by R0 is defined as the number of secondary infections that are
likely to be triggered by a single infectious individual when introduced into a wholly
susceptible population [20]. Here R0 is interpreted as the mean number of secondary
cases of heroin users generated by a typical heroin user not in treatment during his/her
duration of heroin use in a population of potential drug users.
To obtain the basic reproduction number it can be easily observed that the average time
an individual spends as a heroin user without treatment is T0 =
1
µ+ δ1 + ξ + α
and the
probability of surviving this compartment and moving to the treatment compartment
is T1 =
α
µ+ δ1 + ξ + α
. Now the probability of surviving treatment and then returning
to the heroin users class is T2 =
p
p+ σ + δ2 + µ
. Thus, the total average time spent as
a heroin user (not in the treatment compartment) on multiple passes, can be obtained
as
T = T0[1 + T1.T2 + (T1.T2)2 + . . .]. (6.4)
Clearly, the terms inside the square brackets in (6.4) constitute a geometric sequence
(see Appendix K for detailed derivation) and therefore expression (6.4) can be written
as
T = (p+ σ + δ2 + µ)(µ+ δ1 + ξ)(p+ δ2 + σ + µ) + α(σ + δ2 + µ)
. (6.5)
Multiplying (6.5) with the effective contact rate β and the average recruitment rate Λ
µ
yields a heroin basic reproduction number as
R0 =
βΛ(p+ δ2 + µ+ σ)
µα(µ+ δ2 + σ) + µ(µ+ δ1 + ξ)(p+ δ2 + µ+ σ)
. (6.6)
It is easy to observe that R0 is inversely proportional to treatment α, which implies
that if treatment rate is maintained sufficiently high it can control a heroin epidemic
(by reducing R0 to less than one). However, as it will be seen later, when parameter ω
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(representing the extent of saturation of heroin users) is accounted for, this control is
no longer guaranteed.
Theorem 6.4.3 The HFE is locally asymptotically stable provided R0 < 1, otherwise
it is unstable.
This general result has been reviewed in [25] and thus not proved again here. The
theorem implies that heroin users will disappear from the community when R0 < 1 if
the initial sizes of the sub-populations of system (6.1) are in the basin of attraction of
the heroin free equilibrium.
Remark 1 It is instructive to note that the basic reproduction number does not include
the parameter ω that accounts for the extent of saturation of heroin users. In what
follows, the endemic equilibria of the model, where the parameter ω plays a key role in
the emergence of bi-stability, are analysed.
6.4.1 Endemic equilibria
Within the context of the proposed heroin model the endemic equilibrium refers to a
state when heroin addiction is maintained over long time-scales in the population. There-
fore S∗, U∗3 , U∗2 , U∗1 > 0 holds. To obtain the endemic equilibria E∗ = (S∗, U∗3 , U∗2 , U∗1 )
equations (6.1) are set to zero and equilibrium quantities S∗, U∗3 and U∗2 are solved in
terms of U∗1 . That is
S∗ = Λ
βU∗1 + µ
,
U∗3 =
σαU∗1 + ξ(p+ σ + δ2 + µ)(1 + ωU∗1 )U∗1
µ(p+ σ + δ2 + µ)(1 + ωU∗1 )
, (6.7)
U∗2 =
αU∗1
(p+ σ + δ2 + µ)(1 + ωU∗1 )
.
Substituting (6.7) into the second equation of (6.1) and factoring out the solution
U∗1 = 0 yields
f(U∗1 ) = AU∗21 +BU∗1 + C = 0, (6.8)
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where
A = (µ+ δ1 + ξ)(p+ σ + δ2 + µ)βω,
B = (µ+ δ1 + ξ)(p+ σ + δ2 + µ)β + µω(µ+ δ1 + ξ)(p+ σ + δ2 + µ)
+ α(σ + δ2 + µ)β − βΛω(p+ σ + δ2 + µ),
C = [(µ+ δ1 + ξ)(p+ σ + δ2 + µ)µ+ αµ(σ + δ2 + µ)](1−R0).
The quadratic equation (6.8) can be analysed to investigate the existence of multiple
equilibria when the basic reproduction number is below unity.
If the parameter that accounts for the extent of saturation of heroin users in model
(6.1) is excluded, that is ω = 0, (6.8) reduces to a linear equation
U∗1 B˜ + C = 0,
where
B˜ = (µ+ δ1 + ξ)(p+ σ + δ2 + µ)β + α(σ + δ2 + µ)β
so that model (6.1) has the unique solution
U∗1 =
−C
B˜
= µ
β
(R0 − 1)
which is nonnegative if and only if R0 > 1. Hence, if ω = 0, model (6.1) has a unique
endemic equilibrium whenever R0 > 1 and this equilibrium approaches zero as R0
tends to one (R0 → 1+) because C → 0. But there is no positive endemic equilibria if
R0 < 1. These results are summarized in the following Lemma:
Lemma 6.4.1 The heroin epidemic model (6.1) when ω = 0 has a unique positive
(endemic) equilibrium E∗1 = (S∗, U∗3 , U∗2 , U∗1 ) whenever R0 > 1 and no positive endemic
equilibrium otherwise.
In what follows the global stability for both the HFE and the unique endemic equilibrium
E∗1 for the case ω = 0 is investigated.
6.4.2 Global stability for heroin-free equilibrium when ω = 0
To investigate global stability the method presented by Castillo-Chavez et al. [206] is
applied. First let X = (S, U3) and Y = (U2, U1) with X ∈ R2 representing the number
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of individuals not using heroin and Y ∈ R2 representing the number of individuals
using heroin (i.e., heroin users in treatment and heroin users not in treatment). Now
suppose
X ′ = F (X ,Y),
Y ′ = G(X ,Y), G(X , 0) = 0,
where X ′ and Y ′ denote differentiation with respect to time. The HFE is now denoted
by D0 = (X 0, 0), where X 0 = (S0, 0). The following conditions (H1) and (H2) have to
be met to guarantee global asymptotic stability:
(H1) For X ′ = F (X , 0), X 0 is globally asymptotically stable (g.a.s);
(H2) G(X ,Y) = BY − Ĝ(X ,Y), where Ĝ(X ,Y) ≥ 0, for (X ,Y) ∈ ℧.
B = DYG(X , 0) and ℧ is the region where the model (6.1) is biologically realistic.
Then, Castillo-Chavez et al. [58] have shown that the following Lemma is satisfied.
Lemma 6.4.2 The fixed point D0 = (X 0, 0) is a g.a.s equilibrium of model (6.1)
provided that R0 < 1 (locally asymptotically stable) and that assumptions (H1) and
(H2) hold.
Now consider the following Theorem:
Theorem 6.4.4 Suppose R0 < 1. Then the HFE D0 is g.a.s.
Proof Let X = (S, U3) and Y = (U2, U1), and
D0 = (X 0, 0) where X 0 =
(
Λ
µ
, 0
)
.
Then,
X ′ = F (X ,Y) =
 Λ− βU1S − µS
σU2 + ξU1 − µU3
 .
It is straightforward to see that at the heroin free equilibrium (HFE) S = S0 = Λµ ,
F (X 0, 0) =
0
0
 . Thus,
X ′ = F (X , 0) =
Λ− µS
−µU3
 .
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Now, as t→∞, X → X 0. Hence, X 0 is globally asymptotically stable (i.e., condition
(H1) is satisfied).
Now consider
G(X ,Y) =
−(p+ σ + δ2 + µ) α
p βS0 − (µ+ δ1 + ξ + α)
 U2
U1
−
 0
βU1 (S0 − S)

so that,
B =
−(p+ σ + δ2 + µ) α
p βS0 − (µ+ δ1 + ξ)
 and Ĝ(X ,Y) =
 0
βU1(S0 − S)
 .
Since, the total population is bounded by N = S + U3 + U2 + U1 ≤ Λµ , it follows that
S ≤ N ≤ Λ
µ
. Thus, Ĝ(X ,Y) ≥ 0, which now implies that conditions (H1) and (H2) are
satisfied. Consequently by Lemma 6.4.2 the fixed point D0 is globally asymptotically
stable when R0 < 1, which indicates non-existence of multiple non-trivial equilibria
when ω = 0. The epidemiological implication of HFE being g.a.s is that any heroin epi-
demic will be eliminated from the community if the threshold quantity R0 is decreased
to (or maintained at) a value below unity. □
Now for ω > 0, Theorem 6.4.5 follows.
Theorem 6.4.5 For ω > 0 model (6.1) has:
(i) A unique positive endemic equilibrium if B < 0 and either C = 0 or B2−4AC = 0;
(ii) A unique positive endemic equilibrium if C < 0 (i.e., R0 > 1) and B < 0;
(iii) Two positive endemic equilibria if C > 0, B < 0 and B2 − 4AC > 0;
(iv) No positive endemic equilibrium if B > 0 and either C > 0 or B2 < 4AC.
The theorem may be proved as follows. It is obvious to note that in the quadratic
equation (6.8) A is always positive and C is either positive or negative depending on
whether the basic reproduction number is less than or greater than one respectively.
For case (i) where B < 0 and C = 0 (i.e., R0 = 1) then equation (6.8) becomes linear
AU∗1 +B = 0 and has a unique nonzero solution U∗1 = −B/A which is positive if B < 0
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and negative if B > 0. Referring to equation (6.7) it is easy to see that if U∗1 is unique
then so are S∗, U∗2 and U∗3 .
For case (ii) where C < 0 (that is R0 > 1) and B < 0 equation (6.8) is quadratic and
according to Descarte’s Rule of Signs (see [207]), (6.8) has one change of signs indicat-
ing (6.8) has a unique positive root and therefore there is a unique endemic equilibrium.
In case (iii) where B < 0 there is a nonnegative endemic equilibrium at R0 = 1.
However, because equation (6.8) is quadratic and since the equilibrium is continuously
determined by R0 then there must be an interval to the left of R0 = 1 on which two
nonnegative equilibria coexist. That is
U∗1,1 =
−B −√B2 − 4AC
2A , U
∗
1,2 =
−B +√B2 − 4AC
2A . (6.9)
For case (iv) where B > 0 and C > 0 or B2 < 4AC equation (6.8) has no positive real
root as can be seen in equation (6.9), implying non-existence of a positive endemic
equilibrium.
Case (iii) suggests that model (6.1) exhibits the phenomenon of backward bifurcation
since the classical requirement for the occurrence of the phenomenon of backward
bifurcation is satisfied, that is the existence of multiple equilibria when the basic
reproduction number is less than one. Thus, the following Theorem 6.4.6:
Theorem 6.4.6 Model (6.1) has a backward bifurcation at R0 = 1 if and only if B < 0
(i.e., ω > ωc).
Proof. Consider equation (6.8) f(U∗1 ) = AU∗21 +BU∗1 + C = 0. Note that at R0 = 1,
C = 0 implies the graph f(U∗1 ) passes through the origin. If B < 0 it follows that
f(U∗1 ) = 0 has a nonnegative root. Since f(U∗1 ) is a continuous function of C, if C
is increased such that C > 0, there is some open interval of C say (0, ψ) on which
f(U∗1 ) = 0 has two nonnegative roots. That is, there exists two nonnegative endemic
equilibria when R0 < 1. This is indeed true since case (iv) of Theorem 6.4.5 has already
shown that for B ≥ 0 model (6.1) does not have positive real roots when R0 < 1. Note
that at R0 = 1, C = 0 the following equality holds
(µ+ δ1 + ξ)(p+ σ + δ2 + µ)µ+ αµ(µ+ δ2 + σ) = (p+ σ + δ2 + µ)βΛ. (6.10)
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This together with condition B < 0 implies
ω >
(µ+ δ1 + ξ)(p+ σ + δ2 + µ)β + α(σ + δ2 + µ)β
µα(σ + δ2 + µ)
≜ ωc.□ (6.11)
Thus, the phenomenon of backward bifurcation (referring to case (iii) a situation
where there are two endemic equilibria) occurs at the left of R0 = 1 if and only if
condition (6.11) is satisfied. This suggests that backward bifurcation will only occur if
the parameter ω that accounts for the extent of saturation of heroin users exceeds a
certain threshold (i.e., ω > ωc). However, if ω < ωc backward bifurcation cannot occur.
Thus, the parameter ω plays a critical role in the formation of backward bifurcation
for model (6.1). It is instructive to note that similar results as the one shown in
inequality (6.11) can be obtained by Center Manifold Theory (see Appendix L), where
it is emphasized that if ω > ωc the bifurcation coefficient a is positive indicating that
the model system (6.1) undergoes the phenomenon of backward bifurcation. The
epidemiological implication of backward bifurcation is that although it is necessary
to reduce the basic reproduction number below one it is not sufficient to eradicate a
heroin epidemic, rather R0 should be reduced further. In fact, R0 should be reduced
below a certain threshold which shall be denoted by RC0 (see Figure 6.3(b)).
6.4.3 Computation of new threshold for heroin eradication
RC0
Here the critical value of the basic reproduction number where the two non-trivial
endemic equilibria (both stable and unstable) collide and annihilate each other leaving
only the heroin-free equilibrium point as the stationary solution is computed. This is
RC0 in Figure 6.3(b). Λ is chosen as the parameter of backward bifurcation. Note that
in case (iii) of Theorem 6.4.5 equation (6.8) has nonnegative roots corresponding to two
endemic equilibria if and only if C > 0 (i.e., R0 < 1) and B < 0, B2 > 4AC. It follows
that if B = −2√AC equation (6.8) has one nonnegative root −B2A . Supposing there is
backward bifurcation at R0 = 1, then there are two endemic equilibria for an interval of
the basic reproduction number starting from a threshold RC0 defined by B = −2
√
AC
to a point where R0 = 1. To obtain the threshold RC0 which is often referred to as
the critical value of the basic reproduction number, one needs to replace the values
of A, B and C in the equality B2 = 4AC to obtain a quadratic equation in terms of
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Λ. For mathematical tractability redefine coefficients B and C as B = B1 −B2Λ and
C = C1 − C2Λ, where
B1 =(µ+ δ1 + ξ)(p+ σ + δ2 + µ)β + µω(µ+ δ1 + ξ)(p+ σ + δ2 + µ) + α(σ + δ2 + µ)β,
B2 =βω(p+ σ + δ2 + µ),
C1 =µ(µ+ δ1 + ξ)(p+ σ + δ2 + µ) + αµ(σ + δ2 + µ),
C2 =β(p+ σ + δ2 + µ),
B1, B2, C1, C2 > 0.
Note that A > 0 remains as previously defined in equation (6.8). Now the quadratic
equation in terms of Λ can be obtained as
B22Λ2 + (4AC2 − 2B1B2)Λ + (B21 − 4AC1) = 0.
Since the scenario where B < 0 and R0 < 1 is being considered it follows that
C1B2 > C2B1 and thus there is just the single solution
Λc =
B1B2 − 2AC2 + 2
√
A2C22 + AB2(C1B2 − C2B1)
B22
> 0.
Thus, the critical value of basic reproduction number (i.e., the new threshold for heroin
eradication), RC0 , is given as
RC0 =
βΛc(p+ δ2 + µ+ σ)
µα(µ+ δ2 + σ) + µ(µ+ δ1 + ξ)(p+ δ2 + µ+ σ)
.
Consequently, from the above analysis of computation of threshold for heroin eradication
the following Lemma is deduced:
Lemma 6.4.3 (a) If R0 > 1, then model (6.1) has a unique endemic equilibrium point
E∗. In this case a heroin epidemic will persist in the community;
(b) If RC0 < R0 < 1, then model (6.1) has two endemic equilibria E¯1 and E¯2, and
signals that model (6.1) has backward bifurcation;
(c) If R0 < RC0 < 1, then model (6.1) has only the heroin-free equilibrium point D0
and in this case heroin users will disappear.
Figure 6.3 exhibits typical bifurcation diagrams for model (6.1). To obtain the graphs
the recruitment rate Λ is varied while other parameter values are held fixed. The
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parameters used for the numerical simulation that leads to Figure 6.3(a) include ω =
0.11, µ = 0.01, β = 0.001, δ1 = 0.002, δ2 = 0.001, ξ = 0.015, α = 0.9, p = 0.467, σ = 0.1
and 1 ≤ Λ ≤ 3. Figure 6.3(a) represents the forward bifurcation scenario where if
R0 < 1 the heroin-free equilibrium is globally asymptotically stable while when R0 > 1
the heroin epidemic can persist. However, as noted from Figure 6.3(b) increasing
parameter ω from ω = 0.11 to ω = 0.25 such that ω > ωc, a heroin epidemic can
persist once established for a range of R0 values that are below unity which indicates
the occurrence of backward bifurcation. This implies reducing R0 below one will not
necessarily be sufficient for eradication of heroin usage from the community. If R0 is
sufficiently decreased such that R0 < RC0 the positive equilibrium no longer exists and
heroin usage will cease to thrive and eventually fall from its relatively high endemic
level to the heroin-free equilibrium. From Figure 6.3(b) it is observed that when
RC0 ≤ R0 ≤ 1 there is a stable endemic equilibrium, an unstable endemic equilibrium
and a stable heroin-free equilibrium. When R0 > 1 there is only one stable endemic
equilibrium. Figure 6.3(c) shows the effect of the saturation parameter ω on RC0 , namely
that increasing ω decreases RC0 . Figure 6.3(d) shows that increasing the treatment rate
α increases RC0 which epidemiologically implies that high cure rates of heroin users
can lead to shrinking of the backward bifurcation regime.
6.5 Global stability
According to Theorem 6.4.5 model (6.1) may have multiple equilibria when R0 < 1 and
a unique endemic equilibrium whenever R0 > 1. First, global stability of the endemic
equilibrium of model (6.1) is investigated for a special case i.e., when ω = ξ = σ =
0, using the Lyapunov direct method and later proven for the general model (i.e.,
ω, σ, ξ > 0) using a geometric approach.
6.5.1 Global stability using the Lyapunov method (special
case ω = σ = ξ = 0)
Lyapunov functions have previously been used in proving global stability of epidemic
models for instance see [208, 209, 210, 211]. Now consider the following Theorem:
Theorem 6.5.1 If ω = σ = ξ = 0 the unique endemic equilibrium E∗1 of model (6.1)
is globally asymptotically stable in the interior of Ω if R0 > 1.
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(a) (b)
(c) (d)
Figure 6.3: (a) and (b) represent bifurcations where drug users U∗1 are not in treatment;
equilibria are plotted as a function of R0. The blue solid lines represent the stable
equilibria while red solid lines represent unstable equilibria. (a) Represents forward
bifurcation with parameters ω = 0.11 < ωc = 0.1156, µ = 0.01, β = 0.001, δ1 =
0.002, δ2 = 0.001, ξ = 0.015, α = 0.9, p = 0.467, σ = 0.1 and Λ ∈ [1, 3]. (b) Represents
backward bifurcation with parameters as in (a) except ω = 0.25 > ωc = 0.1156. (c)
The critical value RC0 as a function of the saturation parameter ω. The black dotted
line represents the threshold ωc which if exceeded gives rise to a backward bifurcation.
(d) The critical value RC0 as a function of treatment rate α.
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Proof. Defining the following Lyapunov candidate function,
W (S, U1, U2) =
(S − S∗)2
2S∗ +
(
U1 − U∗1 − U∗1 ln
U1
U∗1
)
+ pU
∗
2
αU∗1
(
U2 − U∗2 − U∗2 ln
U2
U∗2
)
,
(6.12)
the time derivative of W (S, U1, U2) along the solutions of system (6.1) is
W ′(S, U1, U2) =
(
S − S∗
S∗
)
dS
dt
+
(
U1 − U∗1
U1
)
dU1
dt
+ pU
∗
2
αU∗1
(
1− U
∗
2
U2
)
dU2
dt
=
(
S − S∗
S∗
)
[Λ− βU1S − µS] (6.13)
+
(
U1 − U∗1
U1
)
[βU1S + pU2 − (µ+ δ1 + α)U1]
+ pU
∗
2
αU∗1
(
1− U
∗
2
U2
)
[αU1 − (p+ δ2 + µ)U2].
Because (S∗, U∗2 , U∗1 ) is an endemic steady point of model (6.1) when ω = ξ = σ = 0,
then it follows that
Λ = βU∗1S∗ + µS∗, (p+ δ2 + µ) =
αU∗1
U∗2
, (µ+ δ1 + α) = βS∗ +
pU∗2
U∗1
. (6.14)
Using (6.14) in equation (6.13) yields
W ′(S, U1, U2) = −
(
S − S∗
S∗
)
(µ(S − S∗) + β(SU1 − S∗U∗1 ))
+ (U1 − U∗1 )
(
β(S − S∗) + p
(
U2
U1
− U
∗
2
U∗1
))
+ pU
∗
2
αU∗1
(
1− U
∗
2
U2
)(
αU1 − αU2U
∗
1
U∗2
)
.
(6.15)
Note that
SU1 − S∗U∗1 = S∗(U1 − U∗1 ) + U1(S − S∗).
Replacing the above equality in equation (6.15) results in
W ′(S, U1, U2) = −
(
(S − S∗)2
S∗
)
(µ+ βU1) + pU∗2
(
2− U
∗
1U2
U1U∗2
− U
∗
2U1
U2U∗1
)
= −
(
(S − S∗)2
S∗
)
(µ+ βU1)− pU∗2
[√
U∗1U2
U1U∗2
−
√
U∗2U1
U2U∗1
]2
.
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Hence, W ′(S, U1, U2) ≤ 0 for all S, U1, U2 > 0. Hence, the heroin endemic equilibrium
E∗1 is stable and W ′(S, U1, U2) = 0 if and only if S = S∗, U2 = U∗2 , U1 = U∗1 . The
largest compact invariant set when ω = ξ = σ = 0 in {(S∗, U∗1 , U∗2 ) ∈ R3+} is the
singleton {E∗1}. Therefore, by LaSalle’s invariance principle the endemic steady state
E∗1 is globally asymptotically stable in the interior of R3+. □
The previous global stability analysis was only relevant for a very specific case. In the
subsequent subsection the geometric approach by Li and Muldowney [98, 191, 212]
is used to obtain sufficient conditions that ensure the unique endemic equilibrium is
globally asymptotically stable for a wide range of parameter values.
6.5.2 A geometric approach to global stability
For the general model global stability is investigated using the Li and Muldowney
[98, 191, 212] generalizations of the Poincare-Bendixson approach for systems of n > 2
ordinary differential equations. This criterion is sometimes referred to as a geometric
approach to global stability [193, 213].
To apply the geometric approach on model (6.1) consider the autonomous dynamical
system dy
dt
= f(y) where
f = (f1, f2, f3, f4)T and f1, f2, f3, f4 represent the right-hand side of system (6.1),
respectively. First, the general mathematical framework of the procedure developed in
Li and Muldowney [98, 189] is outlined.
Suppose the map y 7−→ f(y) is a C1 function for y in an open subset D ⊂ Rn and
consider the following autonomous dynamical system
y′ = f(y). (6.16)
Let y(t, y0) be the solution to equation (6.16) satisfying y(0, y0) = y0. Now the following
basic assumptions are made:
(H3) D is simply connected;
(H4) There exists a compact absorbing set K ⊂ D;
(H5) Equation (6.16) has a unique equilibrium y∗ in D.
Now under the stated assumptions (H3)-(H5), y∗ is said to be globally stable in D if it
is locally stable and all trajectories in D converge to the same equilibrium y∗. That
is system (6.16) has no non-constant periodic solutions. It is important to mention
that global stability can be tested by the Bendixson criteria. For n ≥ 2 a Bendixson
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criterion refers to a condition satisfied by field f which precludes the existence of
non-constant periodic solutions of equation (6.16). When n = 2, (i.e., the planar case)
the classical results (Poincaré-Bendixson theorem and Dulac criteria, see [103]) ade-
quately provide such global conditions. For n ≥ 3 a remarkable approach for proving
global stability is given by the work of Li and Muldowney [98, 189, 191]. They showed
that if conditions (H3)-(H5) hold and differential equation (6.16) fulfills a Bendixson
criterion that is robust under C1 local ϵ-perturbations1 of f at all non-equilibrium non-
wandering2 points for system (6.16), then y∗ is globally stable in D provided it is stable.
Now the new Bendixson criterion based on the use of the Lozinski˘ı measure as developed
in [98] is stated. Consider the differential equation (6.16) under the stated assumptions
(H3)-(H5). Let y 7−→ P (y)
(
n
2
)
×
(
n
2
)
be a matrix-valued function which is C1 for y ∈ D
and consider
A = PfP−1 + PJ [2]P−1 (6.17)
where Pf is the directional derivative of P in the direction of the vector field f in
system (6.16) and is defined as
(pi,j(y))f = (∂pi,j(y)/∂x)T .f(y) = ▽pi,j.f(y). (6.18)
Next, let J [2] represent the second additive compound matrix of J (where J(y) = Df(y)).
In Muldowney [214] the relation of compound matrices to differential equations is
established. It is shown that for an arbitrary n×n matrix J = (Ji,j), J [2] is an
(
n
2
)
×
(
n
2
)
matrix. Now define the following quantity
q¯2 = lim sup
t→∞
sup
y0∈℧
1
t
∫ t
0
ρ(A(s, y0)))ds (6.19)
1 A function g ∈ C1(D −→ Rn) is called a C1 local ϵ-perturbation of f at y0 ∈ D if there exists an
open neighbourhood U of y0 in D such that the support supp(f − g) ⊂ U and |f − g|C1 < ϵ, where
|f − g|C1 = sup{|f(y)− g(y)|+ |fy(y)− gy(y)| : y ∈ D}
2A point y0 ∈ D is said to be non-wandering for system (6.16) if for any neighbourhood U of y0
in D there exists arbitrary large t such that U ∩ y(t, U) ̸= ∅. As an example, any equilibrium, alpha
limit point, or omega limit point is non-wandering.
6.5 Global stability 129
where ρ(A) is the Lozinski˘ı measure of A with respect to vector norm | · | in RN ,
N =
(
n
2
)
and ρ(A) is defined as
ρ(A) = lim
h→0+
|1 + hA| − 1
h
(6.20)
(see [215, 216]). In Li and Muldowney [98] it is proved that if conditions (H3) and (H4)
are satisfied then q¯2 < 0 indicates that there are no orbits giving rise to a simple
closed rectifiable curve in D that is invariant for system (6.16) (that is periodic orbits,
homoclinic orbits and heteroclinic cycles). Furthermore, it has been demonstrated by
Li and Muldowney [98] that under the stated assumptions (H3)-(H5), the quantity
q¯2 < 0 implies the local stability of equilibrium point y∗. As a result the following is
true:
Theorem 6.5.2 (Li and Muldowney [98]). Assuming that conditions (H3)-(H5) hold
the equilibrium point y∗ is globally asymptotically stable in D if a function P (y) and a
Lozinski˘ı measure ρ exists such that quantity the q¯2 < 0.
Observe that whenever R0 > 1, there exists a unique and positive endemic equilibrium
E∗ (see Lemma 6.4.3) for model system (6.1). The method outlined above requires
that (i) the endemic equilibrium E∗ is unique in the interior of ℧ (i.e., condition H5
holds) and (ii) in the interior of ℧ there exists an absorbing compact set (condition
H4 holds). The heroin model studied here with the assumption that R0 > 1 fulfills
conditions H4-H5. It is easy to prove that when R0 > 1, the heroin free equilibrium
D0 is unstable (see Theorem 6.4.3). The instability of the heroin free equilibrium
D0 combined with D0 ∈ δ℧ (where δ℧ defines the boundary of the region ℧) signals
uniform persistence [217]. That is, there exists a positive constant c0 > 0 such that for
every solution (S(t), U1(t), U2(t), U3(t)) of system (6.1) with (S(0), U1(0), U2(0), U3(0))
in the interior of the biologically feasible region ℧ satisfies
lim
t→∞ inf |(S(t), U1(t), U2(t), U3(t))| ≥ c0.
Because of the boundedness of the region ℧, uniform persistence is equivalent to the
existence of a compact set in the interior of ℧ which is absorbing for (6.1) (see [218]).
Hence, condition (H4) is satisfied. Also it is shown that whenever R0 > 1 the model
system (6.1) has only one equilibrium E∗ in the interior of ℧, so that condition H5
is verified. Now for the heroin model system (6.1) the task involves verifying the
Bendixson criterion (6.28). Note that the variable U3 does not affect the first, second
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or third equation of system (6.1). Thus, the fourth equation can be dropped from the
analysis leading to the following subsystem:
dS
dt
= Λ− βU1S − µS,
dU1
dt
= βU1S + pU2 − (µ+ δ1 + ξ)U1 − αU11 + ωU1 , (6.21)
dU2
dt
= αU11 + ωU1
− (p+ σ + δ2 + µ)U2.
The Jacobian matrix of subsystem (6.21) is found to be:
J =

−(βU1 + µ) −βS 0
βU1 βS − (µ+ δ1 + ξ)− α(1+ωU1)2 p
0 α(1+ωU1)2 −(p+ σ + δ2 + µ)

.
In working with Theorem 6.5.2 one needs to make use of additive compound matrices.
For an arbitrary 3× 3 matrix B, the second additive compound matrix B[2] is defined
as:
B =

b11 b12 b13
b21 b22 b23
b31 b32 b33

, and B[2] =

b11 + b22 b23 −b13
b32 b11 + b33 b12
−b31 b21 b22 + b33

.
Thus, the second additive compound matrix of Jacobian matrix J of system (6.21) is
given as
J [2] =

J11 p 0
α
(1+ωU1)2 J22 −βS
0 βU1 J33

,
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where
J11 = −βU1 − (2µ+ δ1 + ξ)− α(1 + ωU1)2 + βS,
J22 = −βU1 − (2µ+ p+ σ + δ2),
J33 = − α(1 + ωU1)2 − (2µ+ p+ σ + δ1 + δ2 + ξ) + βS.
For the model system (6.21) a suitable vector norm | · | in R3 and a 3× 3 matrix-valued
function P (y) is given by:
P (S, U1, U2) =

1 0 0
0 U1
U2
0
0 0 U1
U2

.
Thus
PfP
−1 =

0 0 0
0 U
′
1
U1
− U ′2
U2
0
0 0 U
′
1
U1
− U ′2
U2

and
PJ [2]P−1 =

J11
pU2
U1
0
αU1
(1+ωU1)2U2 J22 −βS
0 βU1 J33

.
Note that upper prime (′) denotes differentiation with respect to time. Thus, A =
PfP
−1 + PJ [2]P−1 can be obtained as
A =

J11
pU2
U1
0
αU1
(1+ωU1)2U2 J22 +
U ′1
U1
− U ′2
U2
−βS
0 βU1 J33 + U
′
1
U1
− U ′2
U2

.
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It is helpful to write matrix A in block form as
A =
A11 A12
A21 A22
 ,
where
A11 = −βU1 − (2µ+ δ1 + ξ)− α(1 + ωU1)2 + βS, A12 =
[
pU2
U1
0
]
,
A21 =
[
αU1
(1+ωU1)2U2 0
]T
, A22 =
J22 + U ′1U1 − U ′2U2 −βS
βU1 J33 + U
′
1
U1
− U ′2
U2
 .
Following Li and Muldowney [98], let (u, v, w) represent the vectors in R3 ∼= R(32). Now
for the norm | · | in R3 select
|(u, v, w)| = max{|u|, |v|+ |w|},
and let ρ represent the Lozinski˘ı measure with respect to this norm. Applying the
method of approximating the ρ(A) as given in [216] leads to
ρ(A) ≤ sup {g1, g2},
where
g1 = ρ1(A11) + |A12|,
g2 = |A21|+ ρ1(A22). (6.22)
Here |A12| and |A21| are operator norms of A12 and A21 with respect to the l1 vector
norm, where they are both regarded as mapping from R2 to R. ρ1(A22) represents the
Lozinski˘ı measure of the 2× 2 matrix A22 with respect to the l1 norm in R2. To obtain
ρ1(A22) sum the absolute value of the off-diagonal elements to the diagonal one in each
column of A22 and then take the maximum of two sums. Assuming that
1
2
(
δ1 + ξ +
α
(1 + ωU1)2
)
> βS. (6.23)
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Numerical simulations show that the inequality (6.23) holds at the parameter ranges of
interest. However, it remains for future work to prove this is true in general. It follows
that,
ρ1(A11) = −βU1 − (2µ+ δ1 + ξ)− α(1 + ωU1)2 + βS,
|A12| = max
{
pU2
U1
, 0
}
= pU2
U1
,
|A21| = max
{
αU1
(1 + ωU1)2U2
, 0
}T
= αU1(1 + ωU1)2U2
,
ρ1(A22) = max
{
U ′1
U1
− U ′2
U2
− (2µ+ p+ σ + δ2), U
′
1
U1
− U ′2
U2
− (2µ+ p+ σ + δ2)− δ1 − ξ − α(1+ωU1)2 + 2βS
}
= U
′
1
U1
− U
′
2
U2
− (2µ+ p+ σ + δ2).
Thus g1 and g2 are respectively
g1 = ρ1(A11) + |A12| = βS + pU2
U1
− βU1 − α(1 + ωU1)2 − (2µ+ δ1 + ξ), (6.24)
g2 = |A21|+ ρ1(A22) = αU1(1 + ωU1)2U2 +
U ′1
U1
− U
′
2
U2
− (2µ+ p+ σ + δ2). (6.25)
Now from the second and third equation of (6.21) it is easy to obtain
U ′1
U1
= βS + pU2
U1
− α(1 + ωU1) − (µ+ δ1 + ξ), (6.26)
U ′2
U2
= αU1(1 + ωU1)U2
− (p+ σ + δ2 + µ). (6.27)
Substituting (6.26) into (6.24) and (6.27) into (6.25) leads to
g1 =
U ′1
U1
− µ− βU1 + αωU1(1 + ωU1)2
≤ U
′
1
U1
− µ+ αωU1(1 + ωU1)2 ,
g2 =
U ′1
U1
− µ− αωU
2
1
(1 + ωU1)2U2
≤ U
′
1
U1
− µ.
Now based on the definition of the method of approximating the Lozinski˘ı measure
ρ(A) as given in Martin [216], the supremum of both g1 and g2, can be approximated.
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Hence,
ρ(A) ≤ sup(g1, g2)
≤ sup
{
U ′1
U1
− µ+ αωU1(1 + ωU1)2 ,
U ′1
U1
− µ
}
=
(
U ′1
U1
− µ
)
+ sup
{
αωU1
(1 + ωU1)2
, 0
}
= U
′
1
U1
− µ+ αωU1(1 + ωU1)2 .
Thus the inequality
ρ(A) ≤ U
′
1
U1
− µ+ αωU1(1 + ωU1)2 .
Now the next step involves substituting ρ(A) into
q¯2 = lim sup
t→∞
sup
y0∈℧
1
t
∫ t
0
ρ(A(s, y0)))ds, (6.28)
and deducing whether q¯2 < 0. And if the inequality q¯2 < 0 does not hold then a
condition that leads to q¯2 < 0 being fulfilled is established.
Considering uniform persistence there exists a c0 > 0 and T > 0 such that t > T implies
S(t) ≥ c0, U1(t) ≥ c0, U2(t) ≥ c0, and U3(t) ≥ c0.
Now by letting Γ1 = αωc0(1+ωc0)2 and Γ2 = µ the following claim is made:
If
Γ1 < Γ2, (6.29)
6.6 Numerical examples 135
then
ρ(A) ≤ U
′
1
U1
− V˜, (6.30)
where
V˜ = µ− αωc0(1 + ωc0)2 > 0.
Now, for t > T it can be deduced that
q¯2 = lim sup
t→∞
1
t
∫ t
0
ρ(A)ds
= lim sup
t→∞
1
t
∫ T
0
ρ(A)ds+ lim sup
t→∞
1
t
∫ t
T
ρ(A)ds
≤ lim sup
t→∞
1
t
log U1(t)
U1(T )
+ lim sup
t→∞
1
t
∫ T
0
ρ(A)ds− lim sup
t→∞
V˜
t− T
t
(6.31)
< 0 when V˜ > 0,
and thus, the Bendixson criterion given by equation (6.28) is verified. Note that with
the stated condition Γ1 < Γ2, V˜ > 0 the limits of the first and second terms of the
equation (6.31) approach zero while the limit of the final term approaches −V˜. Thus,
q¯2 < 0. Since, q¯2 < 0 if and only if condition (6.29) holds true, the following Theorem
6.5.3 is established:
Theorem 6.5.3 Provided R0 > 1, and if Γ1 < Γ2 then the system (6.1) has a unique
endemic equilibrium E∗ which is globally asymptotically stable with respect to solutions
of (6.1) originating in the interior of ℧. □
The validity of Theorem 6.5.3 will be shortly verified numerically.
6.6 Numerical examples
In this section numerical simulations of the heroin epidemic model are presented to
support theoretical findings. Figure 6.4 which shows backward bifurcation is obtained
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by plotting the equilibrium number of heroin users as a function of R0. The figures
present a scenario where R0 is varied via parameter β (i.e., 0.0005 ≤ β ≤ 0.0015) and
other parameters are fixed. Figures 6.4(a)-6.4(d) show that increasing ω leads to the
expansion of the region of bistability while decreasing ω results into contraction of
the bistability region. The heroin eradication threshold (also referred to as critical
reproduction number) RC0 shifts from right to left when ω increases and vice versa
when ω decreases. High values of ω imply there is not enough treatment available for
a large population of heroin users, favouring a situation where there will always be
heroin users within the community even though R0 < 1.
(a) (b) (c) (d)
Figure 6.4: Illustration of the effect of increasing parameter ω that accounts for the
saturation of heroin users. Here the parameters remain as in the caption of Figure
6.3 except Λ = 2 while ω is shown. The heroin eradication thresholds (i.e., RC0 )
corresponding to figures (a)-(d) are respectively 0.5204, 0.6038, 0.7314, 0.9131.
Figures 6.5(a) and 6.5(b) exhibit the time course of the heroin endemic in a param-
eter regime where there is a backward bifurcation. In both figures 6.5(a) and 6.5(b)
R0 = 0.7506 < 1. The figures show the dependence of heroin usage on the size of the ini-
tial conditions supplied to the system, which is a common characteristic of models that
have a bi-stability region. If the model is supplied with initial conditions that are below
the unstable curve (see the red solid line on Figure 6.3(b)) the solution trajectories are
attracted to the heroin free equilibrium while if initial conditions are chosen such that
they are above the unstable curve, then the solution trajectories are attracted to a stable
non-trivial equilibrium. Thus, in the case where there is backward bifurcation, the
initial number of people engaging in heroin use govern the course of the heroin epidemic.
Figures 6.5(c) shows the time course of the number of heroin users when ω (that
accounts for the extent of saturation of heroin users) is varied, while the initial states
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and all other parameter values are fixed to constant values. It can be seen that not
all values of ω will trigger rapid growth towards an endemic equilibrium when R0 < 1.
Indeed, parameter ω has to exceed a certain fixed threshold ωc, hence supporting
theoretical findings, that a non-zero equilibria when R0 < 1 can only be maintained
when ω is greater than ωc (see equation (6.11)). Figure 6.5(d) shows the effect of
treatment α on heroin users. High treatment leads to a steady decline of heroin users.
Figure 6.6 presents a scenario where R0 > 1. In this scenario it is expected that when
a heroin user enters a heroin-free community there will be rapid growth of heroin users
until a globally stable equilibrium point is reached. Recalling that parameter ω does
not appear in R0 it nevertheless does affect the model dynamics. The impact of ω
when R0 > 1 is different from the case where R0 < 1. For R0 < 1 it plays a key role in
inducing bi-stability while for R0 > 1 the parameter ω impacts the heroin dynamics
by determining the time taken for an epidemic to occur. For relatively high ω values
there is a sudden decrease in the susceptible subpopulation while for relatively low
values of ω there is a gradual decrease in the susceptible subpopulation. Moreover,
Figure 6.6(b) depicts that for any given value of ω the heroin users gradually approach
a stable endemic equilibrium point. The only striking difference is the time taken to
reach the heroin endemic equilibrium. At high values of ω the heroin endemic will
rapidly approach an equilibrium.
Now the global stability condition obtained using the geometric approach is verified
using the following parameter values:
(i) β = 0.001, δ1 = 0.002, δ2 = 0.001, ξ = 0.015, µ = 0.01, α = 0.9, p = 0.467, σ =
0.1, ω = 2,Λ = 3, c0 = 50. With these parameters the corresponding R0 =
1.5012 > 1 and Γ1 = 0.0088 < Γ2 = 0.0100. In this scenario condition (6.29) is
satisfied and the model system (6.1) should be globally asymptotically stable.
Figures 6.7(a), 6.7(b), 6.7(c) and 6.7(d) show existence of an apparently stable
equilibrium;
(ii) Using the same set of parameter values as case (i) except ω = 0.05, leads to
Γ1 = 0.1837 > Γ2 = 0.0100. In this case the asymptotic stability condition is not
satisfied and unsurprisingly model system (6.1) has periodic solutions as shown
in figures 6.7(e), 6.7(f), 6.7(g) and 6.7(h). The epidemiological interpretation
of this is that the heroin epidemic will fluctuate between low and high endemic
levels. The cycles are induced by time delays in the transmission processes.
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(a) (b)
(c) (d)
Figure 6.5: (a) and (b) illustrate the dependence of the heroin epidemic extinction or
persistence on the initial states provided to the model. Parameters are ω = 0.15, β =
0.001, δ1 = 0.002, δ2 = 0.001, ξ = 0.015, µ = 0.01, α = 0.9, p = 0.467, σ = 0.1,Λ = 1.5.
With these parameters the corresponding value of R0 is 0.7506. (c) The impact of
increasing parameter ω (the extent of saturation of treatment) on heroin users when
R0 < 1. Parameters used are β = 0.001, δ1 = 0.002, δ2 = 0.001, ξ = 0.015, µ = 0.01, α =
0.9, p = 0.46, σ = 0.1,Λ = 1.5 which correspond to R0 = 0.7427 < 1. (d) The effect of
treatment α on heroin users U1 when all other parameters and initial conditions are
fixed.
6.6.1 Uncertainty and sensitivity analysis
Sensitivity analysis is conducted so as to identify critical inputs of the proposed heroin
epidemic model as well as gain insights on how input uncertainty influences the model
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(a) (b)
Figure 6.6: (a) Shows time series of susceptibles S as a function of parameter ω that
accounts for the extent of saturation of treatment when R0 > 1. (b) Shows time
series of drug users U1 as a function of parameter ω when R0 > 1. In both Figures,
parameters used are the same as in Figure 6.5(a) except p = 0.46,Λ = 3 corresponding
to R0 = 1.4855 > 1.
outcome [219]. To achieve this the Latin hypercube sampling (LHS) technique which
provides a comprehensive method of assessing model sensitivity to parameters over
a multi-dimensional parameter space is used. One of the advantages of using LHS is
that it requires fewer samples of parameters than simple random sampling to achieve
the same accuracy (see [219] and references therein for in-depth discussion of LHS).
In the proposed heroin epidemic model the LHS technique is important due to the
relatively large uncertainty in the model parameter estimates that have been used. The
technique works in combination with the partial rank correlation coefficient (PRCC)
which estimates the sign and strength of the relationship that exists between each
model parameter and any specified output [220, 221]. The PRCC values are bounded
between 1 and -1, with a PRCC value close to 1(-1) indicating very strong positive
(negative) correlation. The relative importance of the model parameters can be directly
evaluated by comparing the values of the PRCC [221]. The uncertainty and sensitivity
analysis using the LHS technique involves first selecting a baseline value and a range for
each parameter of the heroin epidemic model (6.1) (see Table 6.2), and then performing
multiple runs for a given outcome variable or response function. To enhance accuracy,
1500 random samples of parameter values were used for the sensitivity analysis and
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(a) (b) (c) (d)
(e) (f) (g) (h)
Figure 6.7: Validity of the global stability condition. Figures (a), (b), (c) and (d)
represent a scenario where condition (6.29) holds true and global stability is predicted.
Figures (e), (f), (g) and (h) represent a scenario where condition (6.29) does not hold
and oscillations are expected.
significant levels set for pvalue < 0.05.
Figure 6.8 displays the sensitivity analysis results for the number of heroin users not in
treatment U1(t). It is straightforward to see that recruitment rate Λ, effective contact
rate β, relapsing rate of heroin users in treatment to heroin users not in treatment p,
and saturation parameter ω are positively correlated while natural death µ, treatment
rate α, heroin-induced death rates (δ1, δ2), “self cure” rate ξ and successful recovery
rate of heroin users in treatment σ are negatively correlated. Amongst the positively
correlated PRCC values the parameters β, p and ω are strongly positively correlated
with the number of heroin users not in treatment as evidenced by their high PRCC
values. However, at time point year 15 the effective contact rate β has a slightly higher
PRCC value than relapsing rate p suggesting that during the initial stage of a heroin
epidemic effective contact between heroin users U1(t) and susceptibles significantly
contributes to the emergence of a heroin epidemic. On the other hand, at time point
year 30 the situation observed at time point year 15 is reversed. That is relapsing
of heroin users in treatment has a slightly higher PRCC value than the effective
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contact rate β. Hence, in the long-term, relapsing of heroin users in treatment back to
heroin use also plays a role in ensuring that there will always be heroin users within
the community. Thus, in attempting to control heroin usage within the community,
measures that ensure heroin users undergoing treatment do not relapse should be of
great importance. The extent of saturation of heroin users as a result of failure to
treat heroin users promptly, which is accounted by parameter ω, also contributes to
sustaining a heroin epidemic. As suggested by the strongly negatively correlated PRCC
value of parameter σ, ensuring heroin users in treatment are successfully treated (that
is they do not relapse) can substantially reduce the sub-population of heroin users. In
general the sensitivity analysis results suggest that to combat a heroin epidemic, policy
makers and clinicians should target the effective contact rate β, relapsing rate p, and
the extent of saturation of treatment for heroin users.
Figure 6.8: The PRCC output for heroin users U1(t) not in treatment.
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Table 6.2: Parameter baseline values and ranges used in sensitivity analysis.
Parameter baseline value range Source
Λ 2 1-5 assumed
β 0.001 0.0005-0.015 [185]
µ 1/80 0.01125-0.01375 [222]
p 0.467 0.1-0.8 [185]
α 0.5 0.2-0.95 [88]
δ1 0.002 0.0008-0.0025 assumed
δ2 0.001 0.00095-0.002 assumed
ξ 0.5 0.05-0.5 assumed
σ 0.1 0.1-0.7 assumed
ω 0.01 0.008-0.25 [88]
6.7 Summary of the chapter
In this chapter a heroin epidemic model with a density-dependent incidence and
saturated treatment function was formulated. The threshold parameter R0 usually
referred to as the basic reproduction number plays a key role in the prediction of
disease persistence or extinction. Epidemiologically, when R0 exceeds one an epidemic
persists and if it is below unity the disease will die out. This classical viewpoint has
recently been challenged by many researchers since it is not always true a disease will
disappear if R0 is decreased below one. In the present heroin epidemic model the
analytical results indicate that R0 = 1 is indeed the threshold when the parameter
ω = 0. However, when a saturated treatment function (i.e., ω > 0) rather than a
linear treatment rate is used, the heroin model exhibits the phenomenon of backward
bifurcation where a heroin-free equilibrium and two non-trivial equilibria co-exist even
though the basic reproduction number is below unity (see Theorem 6.4.5 case (iii)).
The appearance of backward bifurcation indicates that it is not sufficient to decrease
the basic reproduction number below unity for the eradication of heroin users within
the community. Thus, to effectively control the spread of heroin use one has to reduce
R0 below another threshold referred to as the critical value of the basic reproduction
number RC0 . That is, heroin users can be eradicated if R0 < RC0 < 1.
It is important to note that although the parameter ω might be present in the model,
not every value of ω will lead to bi-stability. Instead ω has to be greater than a certain
threshold ωc which is an aggregate of model parameters (see equation (6.11)). In gen-
eral both analytical (see Appendix L for a Center Manifold approach) and numerical
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results suggest that the saturation parameter ω is responsible for backward bifurcation.
Failure to intervene before heroin users have accumulated in the community will lead
to a situation where a heroin epidemic can continue to exist even though the basic
reproduction number is below one. Improvement of existing medical technology as well
as channelling sufficient resources could significantly facilitate early intervention by
ensuring that heroin users receive treatment promptly.
In addition, global stability properties using both the Lyapunov direct method and
geometric approach by Li and Muldowney have been investigated. It is important to
note that even for a four dimensional model, the use of the two nonlinear stability
techniques becomes nontrivial. In fact when all the parameters of the model are
accounted for, it is difficult if not impossible, to design a Lyapunov function. Using the
geometric approach a global condition that accounts for all parameters is established.
If the condition is satisfied, it signals heroin persistence within the community is
globally stable. However, if the global condition is not satisfied heroin users can
oscillate periodically in number (see Figures 6.7(e), 6.7(f), 6.7(g) and 6.7(h)). Moreover,
sensitivity and uncertainty analysis using LHS results indicate that the effective contact
rate between susceptibles and heroin users β, the relapsing rate of heroin users in
treatment p and the extent of saturation of heroin users ω are the parameters which
contribute to persistence of heroin use within the community.
Chapter 7
Conclusion and future work
This thesis mainly focussed on building epidemiological mathematical models to enhance
understanding of the transmission dynamics of tuberculosis in a human population.
Incorporating biological and epidemiological aspects pertinent for TB transmission,
such as recurrent TB, led to a number of new insights. The contributions emanating
from the findings in this thesis are respectively given in chapter 3, chapter 4 and
chapter 5.
The first question as given in detail in chapter 3 involved correcting an error that is
repeatedly found in epidemic models, in particular models that exhibit the phenomenon
of backward bifurcation. Understanding the phenomenon of backward bifurcation
is imperative because it predicts that disease will continue to spread even when the
basic reproduction number is below the epidemic threshold R0 = 1. Thus, obtaining
the backward bifurcation structure correctly is important to avoid overestimating or
underestimating disease prevalence. Moreover, this chapter clarifies the correct method
of computing the critical value of R0, which is the threshold below which the repro-
duction number needs to be reduced in order to eliminate disease. Comparison of the
correct non-aggregated parameter approach with the incorrect aggregated parameter
approach demonstrates that the two methods are substantially different. This is a
counter-intuitive result given numerous mathematical models have used the aggregated
parameter approach to compute both bifurcation structures as well as critical values
for R0.
The second question (studied in chapter 4) extended the simple TB model developed in
chapter 3 by incorporating realistic TB pathways accounting for recurrent TB. In this
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chapter a new model is formulated with the aim of understanding how recurrent TB can
alter TB dynamics. Applying the Center Manifold Theory it is shown that the model
exhibits the phenomenon of backward bifurcation where unstable and stable equilibria
coexist when the associated reproduction number is less than one. The backward
bifurcation threshold is obtained using analytical analysis as well as confirmed using
the Center Manifold approach. The backward bifurcation threshold so obtained is used
to stress the importance of not ignoring backward bifurcation phenomena, in particular
in the context of TB epidemiology. This is as a result of the past misconception that
backward bifurcation cannot occur in the real world without compromising biological
realism, especially in tuberculosis as a case study [111]. In the past fifteen years this was
understood to be the case as suggested by Lipsitch and coworkers [111]. In this thesis
the misconception is revisited and it is shown that with the incorporation of recurrent
TB pathways, now known to be common especially in high TB burden settings, the
phenomenon of backward bifurcation can occur even without compromising biological
realism.
The chapter also reveals a rare hysteresis effect even where R0 is below unity. This
bi-stability phenomena has not been mentioned in any of the pertinent TB litera-
ture. The findings in chapter 4 are imperative in TB epidemiology in that the results
emphasize how recurrent TB can alter the well- known TB dynamics. Hence, not
taking into account the contribution of recurrent TB to TB burden can lead to clin-
icians and policy makers formulating decisions for combating TB that will be ineffective.
Chapter 5 was inspired by the fact that although previous studies have considered
population-level heterogeneity in susceptibility to reinfection between previously treated
and latently infected persons [91, 97, 159], it has only been in a limited way. No pre-
vious work has considered differential susceptibility across all possible exposure and
treatment histories (i.e., LTBI, treated LTBI and treated TB disease), along with
the population level impact of all relevant public health interventions. Thus, the
chapter attempted to shed some light on two key questions: (a) how variability in
risk of reinfection could alter TB dynamics in a model accounting for heterogeneity
in host susceptibility and (b) how this variability in risk of reinfection influences the
effectiveness of public health interventions. The results deduced in the chapter can
help with our understanding and projection of TB epidemiology. The findings in
chapter 5 show that distinguishing individuals treated with preventive therapy from
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those who were previously treated from active TB can yield new epidemiological insights.
Finally, chapter 6 investigated a heroin epidemic model with a saturated treatment
function. The analysis of the model shows that when a saturated treatment function
rather than a linear treatment rate is used, the heroin model exhibits the phenomenon
of backward bifurcation where a heroin-free equilibrium and two non-trivial equilibria
co-exist even though the basic reproduction number is below unity. In such a situation,
to eliminate heroin addiction from the community, the basic reproduction number has
to be reduced further below unity such that it is below another new threshold referred
to as the critical value of the basic reproduction number. Further analysis of the global
stability using both the Lyapunov direct method and the geometric approach was
conducted. It is noted that even for a four dimensional model, the use of the two
nonlinear stability techniques becomes nontrivial. Applying the geometric approach a
global condition for stability that accounts for all parameters was established. The
condition so obtained was tested numerically and it was observed that heroin persistence
within the community is globally stable if the condition is satisfied. However, if the
global condition is not satisfied heroin users can oscillate periodically in number.
7.0.1 Future work
The study conducted in this thesis has managed to shed some light on the spreading
mechanisms of TB. In particular, on the role of recurrent TB, as well as the role of
heterogeneity in host susceptibility to TB, and on the effectiveness of public health
interventions. This thesis can be extended by considering the following aspects:
(i) Establishing the local and global dynamics of the endemic equilibria of the model
studied in chapter 4;
(ii) Rigorous stability analysis of the model studied in chapter 5, in particular local
and global stability;
(iii) Investigating optimal control of preventive therapy among early and late LTBI
that could enable the public health in designing and implementing effective
measures in controlling the spread of TB in a population;
(iv) Testing the results of Lipsitch and Murray [111] and results obtained in chapter
4 using real data could be important in projecting TB dynamics;
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(v) In chapter 5, it is important to note that at the present time the lack of sensitivity
of model dynamics to σ3 is unclear and is a subject worth exploring in future
research;
(vi) Attempting to estimate parameters of the model studied in chapter 5. Unfortu-
nately current datasets are limited for this purpose.
Appendices
Appendix A: Computation of R0 for the TB model
with recurrent TB
This appendix relates to chapter 4.
Using the method described in chapter 2, the non-negative matrix F and non-singular
M-matrix V are respectively given as
F =
0 (1− q)cβ
0 qcβ
 and V =
µ+ k 0
−k µ+ r + µd
 .
Hence,
FV −1 =
 (1−q)cβk(µ+k)(µ+r+µd) (1−q)cβµ+r+µd
qcβk
(µ+k)(µ+r+µd)
qcβ
µ+r+µd

and the basic reproduction number is now given as
R0 = ρ(FV −1) =
cβ(k + qµ)
(µ+ k)(µ+ r + µd)
, (A1)
where ρ is the spectral radius.
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Appendix B: Theorem deduced when θ = 0
This appendix relates to chapter 4.
Theorem B.2.1 The model (4.1) when σ = θ = 0 has:
(i) A unique positive endemic equilibria if c1 < 0 and R0 = 1, or if the discriminant
△ = c21 − 4c2c0 = 0;
(ii) A unique positive endemic equilibria if R0 > 1;
(iii) Two positive endemic equilibria if the three cond,tions hold: c1 < 0, R0 < 1 and
△ = c21 − 4c2c0 > 0, and thus backward bifurcation;
(iv) No positive endemic equilibria if c1 > 0 and R0 ≤ 1.
Proof It is easy to note that in polynomial (4.12) c2 is always positive. Also c0 > 0
if R0 < 1. For case (i) where c1 < 0 and R0 = 1 (i.e., c0 = 0) the quadratic equation
(4.12) reduces to P2(λ) = c2λ+ c1 = 0 and in this case the model equation (4.1) will
have a unique positive endemic equilibrium since c1 < 0. (Note there would be no
positive equilibrium if c1 ≥ 0.) Moreover, it is instructive to note that in case (i) if the
discriminant △ = 0, then the quadratic equation (4.12) has the repeated root λ = −c12c2 .
In such a case model equation (4.1) has a unique positive endemic equilibrium if c1 < 0,
no positive endemic if c1 > 0 and DFE if c1 = 0 (i.e., λ = 0 which corresponds to DFE).
Similarly, the remaining cases in the proof follow directly from the trivial properties of
the roots of quadratic polynomials.
150
Appendix C: Detailed derivation of backward bifur-
cation threshold pc
This appendix relates to chapter 4.
Proof The proof employs Center Manifold approach as exhibited in Center Manifold
Theorem from Castillo-Chavez and Song [58]. For simplification and understanding
of the Center Manifold Theorem, it is convenient to transform the model variables of
system (4.1) as follows: x1 = S, x2 = E, x3 = I, x4 = R and N =
∑4
j=1 xj. Now letting
X = (x1, x2, x3, x4)T (T denote transpose) the model system (4.1) can be written as
dX
dt
= F (X) where F = (f1, f2, f3, f4)T . Hence,
dx1
dt
= Λ− βcx1x3
x1 + x2 + x3 + x4
− µx1 = f1,
dx2
dt
= (1− q)βcx1x3
x1 + x2 + x3 + x4
+ (1− σ)θβcx3x4
x1 + x2 + x3 + x4
− pβcx2x3
x1 + x2 + x3 + x4
− (µ+ k)x2 = f2,
(C1)
dx3
dt
= qβcx1x3
x1 + x2 + x3 + x4
+ σθβcx3x4
x1 + x2 + x3 + x4
+ pβx2x3
x1 + x2 + x3 + x4
+ kx2 − (µ+ r + µd)x3 = f3,
dx4
dt
= rx3 − θβcx3x4
x1 + x2 + x3 + x4
− µx4 = f4.
Now choosing βc = β˜ as the bifurcation parameter and considering that at R0 = 1,
β˜ = β∗ = (µ+ k)(µ+ r + µd)(k + µq) , the Jacobian matrix of the system (C1) evaluated at
the disease free equilibrium is
H =

−µ 0 β∗ 0
0 −(µ+ k) (1− q)β∗ 0
0 k qβ∗ − (µ+ r + µd) 0
0 0 r −µ
 .
With β˜ = β∗ the transformed system (C1) has a simple eigenvalue with zero real part
and all other eigenvalues are negative (i.e., has a hyperbolic equilibrium point). Thus,
the Center Manifold Theory [58, 223] can be applied to investigate the dynamics of the
transformed system (C1) near β˜ = β∗. It is possible to obtain the right eigenvectors of
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H(P0)|β˜=β∗ which are denoted by w = (w1, w2, w3, w4)T , where
w1 =
−β∗w3
µ
,w2 =
(1− q)β∗w3
(µ+ k) , w4 =
rw3
µ
,w3 = w3 > 0.
Similarl, the left eigenvectors of H(P0)|β˜=β∗ are obtained and are denoted by v =
(v1, v2, v3, v4), where
v1 = 0, v2 =
kv3
µ+ k , v3 = v3 > 0, v4 = 0.
Now the associated bifurcation coefficients, a and b as described in Theorem 4.1 of
[58] can be obtained. For the purpose of clarity Theorem 4.1 of [58] stated in the
mathematical preliminaries is used (see chapter 2).
Computation of a.
The transformed model system (C1) has the following non-vanishing partial derivatives
of H evaluated at disease free equilibrium,
∂2f2
∂x3∂x2
= −2(1− q)β
∗µ
Λ −
2pβ∗µ
Λ ,
∂2f2
∂x3∂x4
= −2(1− q)β
∗µ
Λ +
2(1− σ)θβ∗µ
Λ ,
∂2f3
∂x2∂x3
= −−2qβ
∗µ
Λ +
2pβ∗µ
Λ ,
∂2f3
∂x3∂x4
= −2qβ
∗µ
Λ +
2σθβ∗µ
Λ ,
∂2f2
∂x3∂x3
= −2(1− q)β
∗µ
Λ ,
∂2f3
∂x3∂x3
= −2qβ
∗µ
Λ .
Hence,
a =
4∑
k,i,j=1
vkwiwj
∂2fk(0, 0)
∂xi∂xj
= v2w2w3
∂2f2(0, 0)
∂x2∂x3
+ v2w3w4
∂2f2(0, 0)
∂x3∂x4
+ v3w2w3
∂2f3(0, 0)
∂x2∂x3
+ v3w3w4
∂2f3(0, 0)
∂x3∂x4
+ v2w3w3
∂2f2(0, 0)
∂x3∂x3
+ v3w3w3
∂2f3(0, 0)
∂x3∂x3
= 2µ
2(1−q)β∗2v3w23
Λ(µ+k)
(
p− (k + µq)
(
µ(1−q)(µ+r+µd)+(µ+r)(k+µq)
µ2(1−q)(µ+r+µd)
)
+ rθ(k+σµ)(µ+r+µd)µ2(1−q)
)
(C2)
= 2µ
2(1− q)β∗2v3w23
Λ(µ+ k) (p− pc).
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Computation of b.
The sign of the bifurcation parameter b is associated with the following non-vanishing
partial derivatives of F, also evaluated at disease free equilibrium:
∂2f2
∂x3∂β∗
= (1− q), ∂
2f3
∂x3∂β∗
= q.
Now
b =
4∑
k,i=1
vkwi
∂2fk(0, 0)
∂xi∂β∗
= v2w3
∂2f2(0, 0)
∂x3∂β∗
+ v3w3
∂2f3(0, 0)
∂x3∂β∗
= v3w3
(k + µq)
(µ+ k) > 0.
The eigenvectors v3 and w3 are positive. The bifurcation coefficient b is always
positive. From Theorem 2.4.1 the model system (C1) will exhibit backward bifurcation
phenomena if the bifurcation coefficient a defined by (C2) is positive. It is observed from
equation (C2) that the positivity of a is entirely dependent on the level of exogenous
reinfection parameter p. This suggests existence of a bifurcation threshold below which
backward bifurcation disappears and above which bi-stability phenomena occurs. After
algebraic manipulation it can be shown that the bifurcation coefficient a > 0 whenever
p > pc = (k + µq)
(
µ(1− q)(µ+ r + µd) + (µ+ r)(k + µq)
µ2(1− q)(µ+ r + µd) −
rθ(k + σµ)
µ2(1− q)(µ+ r + µd)
)
= k + µq
µ(1− q)
(
µ(1− q)(µ+ r + µd) + (µ+ r)(k + µq)
µ(µ+ r + µd)
− Fr
)
.
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Appendix D: Basic properties and computation of
R0 for model equation (5.1)
This appendix relates to chapter 5.
Note that all model parameters and variables of model equation (5.1) are considered
to be non-negative since the model represents a human population. First a biologically
and epidemiologically feasible region is established through the following theorem:
Theorem D.4.1 The region
Λ := {(S, L1, L2, I, P,R) ∈ R6+ : S + L1 + L2 + I + P +R ≤ 1}
is positively-invariant and absorbing with respect to the model equation (5.1) with initial
conditions in R6+.
Proof: The proof involves showing that the feasible solution of model equation (5.1)
are uniformly bounded in the region Λ. Supposing S, L1, L2, I, P,R is any solution of
model equation (5.1) with positive initial conditions, then the total population fulfils
the following inequality
dN
dt
≤ µ− µN. (D1)
It follows from (D1) that dN
dt
≤ µ− µN implies that dN
dt
≤ 0 if N ≥ 1. Applying the
standard comparison theorem [106] it can be shown that
N(t) ≤ N(0)e−µt + (1− e−µt).
Specifically, N(t) ≤ 1, if N(0) ≤ 1 for all t > 0. Hence, under the flow induced by equa-
tion (5.1), the region Λ is positively invariant. Moreover, for N(0) > 1, the trajectory
solutions N(t) enters either in the region Λ finite time or asymptotically approaches 1.
Thus, in the region Λ model equation (5.1) is considered to be mathematically and
epidemiologically well posed [20] and the solution of all the trajectories generated by
model (5.1) are in a biologically feasible region Λ.
The model system (5.1) has two important steady states: the disease free equilibrium
and the non-trivial endemic equilibria where TB is expected to persist. By setting
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all the infected states of model (5.1) to zero (i.e., L1,L2, I,P,R = 0) the disease free
equilibrium denoted by Y0 is given as
Y0 = (1, 0, 0, 0, 0, 0).
To compute the basic reproduction number the next generation operator (NGO)
approach developed by [25] (described in detail in chapter 2) is applied. In order to
use the method it is important to distinguish new infections in each class from all
other changes in population. In model (5.1) the infected classes are L1,L2, I,P,R. The
system (5.1) can be written as
Y˙ = F(Y )− V(Y ), (D2)
where Y = (S, L1, L2, I, P, R). F(Y ) represents the rate of appearance of new
infections and V represents the rate of transition from one compartment to another.
Thus,
F(Y ) = (0, βIS, 0, 0, 0, 0)T .
The model system (5.1) has an intrinsic disease free equilibrium given as Y0 =
(1, 0, 0, 0, 0, 0). Now the derivatives of F(Y ) and V(Y ) with respect to the in-
fected compartment, evaluated at disease free equilibrium can respectively, be obtained
as
F =

0 0 β 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0

, V =

k1 0 0 0 0
−(1− f)ϕ k2 0 0 0
−ϕf −η k3 0 −ω
−θ −ρ 0 µ 0
0 0 −(τ + α) 0 k4

with
V −1 =

1
k1
0 0 0 0
k21
1
k2
0 0 0
k31 k32 k33 0 k35
k41
ρ
µk2
0 1
µ
0
k51 k52 k53 0 k55

,
155
where
k1 = (θ + µ+ ϕ),
k2 = (µ+ η + ρ),
k3 = (µ+ d+ τ + α),
k4 = (µ+ ω),
k21 =
(1− f)ϕ
k1k2
,
k31 =
(fϕ(µ+ ρ) + ηϕ)k4
k1k2((µ+ d)k4 + µ(τ + α))
,
k32 =
ηk4
k2((µ+ d)k4 + µ(τ + α))
,
k33 =
k4
(µ+ d)k4 + µ(τ + α)
,
k35 =
ω
(µ+ d)k4 + µ(τ + α)
,
k41 =
k3(µθk1 + µρϕ(1− f)) + (µ+ d)ω(θk2 + ρϕ(1− f))
µk1k2((µ+ d)k4 + µ(τ + α))
,
k51 =
ϕ(τ + α)(f(µ+ ρ) + η)
k1k2((µ+ d)k4 + µ(τ + α))
,
k52 =
η(τ + α)
k2((µ+ d)k4 + µ(τ + α))
,
k53 =
(τ + α)
((µ+ d)k4 + µ(τ + α))
,
k55 =
k3
((µ+ d)k4 + µ(τ + α))
.
Following van den Driessche and Watmough [25] the basic reproduction number is
defined as the spectral radius of the next generation matrix, FV −1 (i.e., R0 = ρ¯(FV −1),
where ρ¯ denote the spectral radius), which for the model system (5.1) is given as
R0 =
β(µ+ ω)(fϕ(µ+ ρ) + ηϕ)
((µ+ d)(µ+ ω) + µ(τ + α))(µ+ η + ρ)(θ + µ+ ϕ) . (D3)
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Appendix E: Interpretation for R0 of model equation
(5.1)
This appendix relates to chapter 5.
The expression for basic reproduction number R0 as given above in equation (D3) can
be decoupled to be expressed as a combination of various pathways leading to active
TB. First starting with a simpler scenario where treated active TB individuals do not
reactivate. That is by setting ω = 0, the R0 expression (D3) can be rewritten as
R′0 =
(
β
µ+ d+ τ + α
)[(
fϕ
µ+ θ + ϕ
)
+
(
(1− f)ϕ
µ+ θ + ϕ
)(
η
µ+ η + ρ
)]
. (E1)
Each factor in R′0 has an epidemiological interpretation as follows:
(i) β
µ+ d+ τ + α represent the average number of secondary cases an individual
with active TB produces;
(ii)
(
fϕ
µ+ θ + ϕ
)
reflect that individuals progress toward active TB through the early
latent compartment;
(iii)
(
(1− f)ϕ
µ+ θ + ϕ
)(
η
µ+ η + ρ
)
, reflect that individuals progress to active TB through
late latent compartment. Note that
(
(1− f)ϕ
µ+ θ + ϕ
)
account for the fraction that
proceed to late latent class while
(
η
µ+ η + ρ
)
is the probability of surviving the
late latent compartment and progressing to active TB.
Now, considering that ω > 0, recovered individuals have an additional chance to
progress to active TB that is independent of re-exposures. This additional contribution
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for the infectious period is given by the term
Υ =1 + (τ + α)
µ+ d+ τ + α
ω
µ+ ω +
(
(τ + α)
µ+ d+ τ + α
ω
µ+ ω
)2
+ · · ·
= 1
1− (τ+α)
µ+d+τ+α
ω
µ+ω
= (µ+ d+ τ + α)(µ+ ω)
µ(µ+ d+ τ + α) + ω(µ+ d) (E2)
that results from the innumerable chances the infected individual has to repeat this
event. The full expression for R0 is then obtained by the product of equations (E1)
and (E2). That is
R0 = ΥR′0.
The following result is deduced from Theorem 2 of [25].
Lemma E.5.1 The DFE Y0 of model equation (5.1) is locally asymptotically stable
(LAS) whenever R0 is below one and unstable whenever R0 exceeds one.
In general it is known that a value of R0 < 1 implies that each individual is only able to
infect less than one individual on average, such that the disease will die out, whereas a
value of R0 > 1 implies that each individual is able to infect more than one individuals
and that endemic disease will persist within the population. Hence, R0 = 1 is a crucial
endemic threshold in determining the epidemic trajectory. In what follows, it is shown
that if all cohorts subject to reinfection have complete immunity (i.e., σi = 0, i = 1, 2, 3)
then the elimination of TB from the community is independent of the initial sizes of
the sub-population. Consequently, the DFE is shown to be globally asymptotically
stable.
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Appendix F: Global stability of DFE for a special
case of model equation (5.1)
This appendix relates to chapter 5.
The global stability of the DFE of model equation (5.1) is analysed for a special
case. That is, in a case where all post-infection cohorts are not reinfected, and hence
σi = 0, (i = 1, 2, 3). Applying a Theorem from [224], the global stability of DFE Y0 (for
a special case) is investigated when the reproduction number is less than one.
Theorem F.6.1 Let X = S and Y = (L1, L2I, P,R) where X ∈ R1 and Y ∈ R5
represent uninfected population and infected population, respectively. Further, let
X ′ = F (X, Y ),
Y ′ = G(X, Y ), G(X, 0) = 0,
where X ′ and Y ′ denote differentiation with respect to time. The DFE can be rewritten
as Y0 = (X∗,0) where X∗ = 1. Now to guarantee a local asymptotic stability the
following conditions (i) and (ii) have to be fulfilled:
(H1) For X ′ = F (X,0), D0 is globally asymptotically stable (g.a.s);
(H2) G(X, Y ) = AY − Ĝ(X, Y ) where Ĝ(X, Y ) ≥ 0, for (X, Y ) ∈ Λ, A = DYG(X∗, 0).
Lemma F.6.1 For σi = 0, the fixed point Y0 = (X∗,0) is a g.a.s equilibrium of model
system (5.1) provided R0 < 1 and that conditions (i) and (ii) hold.
Proof: Let X = S, and Y = (L1, L2, I, P,R) and Y0 = (X∗,0), where X∗ = 1.
Then X ′ = F (X, Y ) = (µ+dI−µS−βIS). At DFE S = 1 so F (X, 0) = (µ−µS) = 0.
Hence,
X ′ = F (X, 0) = (µ− µS) = 0.
As t→∞, X → X∗. This implies that the DFE Y0 is g.a.s (that is condition (H1) is
fulfilled).
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Now consider
G(X, Y ) = AY − Ĝ(X, Y ),
A =

−(θ + µ+ ϕ) 0 βX∗ 0 0
(1− f)ϕ −(µ+ η + ρ) 0 0 0
ϕf η −(µ+ η + ρ) 0 ω
θ ρ 0 −µ 0
0 0 (τ + α) 0 −(µ+ ω)

.
Then,
Ĝ(X, Y ) =

Ĝ1(X, Y )
Ĝ2(X, Y )
Ĝ3(X, Y )
Ĝ4(X, Y )
Ĝ5(X, Y )

=

βI(X∗ − S)
0
0
0
0

.
Given that the total population is bounded such thatN = S+L1+L2+I+P+R ≤ X∗ =
1, it follows that S ≤ N ≤ 1. Hence Ĝ(X, Y ) ≥ 0 which now imply that condition
(H2) is satisfied. Consequently, by Lemma F.6.1 Y0 = (X∗, 0, 0, 0, 0, 0) is globally
asymptotically stable whenever R0 < 1 and σi = 0(i = 1, 2, 3). The epidemiologically
implication of DFE being g.a.s is that TB will be eliminated from the community if
the threshold quantity R0 is maintained (or decreased) to a value below unity.
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Appendix G: Existence of endemic equilibria for model
(5.1)
This appendix relates to chapter 5.
Due to the complex nature of the model system (5.1) the steady states cannot be
explicitely expressed in terms of model parameters. Consequently, all steady states are
written in terms of I∗. Namely
S∗ = µ+ dI
∗
µ+ βI∗ ,
L∗1 =
(µ+ η + ρ+ σ1βI∗)((µ+ d+ τ + α)(µ+ σ3βI∗) + ω ∗ (µ+ d))I∗
(µ+ ω + σ3βI∗)(fϕ(µ+ ρ+ σ1βI∗) + ηϕ)
,
L∗2 =
(1− f)ϕ((µ+ d+ τ + α)(µ+ σ3βI∗) + ω(µ+ d))I∗
(µ+ ω + σ3βI∗)(fϕ(µ+ ρ+ σ1βI∗) + ηϕ)
,
P ∗ = ((µ+ d+ τ + α)(µ+ σ3βI
∗) + ω(µ+ d))(θ(µ+ η + ρ+ σ1βI∗) + ρ(1− f)ϕ)I∗
(µ+ σ2βI∗)(µ+ ω + σ3βI∗)(fϕ(µ+ ρ+ σ1βI∗) + ηϕ)
,
R∗ = (τ + α)I
∗
µ+ ω + σ3βI∗
.
I∗ can be solved from the following polynomial;
g(I∗) = I∗(d4I∗4 + d3I∗3 + d2I∗2 + d1I∗ + d0) = 0,
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where
d4 = −σ1σ2σ3µ(fϕ+ µ+ d+ τ + α)β4,
d3 = σ1σ2β3µ(1− f) ϕ(µ+ d+ τ + α) + σ1σ2σ3µ(1− f)ϕβ3(µ+ d+ τ + α)
+ σ1σ3µβ3(1− f)ϕ(µ+ d+ τ + α) + σ1σ2β3(1− f)ϕω(µ+ d)
+ σ1σ2σ3µβ3θ(µ+ d+ τ + α)
+ σ2σ3β3θ(µ+ η + ρ)(µ+ d+ τ + α) + σ1σ2θβ3µ(µ+ d+ τ + α)
+ σ1σ2θβ3ω(µ+ d) + σ2σ3ρ(1− f)ϕβ3(µ+ d+ τ + α) + σ1σ2σ3µβ3(τ + α)fϕ
+ σ1σ3µβ3(τ + α)fϕ+ σ2σ3β3(τ + α)(fϕ(µ+ ρ) + ηϕ) + σ1σ3µdβ3fϕ
+ σ1σ2d(µ+ ω)β3fϕ+ σ2σ3dβ3(fϕ(µ+ ρ) + ηϕ)
+ σ1σ2σ3µβ4fϕ− σ1σ2σ3µ(θ + µ+ ϕ)β3(µ+ d+ τ + α)
− σ1σ3µβ3(µ+ d+ τ + α)(θ + µ+ ϕ)
− σ2σ3β3(µ+ η + ρ)(µ+ d+ τ + α)(θ + µ+ ϕ)
− σ1σ2β3µ(θ + µ+ ϕ)(µ+ d+ τ + α)
− σ1σ2β3ω(µ+ d)(θ + µ+ ϕ),
d2 = σ1σ2µ2β2(1− f)ϕ(µ+ d+ τ + α) + σ1β2µ2(1− f)ϕ(µ+ d+ τ + α)
+ σ1σ3β2(1− f)ϕµ2(µ+ d+ τ + α) + σ1σ2β2(1− f)ϕωµ(µ+ d)
+ σ1β2(1− f)ϕωµ(µ+ d) + σ2σ3µθβ2(µ+ η + ρ)(µ+ d+ τ + α)
+ σ1σ2β2µ2θ(µ+ d+ τ + α) + σ1σ2µθβ2ω(µ+ d)
+ σ2σ3β2µρ(1− f)ϕ(µ+ d+ τ + α) + σ2β2θ(µ+ η + ρ)µ(µ+ d+ τ + α)
+ σ2β2θ(µ+ η + ρ)ω(µ+ d) + σ2β2ρ(1− f)ϕµ(µ+ d+ τ + α)
+ σ2β2ρ(1− f)ϕω(µ+ d) + σ1σ3β2µ2(τ + α)fϕ
+ σ3β2(τ + α)µ(fϕ(µ+ ρ) + ηϕ) + σ1σ3µ2β3fϕ
+ σ1σ2µ(µ+ ω)β3fϕ+ σ2σ3µβ3(fϕ(µ+ ρ) + ηϕ) + σ1β2dµ(µ+ ω)fϕ
+ σ3β2µd(fϕ(µ+ ρ) + ηϕ) + σ2dβ2(µ+ ω)(fϕ(µ+ ρ) + ηϕ)
+ σ2σ3µβ2(τ + α)(fϕ(µ+ ρ) + ηϕ)− σ1σ3µ2β2(µ+ d+ τ + α)(µ+ ϕ+ θ)
− σ2σ3β2µ(θ + µ+ ϕ)(µ+ η + ρ)(µ+ d+ τ + α)
− σ1σ2β2µ2(θ + µ+ ϕ)(µ+ d+ τ + α)− σ1σ2β2µ(θ + µ+ ϕ)ω(µ+ d)
− σ3β2µ(µ+ θ + ϕ)(µ+ η + ρ)(µ+ d+ τ + α)
− σ1µβ2(θ + µ+ ϕ)ω(µ+ d)− σ2µβ2(θ + µ+ ϕ)(µ+ η + ρ)(µ+ d+ τ + α)
− σ1β2µ2(θ + µ+ ϕ)(µ+ d+ τ + α)− σ2β2(θ + µ+ ϕ)(µ+ η + ρ)ω(µ+ d),
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d1 = σ1β(1− f)ϕµ3(µ+ d+ τ + α) + σ1β(1− f)ϕ(µ+ d)ωµ2
+ σ2βµ2θ(µ+ η + ρ)(µ+ d+ τ + α) + σ2βµθ(µ+ η + ρ)ω(µ+ d)
+ σ2βµ2ρ(1− f)ϕ(µ+ d+ τ + α) + σ2βµρ(1− f)ϕω(µ+ d)
+ σ3β(τ + α)µ2(fϕ(µ+ ρ) + ηϕ) + σ1β2µ2(µ+ ω)fϕ
+ σ3β2µ2(fϕ(µ+ ρ) + ηϕ) + σ2β2µ(µ+ ω)(fϕ(µ+ ρ) + ηϕ)
+ βdµ(µ+ ω)(fϕ(µ+ ρ) + ηϕ)− σ3βµ2(θ + µ+ ϕ)(µ+ η + ρ)(µ+ d+ τ + α)
− σ1βµ3(θ + µ+ ϕ)(µ+ d+ τ + α)− σ1βµ2(θ + µ+ ϕ)ω(µ+ d)
− σ2βµ2(θ + µ+ ϕ)(µ+ η + ρ)(µ+ d+ τ + α)
− σ2βµ(θ + µ+ ϕ)(µ+ η + ρ)ω(µ+ d)
− βµ2(θ + µ+ ϕ)(µ+ η + ρ)(µ+ d+ τ + α)
− βµω(θ + µ+ ϕ)(µ+ d)(µ+ η + ρ),
d0 = βµ2(µ+ ω)(fϕ(µ+ ρ) + ηϕ)
− µ2(θ + µ+ ϕ)(µ+ η + ρ)((µ+ ω)(µ+ d) + µ(τ + α)).
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Appendix H: Procedure for calculating reinfection
threshold as derived in the literature
This appendix relates to chapter 5.
For any given compartmental model with reinfection mechanisms, it is possible to
define the reinfection submodel and subsequently reinfection threshold RT. According
to [97, 121, 178] the RT is interpreted as the transmission potential which if exceeded
reinfection can sustain transmission in a partially immunized population. To describe
the procedure (adopted from [178]) involved in obtaining reinfection submodel in which
RT is obtained consider the following systems of equations:
x′i = fi(x), i = 1, · · · , n+m+ k, (H1)
where x = (x1, · · · , xn+m+k)t with each xi ≥ 0 representing the proportion of individuals
in each compartment. The equations are arranged such that the the first n equations
correspond to the partially immunized classes, followed by the m remaining classes
except for the k which represent the totally susceptible classes that are classified last.
Differentiation between infected, partially immunized and susceptible compartments
should be deduced from the epidemiological description of the model and cannot not
be determined from the structure of the model equations alone. Hence, the first step
involves removing the totally susceptible classes and adding the recruitment rate into
the compartments that are partially immunized. Let y = (x1, · · · , xn+m). Now defining
g¯i(y) = f¯i(y, 0) + ri(y, 0), (H2)
for i = 1, · · · , n + m, where ri is the recruitment rate verifying ri = 0 for i =
n + 1, · · · , n + m and f¯i is given by fi with the rate of transfer of individuals into
the last k compartments set to zero. Specifically this last condition indicate that the
terms accounting for temporary immunity are excluded. Again, it is important to
mention that the recruitment functions ri depend on the epidemiological interpretation
of the model. Supposing there is one compartment subject to reinfection, then the
ri is the sum of all recruitment rates of the model, which correspond to the total
inflow of individuals into the model at each time step. On one hand, it is possible to
have multiple compartments subject to reinfection with varied protection or infection
progression rates. In case of this scenario, for each of the compartments subject to
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reinfection respective reinfection submodels should be considered, hence leading to
several reinfection thresholds. For each submodel, there should be only one or a
matching number of reinfection compartments of interest at a time. Thus, in such case
the recruitment function has to be defined as for the simpler cases. Consequently, the
reinfection submodel is given by the following differential equations of n+m dimension:
y′i = gi(y) = g+i (y)− g−i (y), i = 1, · · · , n+m, (H3)
where y = (y1, · · · , yn+m)t and g+i and g−i are the rates representing inflow and outflow
of individuals in compartment i, respectively. Note that since each function represents
a directed transfer of individuals proportion, they are all nonnegative. Hence, the
following:
(i) If yi ≥ 0, then g+i , g−i ≥ 0, for i = 1, · · · , n+m. On one hand if a compartment
is empty there can be no transfer out of the compartment;
(ii) If yi = 0, then g−i = 0, for i = 1, · · ·n + m. Considering that the disease
transmission model given by (H3) with gi fulfilling conditions (i) and (ii), then
the non-negative cone (yi ≥ 0, i = 1, · · · , n+m) is forward invariant. According
to Theorems 1.1.8 and 1.1.9 of [100] for each non-negative initial condition there
exist a unique nonnegative solution of model equation (H3). Letting Y0 represent
the set of all disease free states, that is Y0 = {y ≥ 0 : yi = 0, i = n+1, · · · , n+m}.
For the disease free subspace Y0 to be invariant one has to assume that if the
population is free of disease then the population will remain disease free. No
(density-independent) immigration of infectives is allowed. This property is stated
as follows;
(iii) If y ∈ Y0, then g+i = 0, for i = n+ 1, · · ·n+m.
This condition means specifically that some immune processes should be set to
zero in the reinfection submodel.
Now after constructing the reinfection submodel (H3) and supposing the submodel
fulfil conditions (i)-(iii). If the reinfection submodel undergo bifurcation through
the transmission parameter β, then the bifurcation will correspond to the reinfection
threshold of the full model. Considering the following linearized system:
y′ = Dg(y0)(y − y0), (H4)
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where Dg is the Jacobian matrix evaluated at the disease free state y0 ∈ Y0. The
bifurcation point for y = y0 can be easily obtained by setting the determinant of Dg to
zero and solving the respective equation for β. Let βRT denote the solution, then βRT
correspond to the point where the stability of the disease free equilibrium occur. Now
to obtain the reinfection threshold in terms of R0, replace β by βRT in the formula for
R0.
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Appendix I: Computation of reinfection thresholds
This appendix relates to chapter 5.
Following case (i), case (ii) and case (iii) as shown in the text of chapter 5, the respective
reinfection submodels of model equation (5.1) can be obtained as
dL2
dt
= λ+ (1− f)ϕL1 − (µ+ ρ+ σ1βI)L2,
dL1
dt
= σ1βIL2 − (θ + µ+ ϕ)L1, (I1)
dI
dt
= ϕfL1 − (µ+ d+ τ + α)I.
dP
dt
= λ+ θL1 − (µ+ σ2βI)P,
dL1
dt
= σ2βIP − (θ + µ+ ϕ)L1, (I2)
dI
dt
= ϕfL1 − (µ+ d+ τ + α)I.
dR
dt
= λ+ (τ + α)I − (µ+ σ3βI)R,
dL1
dt
= σ3βIR− (θ + µ+ ϕ)L1, (I3)
dI
dt
= ϕfL1 − (µ+ d+ τ + α)I.
The reinfection threshold for the first reinfection submodel (I1) can be computed
following the procedure followed for the reinfection submodel for a scenario where
σ1 = σ2 = σ3, (see the text) and it can be found that the reinfection submodel sustains
an endemic equilibrium when transmission is above the critical value given in (5.5).
Consequently, the reinfection threshold written in terms of R0 is similar to equation
(5.6). The other, reinfection thresholds, RT2 and RT3 are obtained from their respective
reinfection submodels (9) and (10) as
β = 1
σ2
(θ + µ+ ϕ)(µ+ d+ τ + α)
ϕf
= RT2,
β = 1
σ3
(θ + µ+ ϕ)(µ+ d+ τ + α)
ϕf
= RT3.
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Similar to RT1, both RT2 and RT3 represent a transmission rate above which disease
prevalences steeply increases. The reinfection thresholds RT2 and RT3 expressed in
terms of R0 are respectively, given as
RRT20 =
1
σ2
(µ+ d+ τ + α)(µ+ ω)(fϕ(µ+ ρ) + ηϕ)
fϕ((µ+ d)(µ+ ω) + µ(τ + α))(µ+ η + ρ) , (I4)
RRT30 =
1
σ3
(µ+ d+ τ + α)(µ+ ω)(fϕ(µ+ ρ) + ηϕ)
fϕ((µ+ d)(µ+ ω) + µ(τ + α))(µ+ η + ρ) . (I5)
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Appendix J: Endemic equilibria of the submodel
(5.3)
This appendix relates to chapter 5.
Let H∗ = L∗2 + P ∗ +R∗ then,the equilibrium of the reinfection submodel (5.3) can be
easily obtained by setting the right-hand terms to zero and evaluating for H∗, L∗1 and
I∗ as
H∗ =(θ + µ+ ϕ)(µ+ d+ τ + α)
fϕσ1β
, (J1)
L∗1 =
(µ+ d+ τ + α)I∗
fϕ
, (J2)
I∗ =
fϕ
[
β − (θ+µ+ϕ)(µ+d+τ+α)
σ1fϕ
]
β[fϕ+ (µ+ d+ τ + α)] . (J3)
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Appendix K: Derivation of R0 for heroin epidemic
model
This appendix relates to chapter 6.
Generally the geometric sequence is given as {a, ar, ar2, ar3, · · · } and the sum of a
certain number of terms of the geometric sequence is given as Sn =
a(1− rn)
1− r where
Sn is the sum of n terms (nth partial sum), a is the first term and r is the common
ratio. Now considering the geometric sequence from expression (6.4).
Note that a = 1 and r = pα(µ+ δ1 + ξ + α)(p+ σ + δ2 + µ)
< 1.
Sn =
a(1− rn)
1− r =
a
1− r since r < 1. (K1)
Substituting a and r in (K1) yield
Sn =
(µ+ δ1 + ξ + α)(p+ σ + δ2 + µ)
(µ+ δ1 + ξ)(p+ σ + δ2 + µ) + α(σ + δ2 + µ)
. (K2)
Multiplying (K2) by 1
µ+ δ1 + ξ + α
gives the required expression
p+ σ + δ2 + µ
(µ+ δ1 + ξ)(p+ σ + δ2 + µ) + α(σ + δ2 + µ)
, (K3)
which if multiplied by the effective contact rate β and the average recruitment rate Λ
µ
yields the basic reproduction number R0.
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Appendix L: Proof of existence of backward bifurca-
tion for heroin epidemic model (6.1)
This appendix relates to chapter 6.
Proof. To prove existence of backward bifurcation in model equation (6.1) the Center
Manifold approach as outlined by Castillo-Chavez and Song in [58] is used. First for
clarity and understanding of the Center Manifold Theory the model equation (6.1)
variables are transformed as follows y1 = S, y2 = U1, y3 = U2, y4 = U3 and the total
population N = ∑4j=1 yj. Define Y = (y1, y2, y3, y4)T (T denote transpose), such that
the model equation (6.1) can be rewritten as dY
dt
= F (y) where F = (f1, f2, f3, f4).
Hence,
dy1
dt
= f1 = Λ− βy1y2 − µy1,
dy2
dt
= f2 = βy1y2 + py3 − (µ+ δ1 + ξ)y2 − αy21 + ωy2 ,
dy3
dt
= f3 =
αy2
1 + ωy2
− (p+ σ + δ2 + µ)y3, (L1)
dy4
dt
= f4 = σy3 + ξy2 − µy4.
Now let β = β∗ be the bifurcation parameter. Observe that at R0 = 1,
β = β∗ = α(µ+ δ2 + σ) + (µ+ δ1 + ξ)(p+ δ2 + µ+ σ)
y∗1(p+ δ2 + µ+ σ)
,
where y∗1 = Λµ = S0. With β = β
∗ the transformed model equation (L1) has a simple
eigenvalue with zero real part and all other eigenvalues are negative (that is has
a hyperbolic equilibrium point). Thus, Center Manifold Theory can be applied to
investigate the local dynamics of the transformed system (L1) near β = β∗. Now the
Jacobian matrix of the transformed system evaluated at heroin free equilibrium HFE
is obtained as
JHFE =

−µ −βS0 0 0
0 βS0 − (µ+ δ1 + ξ + α) p 0
0 α −(p+ σ + δ2 + µ) 0
0 ξ σ −µ
 .
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It is easy to obtain the right eigenvectors of this Jacobian matrix as V¯ = (v˜1, v˜2, v˜3, v˜4)T ,
where 
v˜1
v˜2
v˜3
v˜4

=

−βS0
µ
1
α
p+σ+δ2+µ
ξ(p+σ+δ2+µ)+σα
µ(p+σ+δ2+µ)

v˜2.
v˜2 > 0. Similarly, it is possible to obtain the left eigenvectors which are denoted by
W˜ = (w˜1, w˜2, w˜3, w˜4), so that
w˜1 = 0, w˜2 = w˜2 > 0, w˜3 =
pw˜2
p+ σ + δ2 + µ
, w˜4 = 0.
Now proceeding to obtain the bifurcation coefficients a and b as defined in Theorem
4.1 of [58].
Calculation of coefficient a
First the non-vanishing partial derivatives of the transformed model (L1) evaluated at
heroin free equilibrium are obtained as
∂2f1(0, 0)
∂y1∂y2
= −β∗, ∂
2f2(0, 0)
∂y1∂y2
= β∗, ∂
2f2(0, 0)
∂2y22
= 2ωα, ∂
2f3(0, 0)
∂2y22
= −2ωα,
so that
a =
4∑
k,i,j=1
w˜kv˜iv˜j
∂2fk(0, 0)
∂yi∂yj
= w˜2v˜1v˜2
∂2f2(0, 0)
∂y1∂y2
+ w˜2v˜2v˜2
∂2f2(0, 0)
∂2y22
+ w˜3v˜2v˜2
∂2f3(0, 0)
∂2y22
= 2w˜2v˜22
[
µωα(σ + δ2 + µ)− β∗(α(µ+ δ2 + σ) + (µ+ δ1 + ξ)(p+ δ2 + µ+ σ))
µ(p+ σ + δ2 + µ)
]
= 2w˜2v˜
2
2α(σ + δ2 + µ)
p+ σ + δ2 + µ
[ω − ωc],
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where ωc remains as previously defined in equation (6.11).
Calculation of coefficient b
The bifurcation coefficient b is obtained as
b =
4∑
k,i=1
w˜kv˜i
∂2fk(0, 0)
∂yi∂β∗
=w˜2v˜2Λ
µ
> 0.
According to Theorem 4.1 of [58] if both bifurcation coefficients a and b are positive
then model (6.1) will exhibit backward bifurcation. Observe that b is always positive
while a > 0 if and only if ω > ωc. Thus, if ω > ωc then model (6.1) will exhibit the
phenomenon of backward bifurcation.
Bibliography
[1] WHO. Global tuberculosis report. 2017.
[2] F. Brauer. Mathematical epidemiology is not an oxymoron. BMC Public Health,
9(1):1–11, 2009.
[3] R. M. Anderson and R. M. May. Population biology of infectious diseases. Report
of the dahlem workshop, berlin, 14-19 march 1982. In population biology of
infectious diseases. Report of the Dahlem workshop, Berlin, 14-19 March 1982.
Berlin, German Federal Republic; Springer-Verlag, 1982.
[4] D. M. Morens, G. K. Folkers, and A. S. Fauci. What is a pandemic?, 2009.
[5] F. Brauer and C. Castill-Chavez. Mathematical models in population biology
and epidemiology, volume 40. Springer, 2001.
[6] M. J. Selgelid. Ethics and infectious diseases. In World Congress of Bioethics,
VI, Octomber, 2002, Brasilia, Brazil. Blackwell Publishing, 2006.
[7] P. Piot, M. Bartos, P. D. Ghys, N. Walker, and B. Schwartländer. The global
impact of HIV/AIDS. Nature, 410(6831):968–973, 2001.
[8] L. Esteva, A. B. Gumel, and C. V. De LeóN. Qualitative study of transmission
dynamics of drug-resistant malaria. Mathematical and Computer Modelling, 50
(3):611–630, 2009.
[9] M. Ezzati, A. D. Lopez, A. Rodgers, H. S. Vander, and C. J. Murray. Selected
major risk factors and global and regional burden of disease. The Lancet, 360
(9343):1347–1360, 2002.
Bibliography 174
[10] S. Shrestha and J. O. Lloyd-Smith. Introduction to mathematical modeling of
infectious diseases. Modeling Paradigms and Analysis of Disease Transmission
Models, 75:1, 2010.
[11] P. D. En’Ko. On the course of epidemics of some infectious diseases. International
Journal of Epidemiology, 18(4):749–755, 1889.
[12] W. N. Hammer. Epidemic disease in england–the evidence of variability and the
persistence of type. The Lancet, II, pages 733–739, 1906.
[13] J. Brownlee. Statistical studies in immunity: the theory of an epidemic. Pro-
ceedings of the Royal Society of Edinburgh, 26:484–521, 1907.
[14] R. Ross. The prevention of malaria. John Murray; London, 1911.
[15] W. O. Kermack and A. G. McKendrick. A contribution to the mathematical
theory of epidemics. Proceedings of the Royal Society of London A: Mathematical,
Physical and Engineering Sciences, 115(772):700–721, 1927. ISSN 0950-1207. doi:
10.1098/rspa.1927.0118.
[16] W. O. Kermack and A. G. McKendrick. Contributions to the mathematical
theory of epidemics. ii. the problem of endemicity. Proceedings of the Royal
society of London. Series A, 138(834):55–83, 1932.
[17] W. O. Kermack and A. G. McKendrick. Contributions to the mathematical
theory of epidemics: part III. Proceedings of the Royal Society of London. Series
A, Containing Papers of a Mathematical and Physical Character, 141:94–112,
1933.
[18] H. W. Hethcote and H. R. Thieme. Stability of the endemic equilibrium in
epidemic models with subpopulations. Mathematical Biosciences, 75(2):205–227,
1985.
[19] M. J. Keeling and P. Rohan. Modeling infectious diseases in humans and animals.
Princeton, University Press, 2008.
[20] H. W. Hethcote. The mathematics of infectious diseases. SIAM Review, 42(4):
599–653, 2000.
Bibliography 175
[21] M. A. Safi. Mathematical Analysis of The Role of Quarantine and Isolation in
Epidemiology. PhD thesis, University of Manitoba, 2010.
[22] R. M. May and R. M. Anderson. Population biology of infectious diseases: part
II. Nature, 280(5722):455–461, 1979.
[23] R. M. Anderson, R. M. May, and B. Anderson. Infectious diseases of humans:
dynamics and control, volume 28. Wiley Online Library, 1992.
[24] O. Diekmann and J. A. P. Heesterbeek. Mathematical epidemiology of infectious
diseases: model building, analysis and interpretation, volume 5. John Wiley and
Sons, 2000.
[25] P. van den Driessche and J. Watmough. Reproduction numbers and sub-threshold
endemic equilibria for compartmental models of disease transmission. Mathemat-
ical Biosciences, 180(1):29–48, 2002.
[26] J. A. P. Heesterbeek. A brief history of R0 and a recipe for its calculation. Acta
Biotheoretica, 50(3):189–204, 2002.
[27] O. Diekmann, J. A. P. Heesterbeek, and J. A. J. Metz. On the definition and the
computation of the basic reproduction ratio R0 in models for infectious diseases
in heterogeneous populations. Journal of Mathematical Biology, 28(4):365–382,
1990.
[28] D. J. Gerberry. Pratical aspects of backward bifurcation in a mathematical model
for tuberculosis. Journal of Theoretical Biology, 388(1):15–16, 2016.
[29] W. Huang, K. L. Cooke, and C. Castillo-Chavez. Stability and bifurcation for
a multiple-group model for the dynamics of HIV/AIDS transmission. SIAM
Journal on Applied Mathematics, 52(3):835–854, 1992.
[30] K. P. Hadeler and C. Castillo-Chávez. A core group model for disease transmission.
Mathematical Biosciences, 128(1):41–55, 1995.
[31] K. P. Hadeler and P. van den Driessche. Backward bifurcation in epidemic control.
Mathematical Biosciences, 146(1):15–35, 1997.
Bibliography 176
[32] J. Dushoff. Incorporating immunological ideas in epidemiological models. Journal
of Theoretical Biology, 180(3):181–187, 1996.
[33] Z. Feng, J. Velasco-Hernandez, and B. Tapia-Santos. A mathematical model for
coupling within-host and between-host dynamics in an environmentally-driven
infectious disease. Mathematical Biosciences, 241(1):49–55, 2013.
[34] J. Dushoff, W. Huang, and C. Castillo-Chavez. Backwards bifurcations and
catastrophe in simple models of fatal diseases. Journal of Mathematical Biology,
36(3):227–248, 1998.
[35] B. Buonomo and C. Vargas-Deón. Stability and bifurcation analysis of a vector-
bias model of malaria transmission. Mathematical Biosciences, 242(1):59–67,
2013.
[36] D. Greenhalgh, O. Diekmann, and M. C. M. de Jong. Subcritical endemic steady
states in mathematical models for animal infections with incomplete immunity.
Mathematical Biosciences, 165(1):1–25, 2000.
[37] M. Safan, H. Heesterbeek, and K. Dietz. The minimum effort required to eradicate
infections in models with backward bifurcations. Journal of Mathematical Biology,
53(4):703–718, 2006.
[38] T. C. Reluga and J. Medlock. Resistance mechanisms matter in SIR models.
Mathematical Biosciences and Engineering, 4(3):1–9, 2007.
[39] T. C. Reluga, J. Medlock, and A. S. Perelson. Backward bifurcations and multiple
equilibria in epidemic models with structured immunity. Journal of Theoretical
Biology, 252(1):155–165, 2008.
[40] F. B. Agusto, S. Y. Del Valle, K. W. Blayneh, C. N. Ngonghala, M. J. Goncalves,
N. Li, R. Zhao, and H. Gong. The impact of bed-net use on malaria prevalence.
Journal of Theoretical Biology, 320(1):58–65, 2013.
[41] P. van den Driessche and J. Watmough. A simple sis epidemic model with a
backward bifurcation. Journal of Mathematical Biology, 40(6):525–540, 2000.
[42] C. M. Kribs-Zaleta and J. X. Velasco-Hernández. A simple vaccination model
with multiple endemic states. Mathematical Biosciences, 164(2):183–201, 2000.
Bibliography 177
[43] M. Martcheva and H. R. Thieme. Progression age enhancing backward bifurcation
in an epidemic model with super-infection. Journal of Mathematical Biology, 46
(5):385–424, 2003.
[44] F. Brauer. Backward bifurcations in simple vaccination models. Journal of
Mathematical Analysis and Applications, 298(2):418–431, 2004.
[45] F. Brauer and C. Castillo-Chavez. Mathematical Models in Population Biology
and Epidemiology, volume 40. Springer-Verlag, New York, 2011.
[46] H. Gómez-Acevedo and M. Y. Li. Backward bifurcation in a model for HTLV-I
infection of CD4+ T cells. Bulletin of Mathematical Biology, 67(1):101–114,
2005.
[47] B. Cooper, G. F. Medley, S. P. Stone, C. C. Kibbler, J. A. Cookson, B.
D.and Roberts, G. Duckworth, R. Lai, and S. Ebrahim. Methicillin-resistant
staphylococcus aureus in hospitals and the community: stealth dynamics and
control catastrophes. Proceedings of the National Academy of Sciences of the
United States of America, 101(27):10223–10228, 2004.
[48] W. Wang. Backward bifurcation of an epidemic model with treatment. Mathe-
matical Biosciences, 201(1):58–71, 2006.
[49] J. Cui, X. Mu, and H. Wan. Saturation recovery leads to multiple endemic
equilibria and backward bifurcation. Journal of Theoretical Biology, 254(2):
275–283, 2008.
[50] Z. Hu, W. Ma, and S. Ruan. Analysis of SIR epidemic models with nonlinear
incidence rate and treatment. Mathematical Biosciences, 238(1):12–20, 2012.
[51] O. Sharomi, C. N. Podder, A. B. Gumel, E. H. Elbasha, and J. Watmough.
Role of incidence function in vaccine-induced backward bifurcation in some HIV
models. Mathematical Biosciences, 210(2):436–463, 2007.
[52] C. P. Bhunu, W. Garira, and Z. Mukandavire. Modeling HIV/AIDS and tuber-
culosis coinfection. Bulletin of Mathematical Biology, 71(7):1745–1780, 2009.
Bibliography 178
[53] F. Nyabadza and Z. Mukandavire. Modelling HIV/AIDS in the presence of an
HIV testing and screening campaign. Journal of Theoretical Biology, 280(1):
167–179, 2011.
[54] N. Hussaini, M. Winter, and A. B. Gumel. Qualitative assessment of the role of
public health education program on HIV transmission dynamics. Mathematical
Medicine and Biology, pages 245–270, 2010.
[55] D. Greenhalgh and M. Griffiths. Backward bifurcation, equilibrium and sta-
bility phenomena in a three-stage extended brsv epidemic model. Journal of
Mathematical Biology, 59(1):1–36, 2009.
[56] Z. Feng, C. Castillo-Chavez, and A. F. Capurro. A model for tuberculosis with
exogenous reinfection. Theoretical Population Biology, 57(3):235–247, 2000.
[57] B. H. Singer, D. E. Kirschner, U. Ledzewicz, H. Schättler, M. Baurmann, W. Eben-
höh, U. Feudel, Z. Feng, R. Swihart, and Y. Yi. Influence of backward bifurcation
on interpretation of R0 in a model of epidemic tuberculosis with reinfection. Ann
Arbor, 1001:48109–0620, 2004.
[58] C. Castillo-Chavez and B. Song. Dynamical models of tuberculosis and their
applications. Math. Biosci. Eng, 1(2):361–404, 2004.
[59] H. M. Yang and S. M. Raimundo. Assessing the effects of multiple infections
and long latency in the dynamics of tuberculosis. Theor. Biol. Med. Model, 7:41,
2010.
[60] I. M. Wangari, S. Davis, and L. Stone. Backward bifurcation in epidemic models:
Problems arising with aggregated bifurcation parameters. Applied Mathematical
Modelling, 40(1):1669–1675, 2015.
[61] I. M. Wangari and L. Stone. Backward bifurcation and hysteresis in models of
recurrent tuberculosis. PLoS One, 13(3):1–29, 2018.
[62] I. M. Wangari, J. Trauer, and L. Stone. Modelling heterogeneity in host suscep-
tibility to tuberculosis and its effect on public health interventions. PloS one, 13
(11):1–26, 2018.
Bibliography 179
[63] S. M. Garba, A. B. Gumel, and M. R. Abu Bakar. Backward bifurcations in
dengue transmission dynamics. Mathematical Biosciences, 215(1):11–25, 2008.
[64] M. A. Miller, C. Viboud, M. Balinska, and L. Simonsen. The signature features of
influenza pandemics—implications for policy. New England Journal of Medicine,
360(25):2595–2598, 2009.
[65] K. W. Blayneh, A. B. Gumel, S. Lenhart, and T. Clayton. Backward bifurcation
and optimal control in transmission dynamics of west nile virus. Bulletin of
Mathematical Biology, 72(4):1006–1028, 2010.
[66] H. Wan and H. Zhu. The backward bifurcation in compartmental models for
west nile virus. Mathematical Biosciences, 227(1):20–28, 2010.
[67] G. F. Medley, N. A. Lindop, W. J. Edmunds, and D. J. Nokes. Hepatitis-b virus
endemicity: heterogeneity, catastrophic dynamics and control. Nature Medicine,
7(5):619–624, 2001.
[68] R. Qesmi, J. Wu, J. Wu, and J. M. Heffernan. Influence of backward bifurcation
in a model of hepatitis B and C viruses. Mathematical Biosciences, 224(2):
118–125, 2010.
[69] F. B. Agusto and A. B. Gumel. Qualitative dynamics of lowly-and highly-
pathogenic avian influenza strains. Mathematical Biosciences, 243(2):147–162,
2013.
[70] O. Sharomi, C. N. Podder, A. B. Gumel, S. M. Mahmud, and E. Rubinstein.
Modelling the transmission dynamics and control of the novel 2009 swine influenza
(h1n1) pandemic. Bulletin of Mathematical Biology, 73(3):515–548, 2011.
[71] J. Arino, A. Ducrot, and P. Zongo. A metapopulation model for malaria with
transmission-blocking partial immunity in hosts. Journal of Mathematical Biology,
64(3):423–448, 2012.
[72] J. M. Tchuenche, C. Chiyaka, D. Chan, A. Matthews, and G. Mayer. A math-
ematical model for antimalarial drug resistance. Mathematical Medicine and
Biology, 28(4):335–355, 2011.
Bibliography 180
[73] C. N. Ngonghala, G. A. Ngwa, and M. I. Teboh-Ewungkem. Periodic oscillations
and backward bifurcation in a model for the dynamics of malaria transmission.
Mathematical Biosciences, 240(1):45–62, 2012.
[74] L. Wu, B. Song, W. Du, and J. Lou. Mathematical modelling and control of
echinococcus in Qinghai province, China. Math. Biosci. Eng, 10:425–444, 2013.
[75] F. Nyabadza and S. D. Hove-Musekwa. From heroin epidemics to metham-
phetamine epidemics: Modelling substance abuse in a South African province.
Mathematical Biosciences, 225(2):132–140, 2010.
[76] I. M. Wangari and L. Stone. Analysis of a heroin epidemic model with saturated
treatment function. Journal of Applied Mathematics, 2017:1–21, 2017.
[77] C. Y. Chiang and L. W. Riley. Exogenous reinfection in tuberculosis. The Lancet
Infectious Disease, 5(10):629–636, 2005.
[78] S. J. McNabb, C. R. Braden, and T. R. Navin. DNA fingerprinting of mycobac-
terium tuberculosis: lessons learned and implications for the future. Emerging
Infectious Diseases, 8(11):1314–9, 2002.
[79] R. E. Chaisson and G. J. Churchyard. Recurrent tuberculosis: relapse, reinfection,
and HIV. Journal of Infectious Diseases, 201(5):653–655, 2010.
[80] H. Luzze, D. F. Johnson, K. Dickman, H. Mayanja-Kizza, A. Okwera, K. Eisenach,
M. D. Cave, C. C. Whalen, J. L. Johnson, W. H. Boom, and M. Joloba. Relapse
more common than reinfection in recurrent tuberculosis 1–2 years post treatment
in urban uganda. The International Journal of Tuberculosis and Lung Disease,
17(3):361–367, 2013.
[81] J. A. Guerra-Assunção, R. M. Houben, A. C. Crampin, T. Mzembe, K. Mallard,
F. Coll, P. Khan, L. Banda, A. Chiwaya, R. M. Pereira, David H., P. Julian,
G. C. Taane, and Judith R. G. Relapse or reinfection with tuberculosis: a whole
genome sequencing approach in a large population-based cohort with high HIV
prevalence and active follow-up. The Journal of Infectious Diseases, 211(7):
1154–63, 2015.
Bibliography 181
[82] K. Styblo. Epidemiology of tuberculosis. royal netherlands tuberculosis association
selected papers. The Hague, Royal Netherlands Tuberculosis Association, 1991.
[83] P. G. Smith and A. R. Moss. Epidemiology of tuberculosis, in tuberculosis:
pathogenesis. Prevention and Control (BR Bloom) Ed. Am. Soc. Microbial.,
Washington, DC, 1994.
[84] S. Verver, R. M. Warren, N. Beyers, M. Richardson, G. D. van der Spuy, M. W.
Borgdorff, D. A. Enarson, M. A. Behr, and P. D. van Helden. Rate of reinfection
tuberculosis after successful treatment is higher than rate of new tuberculosis.
American Journal of Respiratory and Critical Care Medicine, 171(12):1430–1435,
2005.
[85] T. K. Kar and P. K. Mondal. Global dynamics of a tuberculosis epidemic model
and the influence of backward bifurcation. Journal of Mathematical Modelling
and Algorithms, 11(4):433–459, 2012.
[86] M. A. Safi and A. B. Gumel. Mathematical analysis of a disease transmis-
sion model with quarantine, isolation and an imperfect vaccine. Computers &
Mathematics with Applications, 61(10):3044–3070, 2011.
[87] R. Anguelov, S. M. Garba, and S. Usaini. Backward bifurcation analysis of
epidemiological model with partial immunity. Computers & Mathematics with
Applications, 68(9):931–940, 2014.
[88] X. Zhang and X. Liu. Backward bifurcation of an epidemic model with saturated
treatment function. Journal of Mathematical Analysis and Applications, 348(1):
433–443, 2008.
[89] X. Zhang and X. Liu. Backward bifurcation and global dynamics of an sis
epidemic model with general incidence rate and treatment. Nonlinear Analysis:
Real World Applications, 10(2):565–575, 2009.
[90] X. Li, W. Li, and M. Ghosh. Stability and bifurcation of an SIR epidemic model
with nonlinear incidence and treatment. Applied Mathematics and Computation,
210(1):141–150, 2009.
Bibliography 182
[91] M. Gabriela M. Gomes, R. Águas, J. S. Lopes, M. C. Nunes, C. Rebelo, P. Ro-
drigues, and C. J. Struchiner. How host heterogeneity governs tuberculosis
reinfection? Proceedings. Biological sciences, 2012.
[92] R. Panjabi, G. W. Comstock, and J. E. Golub. Recurrent tuberculosis and its
risk factors: adequately treated patients are still at high risk [review article]. The
International Journal of Tuberculosis and Lung Disease, 11(8):828–837, 2007.
[93] K. Dietz. The estimation of the basic reproduction number for infectious diseases.
Statistical Methods in Medical Research, 2(1):23–41, 1993.
[94] S. M. Blower, A. R. Mclean, T. C. Porco, P. M. Small, P. C. Hopewell, M. A.
Sanchez, and A. R. Moss. The intrinsic transmission dynamics of tuberculosis
epidemics. Nature Medicine, 1(8):815–821, 1995.
[95] S. Basu, E. Orenstein, and A. P. Galvani. The theoretical influence of immunity
between strain groups on the progression of drug-resistant tuberculosis epidemics.
Journal of Infectious Diseases, 198(10):1502–1513, 2008.
[96] P. Rodrigues, M. G. M. Gomes, and C. Rebelo. Drug resistance in tuberculosis—a
reinfection model. Theoretical Population Biology, 71(2):196–212, 2007.
[97] M. G. M. Gomes, P. Rondrigues, F. M. Hilker, N. B. Mantilla-Beniers,
M. Muehlen, A. C. Paulo, and G. F. Medley. Implications of partial immu-
nity on the prospects for tuberculosis control by post-exposure interventions.
Journal of Theoretical Biology, 248(4):608–617, 2007.
[98] M. Y. Li and J. S. Muldowney. A geometric approach to global-stability problems.
SIAM Journal on Mathematical Analysis, 27(4):1070–1083, 1996.
[99] L. Perko. Differential equations and dynamical systems, volume 7. Springer
Science & Business Media, 2013.
[100] S. Wiggins. Introduction to applied nonlinear dynamical systems and chaos,
volume 2. Springer Science & Business Media, 2003.
[101] R. J. Plemmons. M-matrix characterizations. I—nonsingular M-matrices. Linear
Algebra and its Applications, 18(2):175–188, 1977.
Bibliography 183
[102] C. Gros. Bifurcations and chaos in dynamical systems. In Complex and Adaptive
Dynamical Systems, pages 43–77. Springer, 2015.
[103] J. Guckenheimer and P. J. Holmes. Nonlinear oscillations, dynamical systems,
and bifurcations of vector fields, volume 42. Springer Science & Business Media,
2013.
[104] D. H. Knipl and G. Röst. Backward bifurcation in sivs model with immigration
of non-infectives. Biomath, 2(2):Article–ID, 2014.
[105] H. R. Thieme. Mathematics in population biology. Princeton University Press,
2003.
[106] H. L. Smith. The theory of the chemostat: dynamics of microbial competition,
volume 13. Cambridge university press, 1995.
[107] C. P. Bhunu. Mathematical analysis of a three-strain tuberculosis transmission
model. Applied Mathematical Modelling, 35(9):4647–4660, 2011.
[108] J. P. Aparicio, A. F. Capurro, and C. Castillo-Chavez. Long-term dynamics and
re-emergence of tuberculosis. Institute for Mathematics and Its Applications,
125:351, 2002.
[109] J. P. Aparicio and C. Castillo-Chavez. Mathematical modelling of tuberculosis
epidemics. Math Biosci Eng, 6(2):209–237, 2009.
[110] G. Shen, Z. Xue, B. Sun, X. Gui, M. Shen, J. Mei, and Q. Gao. Recurrent
tuberculosis and exogenous reinfection, Shanghai, China-volume 12, number
11—november 2006-emerging infectious disease journal-CDC. Emerging Infectious
Diseases, 12:1176–1178, 2006.
[111] M. Lipsitch and M. B. Murray. Multiple equilibria: tuberculosis transmission
require unrealistic assumptions. Theoretical Population Biology, 63(2):169–170,
2003.
[112] WHO. Global Tuberculosis Report 2014. World Health Organization, 2014.
[113] T. R. Frieden, T. R. Sterling, S. S. Munsiff, C. J. Watt, and C. Dye. Tuberculosis.
The Lancet, 362(9387):887, 2003.
Bibliography 184
[114] C. Dye, S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione. Global burden
of tuberculosis: Estimated incidence, prevalence, and mortality by country. Jama,
282(7):677–686, 1999.
[115] R. M. G. J. Houben and P. J. Dodd. The global burden of latent tuberculosis
infection: a re-estimation using mathematical modelling. PLoS Med, 13(10):
e1002152, 2016.
[116] J. Dhillon and D. A. Mitchison. Effect of vaccines in a murine model of dormant
tuberculosis. Tubercle and Lung Disease, 75(1):61–64, 1994.
[117] T. C. Porco and S. M. Blower. Quantifying the intrinsic transmission dynamics
of tuberculosis. Journal of Theoretical Population Biology, 54(2):117–132, 1998.
[118] C. A. Karus. Tuberculosis: an overview of pathogenesis and prevention. Nurse
Practitioner, 8(2):21–28, 1983.
[119] M. L. Lambert, E. Hasker, A. V. Deun, D. Roberfroid, M. Boelaert, and Van der
S. P. Recurrence in tuberculosis: relapse or reinfection? The Lancet Infectious
Diseases, 3(5):282–287, 2003.
[120] M. Zignol, A. Wright, E. Jaramillo, P. Nunn, and M. C. Raviglione. Patients with
previously treated tuberculosis no longer neglected. Clinical Infectious Diseases,
44(1):61–64, 2007.
[121] M. Gomes, M. Gabriela, A. O. Franco, M. C. Gomes, and G. F. Medley. The
reinfection threshold promotes variability in tuberculosis epidemiology and vaccine
efficacy. Proceedings of the Royal Society of London. Series B: Biological Sciences,
271(1539):617–623, 2004.
[122] M. Herrera, P. Bosch, M. Nájera, and X. Aguilera. Modeling the spread of tuber-
culosis in semiclosed communities. Computational and Mathematical Methods
in Medicine, 2013, 2013.
[123] R. E. Slavin, T. J. Walsh, and A. D. Pollack. Late generalized tuberculosis: a
clinical pathologic analysis and comparison of 100 cases in the preantibiotic and
antibiotic eras. Medicine, 59(5):352–366, 1980.
Bibliography 185
[124] E. H. Elbasha and A. B. Gumel. Theoretical assessment of public health impact
of imperfect prophylactic HIV-1 vaccines with therapeutic benefits. Bulletin of
Mathematical Biology, 68(3):577–614, 2006.
[125] R. De Boer and M. Y. Li. Density dependence in disease incidence and its
impacts on transmission dynamics. Canadian Applied Mathematics Quarternary,
19(3), 2011.
[126] X. Wang, Z. Feng, J. Aparicio, and C. Castillo-Chavez. On the dynamics of rein-
fections: The case of tuberculosis. In International Symposium on Mathematical
and Compuation Biology (ed. Rubem P. Mondaini), BIOMAT, pages 304–330,
2009.
[127] J. A. P. Heesterbeek. Mathematical epidemiology of infectious diseases: model
building, analysis and interpretation, volume 5. John Wiley and Sons, 2008.
[128] Z. W. Jia, G. Y. Tang, Z. Jin, C. Dye, S. J. Vlas, X. W. Li, D. Feng, L. Fang, W. J.
Zhao, and W. C. Cao. Modeling the impact of immigration on the epidemiology
of tuberculosis. Theoretical Population Biology, 73(3):437–448, 2008.
[129] D. H. Knipl and G. Röst. Backward bifurcation in sivs model with immigration
of non-infectives. Biomath, 2(2):1–14, 2014.
[130] S. M. Blower, P. M. Small, and P. C. Hopewell. Control strategies for tuberculosis
epidemics: new models for old problems. Science, 273(5274):1–4, 1996.
[131] Z. Feng, W. Huang, and C. Castillo-Chavez. On the role of variable latent periods
in mathematical models for tuberculosis. Journal of Dynamics and Differential
Equations, 13(2):425–452, 2001.
[132] B. M. Murphy, B. H. Singer, and D. Kirschner. On treatmnet of tuberculosis
in heterogeneous populations. Journal of Theoretical Biology, 223(4):391–404,
2003.
[133] E. H. Elbasha and A. B. Gumel. Theoretical assessment of public health impact
of imperfect prophylactic HIV-1 vaccines with therapeutic benefits. Bulletin of
Mathematical Biology, 68(3):577–614, 2006.
Bibliography 186
[134] J. R. Andrews, F. Noubary, R. P. Walensky, R. Cerda, E. Losina, and C. R.
Horsburgh. Risk of progression to active tuberculosis following reinfection with
mycobacterium tuberculosis. Clinical Infectious Diseases, 54(6):784–791, 2012.
[135] S. M. Raimundo and H. M. Yang. Transmission of tuberculosis with exogenous
re-infection and endogenous reactivation. Mathematical Population Studies, 13
(4):181–203, 2006.
[136] O. Diekmann, J. A. P. Heesterbeek, and M. G. Roberts. The construction of
next-generation matrices for compartmental epidemic models. Journal of the
Royal Society Interface, pages 873–883, 2009.
[137] J. R. Pinkert. An exact method for finding the roots of a complex polynomial.
ACM Transactions on Mathematical Software (TOMS), 2(4):351–363, 1976.
[138] A. van Rie, R. Warren, M. Richardson, T. C. Victor, R. P. Gie, D. A. Enarson,
N. Beyers, and P. D. van Helden. Exogenous reinfection as a cause of recurrent
tuberculosis after curative treatment. New England Journal of Medicine, 341
(16):1174–1179, 1999.
[139] E. Nardell, B. McInnis, B. Thomas, and S. Weidhaas. Exogenous reinfection
with tuberculosis in a shelter for the homeless. New England Journal of Medicine,
315(25):1570–1575, 1986.
[140] E. Vynnycky and P. E. M. Fine. The natural history of tuberculosis: the implica-
tions of age-dependent risks of disease and the role of reinfection. Epidemiology
and Infection, 119(2):183–201, 1997.
[141] J. A. Caminero, M. J. Pena, M. I. Campos-Herrero, J. C. Rodriguez, O. Afonso,
C. Martin, J. M. Pavon, M. J. Torres, M. Burgos, and P. Cabrera. Exogenous
reinfection with tuberculosis on a european island with a moderate incidence of
disease. American Journal of Respiratory and Critical Care Medicine, 163(3):
717–720, 2001.
[142] M. B. Murray and T. H. Cohen. Incident tuberculosis among recent us immigrants
and exogenous reinfection. 11(5):725–728, 2005.
Bibliography 187
[143] R. M. Warren, T. C. Victor, E. M. Streicher, M. Richardson, N. Beyers, N. C. G.
van Pittius, and P. D. van Helden. Patients with active tuberculosis often have
different strains in the same sputum specimen. American Journal of Respiratory
and Critical Care Medicine, 169(5):610–614, 2004.
[144] A. B. Gumel. Causes of backward bifurcations in some epidemiological models.
Journal of Mathematical Analysis and Applications, 395(1):355–365, 2012.
[145] W. W. Stead. Pathogenesis of a first episode of chronic pulmonary tuberculosis in
man: recrudescence of residuals of the primary infection or exogenous reinfection?
American Review of Respiratory Disease, 95(5):729–745, 1967.
[146] S. Basu and A. P. Galvani. The transmission and control of XDR TB in South
Africa: an operations research and mathematical modelling approach. Epidemiol.
Infect, 136(12):1585–1598, 2008.
[147] I. Sutherland, E. Švandová, and S. Radhakrishna. The development of clinical
tuberculosis following infection with tubercle bacilli: 1. a theoretical model for
the development of clinical tuberculosis following infection, linking from data on
the risk of tuberculous infection and the incidence of clinical tuberculosis in the
netherlands. Tubercle, 63(4):255–268, 1982.
[148] M. Clark and E. Vynnycky. The use of maximum likelihood methods to estimate
the risk of tuberculosis infection and disease in a canadian first nations populations.
International Journal of Epidemiology, 33(3):477–484, 2004.
[149] E. Brooks-Pollock, M. C. Becerra, E. Goldstein, T. Cohen, and M. B. Murray.
Epidemiologic inference from the distribution of tuberculosis cases in households
in lima, peru. Journal of Infectious Diseases, 203(11):1582–1589, 2011.
[150] C. Dye and B. G. Williams. Eliminating human tuberculosis in the twenty-first
century. Journal of the Royal Society Interface, 5(23):653–662, 2008.
[151] D. W. Dowdy, C. Dye, and T. Cohen. Data needs for evidence-based decisions: a
tuberculosis modeler’s [review article]. The International Journal of Tuberculosis
and Lung Disease, 17(7):866–877, 2013.
Bibliography 188
[152] C. Castillo-Chavez and Z. Feng. To treat or not to treat: the case of tuberculosis.
Journal of Mathematical Biology, 35(6):629–656, 1997.
[153] P. Wu, E. H. Y. Lau, B. J. Cowling, C. Leung, C. Tam, and G. M. Leung. The
transmission dynamics of tuberculosis in a recently developed Chinese city. PLos
One, 5(5):1–9, 2010.
[154] R. Sahadevan, S. Narayanan, C. N. Paramasivan, R. Prabhakar, and P. R.
Narayanan. Restriction fragment length polymorphism typing of clinical isolates
of mycobacterium tuberculosis from patients with pulmonary tuberculosis in
madras, india, by use of direct-repeat probe. Journal of Clinical Microbiology,
33(11):3037–3039, 1995.
[155] S. Das, C. N. Paramasivan, D. B Lowrie, R. Prabhakar, and P. R. Narayanan.
Is6110 restriction fragment length polymorphism typing of clinical isolates of
mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras,
South India. Tubercle and Lung Disease, 76(6):550–554, 1995.
[156] P. Sonnenberg. HIV-1 recurrence, relapse, and reinfection of tuberculosis after
cure: a cohort study in South African mineworkers. Lancet, 359(9323):2120–2120,
2002.
[157] M. E. Balcells, S. L. Thomas, P. Godfrey-Faussett, and A. D. Grant. Isoniazid
preventive therapy and risk for resistant tuberculosis. Emerging Infectious
Diseases, 12(5):744–751, 2006.
[158] G. J. Churchyard, K. L. Fielding, J. J. Lewis, L. Coetzee, E. L. Corbett,
P. Godfrey-Faussett, R. J. Hayes, R. E. Chaisson, and A. D. Grant. A trial
of mass isoniazid preventative therapy for tuberculosis control. New England
Journal of Medicine, 370(4):301–310, 2014.
[159] S. T. R. Pinho, P. Rodrigues, R. F. S. Andrade, H. Serra, J. S. Lopes, and
M. G. M. Gomes. Impact of tuberculosis treatment length and adherence under
different transmission intensities. Theoretical Population Biology, 104:68–77,
2015.
Bibliography 189
[160] T. Cohen, C. Colijn, B. Finklea, and M. Murray. Exogenous re-infection and
the dynamics of tuberculosis epidemics: Local effects in a network model of
transmission. Journal of The Royal Society Interface, 4(14):523–531, 2007.
[161] H. Waaler and S. Anderson. The use of mathematical models in the study of
the epidemiology of tuberculosis. American Journal of Public Health, 52(1):
1002–1013, 1962.
[162] R. Diel, R. Loddenkemper, S. Niemann, K. Meywald-Walter, and A. Nienhaus.
Negative and positive predictive value of a whole-blood interfelon-gamma release
assay for developing active tuberculosis: an update. Am J.Respir, 183(1):88–95,
2011.
[163] P. Rondrigues, M. G. Gomes, and C. Rebelo. Drug resistance in tuberculosis- a
reinfection model. Theoretical Population Biology, 71(2):196–212, 2007.
[164] R. Ragonnet, J. M. Trauer, N. Scott, M. T. Meehan, J. T. Denholm, and E. S.
McBryde. Optimally capturing latency dynamics in models of tuberculosis
transmission. Epidemics, 21(1):39–47, 2017.
[165] J. M. Trauer, J. T. Denholm, and E. S. McBryde. Construction of a mathematical
model for tuberculosis transmission in highly endemic regions of the asia-pacific.
Journal of Theoretical Biology, 358:74–84, 2014.
[166] R. Ragonnet, J. M. Trauer, E. S. McBryde, R. M. G. J. Houben, J. T. Denholm,
A. Handel, and T. Summer. Is IPT more effective in high-burden settings?
modelling the effect of tuberculosis incidence on ipt impact. The International
Journal of Tuberculosis and Lung Disease, 21(1):60–66, 2017.
[167] E. Ziv, C. L. Daley, and S. M. Blower. Early therapy for latent tuberculosis
infection. American Journal of Epidemiology, 153(4):381–385, 2001.
[168] J. P. Aparicio, A. F. Capurro, and C. Castillo-Chavez. Transmission and dynamics
of tuberculosis on generealized households. Theoretical Population Biology, 206
(3):327–341, 2000.
[169] L. J. Abu-Raddad, L. Sabetelli, J. T. Achterberg, J. D. Sugimoto, I. M. Longini,
C. Dye, and M. E. Halloran. Epidemiolgical benefits of more-effective tuberculosis
Bibliography 190
vaccines, drugs, and diagnostics. Proceedings of the National Academy of Sciences,
106(33):13980–13985, 2009.
[170] C. Dye and M. A. Espinal. Will tuberculosis become resistant to all antibiotics?
Proceedings of the Royal Society of London B: Biological Sciences, 268(1462):
45–52, 2001.
[171] M. G. M. Gomes, L. J. White, and G. F. Medley. The reinfection threshold.
Journal of Theoretical Biology, 236(1):111–113, 2005.
[172] M. G. M. Gomes, E. Gjini, J. S. Lopes, C. Souto-Maior, and C. Rebelo. A theoret-
ical framework to identify invariant thresholds in infectious disease epidemiology.
Journal of Theoretical Biology, 395:97–102, 2016.
[173] E. W. Tiemersma, M. J. van der Werf, W. Martien, B. G. Williams, and N. J. D.
Nagelkerke. Natural history of tuberculosis: duration and fatality of untreated
pulmonary tuberculosis in HIV-negative patients: a systematc review. PLos One,
6(4):1–3, 2011.
[174] P. M. Small and P. I. Fujiwara. Management of tuberculosis in the united states.
New England Journal of Medicine, 345(3):189–200, 2001.
[175] B. R. Bloom and P. E. M. Fine. The BCG experience: implications for future vac-
cines against tuberculosis. Tuberculosis: Pathogenesis, Protection, and Control.
ASM Press, Washington, DC, pages 531–557, 1994.
[176] J. C. R. Horsburgh, M. O’Donnell, S. Chamblee, J. L. Moreland, J. Johnson,
B. J. Marsh, M. Narita, L. S. Johnson, and C. F. von Reyn. Revisiting rates of
reactivation tuberculosis: a population-based approach. American Journal of
Respiratory and Critical Care Medicine, 182(3):420–425, 2010.
[177] J. S. Lopes, P. Rodrigues, S. T. Pinho, R. S. Andrade, R. Duarte, and M. G. M.
Gomes. Interpreting measures of tuberculosis transmission: a case study on the
portuguese population. BMC Infectious Diseases, 14(1):1, 2014.
[178] P. C. C. G. Rodrigues and S. Patrício. Modelling tuberculosis: A compromise
between biological realism and mathematical tractability. PhD thesis, 2009.
published thesis.
Bibliography 191
[179] C. Munsey. Heroin® and aspirin® the connection! & the collection!-Part I. 2005.
[180] National Institute on Drug Abuse and United States of America. Research Report
Series: Heroine. 2014.
[181] X. Li, Y. Zhou, and B. Stanton. Illicit drug initiation among institutionalized
drug users in China. Addiction, 97(5):575–582, 2002.
[182] R. J. Garten, S. Lai, J. Zhang, W. Liu, J. Chen, D. Vlahov, and X. F. Yu. Rapid
transmission of hepatitis C virus among young injecting heroine users in Southern
China. International Journal of Epidemiology, 33(1):182–188, 2004.
[183] R. M. Anderson and R. M. May. Population biology of infectious diseases: part
I. Nature, 280(5721):361–367, 1979.
[184] C. White, E. Comiskey. Heroine epidemics, treatment and ode modelling. Math-
ematical Biosciences, 208(1):312–324, 2007.
[185] G. Mulone and B. Straughan. A note on heroine epidemics. Mathematical
Biosciences, 218(2):138–141, 2009.
[186] X. Wang, J. Yang, and X. Li. Dynamics of a heroine epidemic model with vary
population. Applied Mathematics, 2(6):732, 2011.
[187] G. P. Samanta. Dynamic behaviour for a nonautonomous heroine epidemic
model with time delay. Journal of Applied Mathematics and Computing, 35(1-2):
161–178, 2011.
[188] M. Y. Li, J. R. Graef, L. Wang, and J. Karsai. Global dynamics of a SEIR model
with varying total population size. Mathematical Biosciences, 160(2):191–213,
1999.
[189] M. Y. Li and J. S. Muldowney. Global stability for the SEIR model in epidemiology.
Mathematical Biosciences, 125(2):155–164, 1995.
[190] A. M. Lyapunov. The general problem of the stability of motion. International
Journal of Control, 55(3):531–534, 1992.
[191] Y. Li and J. S. Muldowney. On bendixson’s criterion. Journal of Differential
Equations, 106(1):27–39, 1993.
Bibliography 192
[192] M. Y. Li and J. S. Muldowney. On R. A. Smith’s autonomous convergence
theorem. Journal of Mathematics, 25(1):72, 1995.
[193] J. Arino, C. C. McCluskey, and P. van den Driessche. Global results for an
epidemic model with vaccination that exhibits backward bifurcations. SIAM
Journal on Applied Mathematics, 64(1):260–276, 2003.
[194] H. L. Smith, L. Wang, and M. Y. Li. Global dynamics of an SEIR epidemic
model with vertical transmission. SIAM Journal on Applied Mathematics, 62(1):
58–69, 2001.
[195] J. Tumwiine, J. Y. T. Mugisha, and L. S. Luboobi. A host-vector model for malaria
with infective immigrants. Journal of Mathematical Analysis and Applications,
361(1):139–149, 2010.
[196] L. Wang and M. Y. Li. Mathematical analysis of the global dynamics of a model
for HIV infection of CD4+ T cells. Mathematical Biosciences, 200(1):44–57,
2006.
[197] E. Beretta, F. Solimano, and Y. Takeuchi. Negative criteria for the existence of
periodic solutions in a class of delay-differential equations. Nonlinear Analysis:
Theory, Methods & Applications, 50(7):941–966, 2002.
[198] M. M. Ballyk, C. C. McCluskey, and G. S. K. Wolkowicz. Global analysis of
competition for perfectly substitutable resources with linear response. Journal of
Mathematical Biology, 51(4):458–490, 2005.
[199] A. B. Gumel, C. C. McCluskey, and J. Watmough. An SVEIR model for assessing
potential impact of an imperfect ant-SARS vaccine. Mathematical Biosciences
and Engineering, 3(3):485–512, 2006.
[200] N. T Bailey. The mathematical theory of infectious diseases and its applications.
Charles Griffin & Company Ltd, 5a Crendon Street, High Wycombe, Bucks HP13
6LE, 1975.
[201] Z. Ma, Y. Zhou, W. Wang, and Z. JIn. Mathematical models and dynamics of
infectious diseases. China sci. press, Beijing, 2004.
Bibliography 193
[202] Research outcome study in ireland (ROSIE): Evaluating drug treatment effec-
tiveness, baseline findings, March 2005.
[203] B. L. Fang, Xue-Zhi, M. Martcheva, and L. Cai. Global asymptotic properties of a
heroine epidemic model with treat-age. Applied Mathematics and Computational,
263:315–331, 2015.
[204] W. Wang and S. Ruan. Bifurcations in an epidemic model with constant removal
rate of the infectives. Journal of Mathematical Analysis and Applications, 291
(2):775–793, 2004.
[205] W. Wang. Backward bifurcations of an epidemic model with treatment. Mathe-
matical Biosciences, 201(1):58–71, 2006.
[206] C. Castillo-Chávez, S. Blower, P. Driessche, D. Kirschner, and A. Yakubu.
Mathematical approaches for emerging and reemerging infectious diseases: models,
methods, and theory, volume 126. Springer, 2002.
[207] S. A. Levin. Descartes’ rule of signs-how hard can it be? Preprint, 2002.
[208] B. Fang, X. Li, M. Martcheva, and L. Cai. Global stability for a heroine model
with age-dependent susceptibility. Journal of System Science Complex, 1:1–15,
2013.
[209] C. C. McCluskey. Lyapunov functions for tuberculosis models with fast and slow
progression. Mathematical Biosciences and Engineering: MBE, 3(4):603, 2006.
[210] N. Bame, S. Bowong, J. Mbang, G. Sallat, and J. Tewa. Global stability analysis
for SEIS models with n latent classes. Mathematical Biosciences and Engineering,
5(1):20, 2008.
[211] A. Korobeinkov and G. C. Wake. Lyapunov functions and global stability for
SIR, SIRS, and SIS epidemiological models. Applied Mathematics Letters, 15(8):
955–960, 2002.
[212] M. Y. Li and J. S. Muldowney. A geometric approach to global-stability problems.
Journal of Differential Equations, 168(4):295–320, 2000.
Bibliography 194
[213] E. Beretta, R. Kon, and Y. Takeuchi. Non-existence of periodic solutions in
delayed Lotka-Volterra systems. Nonlinear Anal Real World Application, 3:
107–129, 2002.
[214] J. S. Muldowney. Compound matrices and ordinary differential equations. Rocky
Mountain Journal of Mathematics, 20(4), 1990.
[215] W. A. Coppel. Stability and asymptotic behaviour of differential equations.
Heath, 1965.
[216] R. H. Martin. Logarithmic norms and projections applied to linear differential
systems. Journal of Mathematical Analysis and Applications, 45(2):432–454,
1974.
[217] H. I. Freedman, S. Ruan, and M. Tang. Uniform persistence and flows near a
closed positively invariant set. Journal of Dynamics and Differential Equations,
6(4):583–600, 1994.
[218] V. Hutson and K. Schmitt. Permanence and the dynamics of biological systems.
Mathematical Biosciences, 111(1):1–71, 1992.
[219] S. Marino, I. B. Hogue, C. J. Ray, and D. E. Kirschner. A methodology for
performing global uncertainty and sensitivity analysis in systems biology. Journal
of Theoretical Biology, 254(1):178–196, 2008.
[220] F. Chirove, Sutimin, E. Soewono, and N. Nuraini. Analysis of combined langer-
hans and CD4+ˆ T cells HIV infection. SIAM Journal on Applied Mathematics,
74(4):1174–1193, 2014.
[221] S. M. Blower and H. Dowlatabadi. Sensitivity and uncertainty analysis of complex
models of disease transmission: an HIV model, as an example. International
Statistical Review/Revue Internationale de Statistique, 62(2):229–243, 1994.
[222] L. Simpson and A. B. Gumel. Mathematical assessment of the role of pre-
exposure prophylaxis on HIV transmission dynamics. Applied Mathematics and
Computation, 293(1):168–193, 2017.
[223] M. A. Safi and A. B. Gumel. Dynamics analysis of a quarantine model in two
patches. Mathematical Methods in the Applied Sciences, 38(2):349–364, 2014.
Bibliography 195
[224] C. Castillo-Chavez, Z. Feng, and W. Huang. On the computation of R0 and its
role on global stability in mathematical approaches for emerging and re-emerging
infectious diseases, part I, IMA, 125.
